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Abstract 
MRI of exogenous imaging agents offers a safely repeatable modality to assess regional 
pulmonary ventilation. A small number of studies have validated the safety and potential 
utility of 19F imaging of inhaled thermally polarised perfluoropropane. However, the relative 
scarcity of signal in restrictive breath hold length acquisition times inhibits translation of this 
technique to clinical application. This work presents methods used to maximise the attainable 
image quality of inhaled perfluoropropane. Novel quantitative measures of ventilation and 
perfusion have been investigated and discussed. 
A preliminary healthy volunteer study was conducted to verify the efficacy of the imaging 
technique and to assess perfluoropropane wash-in and wash-out rates. Quantitative 
assessment of the suitability of four RF coil designs was performed, comparing power 
efficiency with loading and signal homogeneity within the sensitive volume of each coil. The 
3D spoiled gradient echo sequence was simulated, accounting for the power performance of 
the chosen birdcage coil design, for calculation of acquisition parameter values required to 
achieve the highest SNR in a fixed acquisition period for 19F-MRI of inhaled 
perfluoropropane. Studies on resolution phantoms and healthy volunteers assessed the 
performance of the optimised imaging protocol, in combination with a compressed sensing 
technique that permitted up to three-fold acceleration. 
Two novel lung-representative phantoms were fabricated and used to investigate the 
behaviour of the MR properties of inhaled perfluoropropane with changing structural and 
magnetic environments. Finally, a method for lengthening the T2* of inhaled 
perfluoropropane by susceptibility matching the alveolar tissue to the inhaled gas by 
intravenous injection of a highly paramagnetic contrast agent is presented. Initial development 
work was conducted in phantoms and rodents before translation to healthy volunteers. This 
technique offers the potential to concurrently acquire images reflecting both pulmonary 
ventilation and perfusion. 
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       Chapter 1: 
MRI of Pulmonary Ventilation: Theoretical Background and Literature 
Review 
1.1 Respiratory physiology and pathophysiology 
Clinical understanding of obstructive lung disease has been refined in parallel with our 
knowledge of lung function. Despite this, it has a steadily increasing incidence of morbidity 
and mortality globally, with early identification a principle step to improved treatment 
outcome (Vestbo et al., 2013; Vogelmeier et al., 2017). This section presents a very brief 
overview of pulmonary physiology and the impact of obstructive lung disease upon 
ventilation to guide direction in the development of a 19F-MRI based modality for imaging 
pulmonary ventilation. The following background, unless referenced otherwise, is based upon 
the reference texts Respiratory Physiology (West, 2012) and Pulmonary Pathophysiology 
(West, 2008).  
1.1.1 Pulmonary anatomy 
There are a total of typically 23 bifurcations along the respiratory tract beginning at the 
trachea, with a gradual narrowing and shortening at each generation. The terminal bronchioles 
at generation 16 mark the end of the conducting region of the lungs. These divide into the 
respiratory bronchioles, and finally pulmonary acini, made up of alveolar ducts, and alveolar 
sacs, which together form the respiratory zone. The dichotomous nature of these bifurcations 
over many generations produce good ventilation homogeneity over the full lung volume in 
healthy individuals, with the structure generating 480 million alveoli in an average adult 
human lung (Ochs et al., 2004). This creates a large lung surface area to gas volume ratio, 
resulting in an efficient interchange boundary for gases. 
1.1.2 Respiratory mechanics 
Ventilation is the exchange of air between the lung and the atmosphere, and is the process by 
which oxygenated air is transported into the lungs for gas exchange (perfusion) between the 
alveoli and capillaries. In this process, carbon dioxide along with deoxygenated air is 
removed from the lungs. During relaxed inhalation, the diaphragm contracts, and the external 
intercostal muscles widen and lift the ribcage. These actions increase the volume of the 
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thoracic cavity. The process of ventilation then occurs by the decreased pressure formed in 
the thoracic cavity causing the lungs to expand. Exhalation at rest is a passive process, 
whereby the diaphragm and external intercostal muscles relax. This increases the relative 
pressure of the thoracic cavity to larger than that of the external environment, forcing the 
lungs to compress, and air to be exhaled. 
Forced breathing utilises additional accessory muscles in the torso. By engaging more 
muscles, deeper inhalations can be achieved. Active exhalations can also be performed by 
forcing the thoracic cavity to decrease further in volume than what can be achieved passively. 
1.1.3 Pulmonary volumes  
There are several key terms used to quantify pulmonary volumes at specific points in both 
tidal breathing and forced breathing respiratory cycles (Lutfi, 2017). These are summarised in 
Figure 1-1.  
The tidal volume (TV) is the volume of air displaced during relaxed ventilation. In a healthy 
adult, this volume is typically approximately 500 ml. The vital capacity (VC) is the volume of 
air displaced during forced breathing between maximum inhalation and maximum exhalation. 
In healthy adults, this volume is typically around 3 – 5 L, varying with gender (Thurlbeck, 
Figure 1-1: Typical lung volumes and capacities for a healthy subject 
depicted on a spirometric trace. Only a small fraction of the total lung 
volume is exchanged in tidal breathing. Deep respiratory manoeuvres 
that engage the accessory muscles of the respiratory system are 
required to exchange a volume of air close the vital capacity. 
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1982) and height (Bhatti et al., 2014). After maximal exhalation, the volume of gas remaining 
in the lungs is known as the residual volume (RV), approximately 1 L in healthy adults. The 
total volume of air in the lungs is known as the total lung capacity (TLC), and ranges from 4 – 
6 L in healthy adults.  
Spirometric tests are regularly used to assess pulmonary volumes in the clinical environment; 
in this case lung function is often described by FEV1, defined as the volume exhaled in the 
first one second of forced expiration after maximal inhalation, and FVC the total volume 
exhaled following maximal inhalation. 
1.1.4 Ventilation homogeneity in healthy subjects 
Studies as early as the 1960s have shown that ventilation in the healthy human lung is not 
entirely homogeneous and is greater in the dependent (lowermost) part of the lung (Bryan et 
al., 1964). This natural level of ventilation heterogeneity is primarily due to the mechanics of 
the lung under the effect of gravity; the gravitational force causes an intrapleural pressure 
gradient between the apex and base of the lungs (Milic-Emili et al., 1966). This intrapleural 
pressure gradient results in higher relative ventilation at the lung base. In the upright position, 
there is a ventilation inhomogeneity between the apex and base of the lungs of 1:1.6 (Bryan et 
al., 1964). There also remains a detectable ventilation gradient in the supine position both in 
the cranial to caudal direction as well as from superior to inferior (Amis et al., 1984; 
Orphanidou et al., 1986; Musch et al., 2002). Pulmonary ventilation is also known to be age 
dependent (Holland et al., 1968), as well as dependent upon the speed and volume of gas 
inspired (Frerichs et al., 2001). This demonstrates that there is a small but measureable and 
variable level of ventilation inhomogeneity in healthy subjects. As MR studies are almost 
always restricted to only measuring the ventilation in the supine or prone positions, it is 
salient to recognise that the ventilation homogeneity measured differs from that of an upright 
subject breathing spontaneously. 
1.1.5 Respiratory pathophysiology 
Lung disease can be broadly classified as either restrictive or obstructive, representing the 
mechanism by which the efficiency of ventilation is reduced. Restrictive lung disease limits 
expansion of the lung. This could be caused by weakened musculature, or a build-up of 
fibrotic tissue in the lung parenchyma. Obstructive lung disease is characterised by increased 
regional airway resistance, resulting in significantly increased ventilation heterogeneity 
compared to that found in healthy lungs (Galvin et al., 2007). Obstructive lung disease, 
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specifically asthma and chronic obstructive pulmonary disease (COPD) is the primary focus 
of the work presented here.  
Asthma is characterised by a reversible obstruction of the bronchial airways caused by 
increased responsiveness to external allergenic stimuli. Bronchoconstriction and inflammation 
occurs, along with production of excess mucus, all of which results in an increase in airway 
resistance, causing dyspnoea (Kudo et al., 2013). This can lead to increased ventilation 
heterogeneity, caused by unmatched airflow resistance along equivalent branches after each 
bifurcation. During acute asthmatic episodes, the lungs are typically hyperinflated, and the 
accessory muscles are utilised. Expiratory flow rates (FEV1, FVC) are reduced, whereas static 
volumes (TLC, RV) are increased. Less pronounced but measureable changes in flow rates 
and volumes are seen between exacerbations. Asthma is associated with considerable 
morbidity; the lifetime prevalence of clinically diagnosed asthma in the UK is 15.6%, with 
93,000 people receiving of in-patient treatment annually (Mukherjee et al., 2016). 
The pathophysiology of COPD is complex and can vary considerably between patients, with 
early disease often being asymptomatic. Key characteristics include permanent destructive 
enlargement of the lung parenchyma (known as emphysema), and narrowing of the airways 
due to inflammation and scarring. These factors combined can result in reduced compliance 
caused by the loss of elastic recoil of the alveolar walls. Dynamic compression, often 
resulting in air trapping behind the collapsed airway, and therefore difficulty fully exhaling is 
also commonly seen. Trapped air in emphysematous areas produces spatially localised 
ventilation inhomogeneities (Celli et al., 2004). In COPD patients, similarly to asthmatic 
patients, reduced flow rates and increased lung volumes are seen, causing an increased 
expiratory time. However, in COPD this is minimally reversed after treatment. COPD is the 
second most common lung disease in the UK, affecting 2% of the UK population, and 
accounting for 140,000 hospital admissions annually. It is also associated with high mortality 
rates, accounting for 5% of all deaths annually in the UK in recent years (Snell et al., 2016). 
Figure 1-2 illustrates the typical change in pulmonary volumes that is seen in obstructive lung 
disease patients relative to healthy subjects. 
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Airway resistance is often present in both COPD and asthma. The change in airway resistance 
with radius can be approximated by the Hagen-Poiseuille equation, which expresses that 
airway resistance is proportional to the reciprocal of the radius to the power of four (Ogrady 
et al., 1997). Consequently, it only takes a small change in radius to greatly affect the 
resistance of the airways. Although the individual small bronchioles have the highest 
resistance, the large quantity of them offsets their increased resistance. This is true even for 
peripheral airways in COPD patients where their resistance can double. In the human lung, it 
is the bronchi in the 4th to 8th generations that impart the highest resistance on inhaled air 
(Irvin, 2011). 
Spatial disparity in ventilation due to increased airway resistance, enlarged alveoli, and areas 
of air trapping are therefore key characteristics associated with obstructive lung disease. 
Detection of each of these pathological features is considered in the development of the 
pulmonary imaging modality detailed in the following chapters. 
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Figure 1-2: Relative lung volumes in healthy 
subjects and patients with obstructive lung 
disease. Notably, an increase in total lung 
capacity (TLC) and residual volume (RV) is 
present. Tidal volume (TV), and vital capacity 
(VC) remain approximately constant. 
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1.2 Magnetic resonance theory 
Nuclear spin angular momentum is a fundamental property of atomic nuclei that was first 
postulated by Wolfgang Pauli in the early 1920s (Pauli, 1924). In 1946, Felix Bloch and 
Edward Mills Purcell simultaneously published their independent discoveries of nuclear 
magnetic resonance (NMR) (Bloch et al., 1946; Purcell et al., 1946) – a process that uses an 
external magnetic field to detect and quantify nuclear spin angular momentum. They were 
jointly awarded the 1952 Nobel Prize in Physics for their discovery.  
Herman Carr is credited for introducing the use of magnetic field gradients, and from this 
producing the first one-dimensional NMR spectra, described in this PhD thesis in 1952 and 
published shortly after (Carr and Purcell, 1954). This formed the foundation for developing 
NMR into an imaging technique, MRI, thus allowing the first 2D and 3D images to be 
acquired by Lauterbur and Mansfield (Lauterbur, 1973; Mansfield and Grannell, 1975). The 
first in vivo human image was published in 1977 (Damadian et al., 1977), and the first 
diagnostic image was published shortly after in Aberdeen (Smith et al., 1981). It was in this 
same period that fluorine-19 (19F) MRI was first proposed (Holland et al., 1977), and the first 
application of 19F MRI to lung imaging was reported in the following decade (Rinck et al., 
1984).  
The following section outlines the basic theoretical foundation of nuclear magnetic resonance 
spectroscopy and imaging. Further explanation of select MR concepts relevant to the 
methodological developments that follow in this thesis are also given. 
1.2.1 Nuclear spin angular momentum and polarisation 
All nuclei have a fundamental intrinsic nuclear property, like mass and charge, called nuclear 
angular momentum, or spin. Spin, 𝑰, is characterised by its angular momentum quantum 
number, 𝐼, which can take a fixed half-integer or integer value, dependent on the pairing of 
protons and neutrons (nucleons) in the nucleus. 𝑰 is also characterised by its spin angular 
momentum projection quantum number, 𝑚, which describes the direction of the spin along an 
arbitrary axis, known as a spin state. 𝑚 can take the values: 
𝑚 =	−𝐼, −𝐼 + 1,−𝐼 + 2,… , 𝐼 1.1 
Each nucleus therefore has 2𝐼 + 1 allowed spin states. 
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All nuclei with non-zero nuclear spins (ie. one unpaired nucleon) exhibit NMR. They are 
analogous to charged particles moving in a perpetual loop, which generates an associated 
magnetic dipole moment,	𝝁. The magnetic dipole moment produced is related to nuclear spin 
by the gyromagnetic ratio,	𝛾, a constant specific to each nucleus type, such that: 
𝝁 = 𝛾𝑰 1.2 
The bulk magnetisation, 𝑴, is the sum of all the individual magnetic moments in the material 
of interest. Normally, 𝑴 is zero because the magnetic moments are randomly orientated. 
However, application of an external static magnetic field,	𝑩𝟎, imparts a torque on each of the 
magnetic moments, causing them to align with the field. This produces a non-zero net 
magnetisation. This principle forms the basis of NMR. 
 The majority of NMR techniques applied in vivo utilise 1H nuclei as the signal source, due to 
their large natural abundance within water and fat molecules. 19F is one of many other MR-
sensitive nuclei, and analogously to 1H, has 𝐼 = 9:. A comparison of the magnetic properties of 
1H and 19F is shown in Table 1.1. 
Therefore, for 𝐼 = 9:, in the case of both 1H and 19F, there are two spin states: 𝑚 = ±9:, in 
accordance with Equation 1.1. These are degenerate until an external magnetic field is 
applied, in which case Zeeman splitting occurs and the two spin states can be measured 
(Brown et al., 2014). The nuclear spins orientate either parallel or anti-parallel to the 
magnitude of the magnetic field in the nominal z-direction, 𝐵=. The energy difference 
between the parallel ground state and the anti-parallel excited state is given by (Brown et al., 
2014): 
Nucleus Number 
of 
unpaired 
protons 
Number 
of 
unpaired 
neutrons 
Natural 
abundance 
(%) 
Biological 
abundance 
(%) 
Gyro-
magnetic 
ratio, 𝜸 
(MHz/T) 
Spin 
quantum 
number, 𝑰 
𝐇𝟏𝟏  1 0 99.99 63 42.58 12 𝐅𝟗𝟏𝟗  1 0 100 0 40.05 12 
Table 1.1: NMR properties of 1H and 19F. The biological abundance is described as being 
the atomic percentage of one type of atom in the human body from Emsley (1998). All 
other values were taken from Bruno and Svoronos (2010). 
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Where ℏ is the reduced Planck constant, ℏ = D:E = 1.05×10HIJ	J	s.  
The parallel position is favoured due to it being a lower energy state. The proportion of nuclei 
in the parallel, 𝑁N, to the antiparallel state, 𝑁ON, is determined by the Boltzmann distribution 
(McDowell, 1999): 
Where 𝑘 is the Boltzmann constant, 𝑘 = 1.38	×	10H:I	kg	sH:	KH9, and 𝑇 is the absolute 
temperature (body temperature is approximately 310 K). It can therefore be seen that the ratio 
of nuclei in each state increases with magnetic field and gyromagnetic ratio, and decreases 
with temperature. 
For 19F (𝜔= = 120.15 MHz at 𝐵= = 3.0 T), at body temperature, XYZXZ = 0.999997. That is, for 
1,000,000 nuclei in the higher energy anti-parallel position, there is expected to be 1,000,003 
nuclei in the lower energy parallel position. This ~10H^ excess of nuclei in the parallel 
position is the source of the net magnetisation, 𝑴, pointing in the direction of the external 𝐵= 
field. This excess is detected by NMR.  
This small polarisation necessitates a high spin density, which for protons in tissues is of the 
order of 1022 cm-3 (Kauczor et al., 1998). In contrast, the biological abundance of 19F is 
effectively zero. Where the physiological concentration of 19F is above the detection limit 
(~10HIµmol	gH9 wet tissue weight) such as in the teeth and bone matrix, it is immobilised, 
and therefore undetectable (Ruiz-Cabello et al., 2011). Therefore, any 19F signal must come 
from an imaging agent administered to the subject. This has the useful effect of avoiding 
endogenous background signal. 
Substitution of the Bohr condition, Equation 1.5, where 𝑣 is frequency in hertz, into Equation 
1.3 yields the angular Larmor frequency, 𝜔=	(rad s-1), of the nucleus: 
∆𝐸 = 𝛾𝐵=ℏ 1.3 
𝑁ON𝑁N = 𝑒H∆e fg 1.4 
∆𝐸 = ℎ𝑣 = ℏ𝜔= 1.5 
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The nuclear magnetic moments therefore precess around 𝐵= at frequency 𝜔=, rather than 
aligning exactly with 𝐵=, illustrated in Figure 1-3. 
 
1.2.2 Nuclear excitation  
It is possible for nuclei to transition between the two spin states by absorbing an amount of 
energy that is equal to the Δ𝐸 between the two states. The energy required falls in the radio 
frequency (RF) range. The geometry of RF pulse producing hardware is designed such that 
when an RF pulse at the Larmor frequency of the nucleus is applied, a small magnetic field, 𝑩𝟏, is generated perpendicular to the static 𝑩𝟎 field. The torque produced (𝑴	×	𝑩𝟏) tips the 
magnetisation vector towards the transverse plane by a flip angle, 𝜃, described by (Bloch, 
1946): 
The angle subtended is therefore proportional to the length of the RF pulse. There is an equal 
𝜔= = 𝛾𝐵= 1.6 
𝜃 = 𝛾	𝑩𝟏(𝑡)		𝑑𝑡o=  1.7 
B
0 
M  ω0 
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Figure 1-3: a. Illustration of the precession of the spin magnetic moment, 𝝁, around an external 
static magnetic field, 𝐵0, pointing along the z-axis. 𝝁 precesses around 𝑩𝟎 at the Larmor 
frequency,	𝜔=. b. The net magnetisation, 𝑴, from many nuclei experiencing the same external 𝑩𝟎 field is along the positive z-axis, as the spins precess out of phase, and a small excess (not to 
scale) inhabit the lower energy parallel spin state. 
∆𝐸 = ℏ𝜔= 
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probability of any nucleus switching between the two energy states, however as there are 
more nuclei in the lower energy state, the transition to the higher energy state is most likely 
until there are equal populations in each (saturation). On a macroscopic level, the RF pulse 
will cause the net magnetisation to tip towards the x-y plane, so a 90o flip angle is 
representative of saturation occurring on the nuclear level. 
1.2.3 Nuclear relaxation and the Bloch equations 
Immediately following a RF pulse, several relaxation processes occur that are dependent on 
the material being imaged and its environment which cause the nuclear signal to decay. Felix 
Bloch (1946) developed phenomenological equations that formally describe this macroscopic 
nuclear magnetisation, and the relaxation mechanisms that follow.  
Longitudinal relaxation 
Nuclei return to their equilibrium state along the z-axis by stimulated emission, and the 
energy that was absorbed from the RF pulse is transferred from the nuclei to the surrounding 
lattice as heat. This process, also known as spin-lattice relaxation, is defined by the empirical 
Bloch equation: 
Where the cross product describes the initial flip without any relaxation, seen in Equation 1.7. 
T1 is the time required for the system to 63% of the equilibrium value, and is known as the 
longitudinal relaxation time (Nitz and Reimer, 1999). 𝑀q(𝑡) is the proportion of the 
equilibrium value, 𝑀=, remaining after time, 𝑡. 
By integration, the amount of net nuclear magnetisation lost over the time of the relaxation 
process after saturation can therefore be written as the exponential: 
T1 is dependent on the external magnetic field strength and the rotation speed of the molecule 
(Bloembergen et al., 1948). 
 
𝑑𝑀q(𝑡)𝑑𝑡 = 𝛾(𝑴 𝑡 ×𝑩 𝑡 )q + 1𝑇9 (𝑀= −𝑀q(𝑡)) 1.8 
𝑀q(𝑡) = 𝑀= + 𝑀q(0) − 𝑀= 𝑒Ho gr 1.9 
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Transverse relaxation 
There is a loss of phase coherence in the x-y plane after excitation. This is known as 
transverse, or T2 relaxation. Transverse relaxation is caused by the nuclei experiencing a 
slightly different magnetic field to 𝐵= due to interference from magnetic moments of 
neighbouring nuclei (Nitz and Reimer, 1999). As the nuclei come into contact with many 
other magnetic moments, their precessional frequencies vary, and their transverse 
magnetisations dephase from each other. The Bloch equations that describe this are: 
Where 𝑇: is the time after which net the magnetisation, 𝑀s,t, decays to 37% of its original 
value. Again, by analysis this occurs according to: 
This process produces an exponential decay of the magnitude of coherent transverse 
magnetisation. Unlike T1 relaxation, no energy is lost during this process, but energy is 
transferred between nuclei. It is therefore referred to as spin-spin relaxation. 
The three Bloch equations can be combined to present the total evolution of magnetisation in 
a system interacting with an external magnetic field: 
Where 𝒙,	𝒚 and 𝒛	are the unit vectors in the x, y, and z directions respectively. 
In practice, the transverse relaxation time is further shortened by regional magnetic field 
inhomogeneities. This can be caused by an imperfectly shimmed 𝐵= field, or inhomogeneities 
in the local environment caused by differences in magnetic susceptibility at the boundaries of 
two tissues. This therefore changes the resonant frequency of the nuclei, which is dependent 
on the strength of the magnetic field they experience. An extreme case of this is seen in the 
𝑑𝑀s(𝑡)𝑑𝑡 = 𝛾(𝑴 𝑡 ×𝑩 𝑡 )s − 𝑀s(𝑡)𝑇:  1.10 
𝑑𝑀t 𝑡𝑑𝑡 = 𝛾(𝑴 𝑡 ×𝑩 𝑡 )t − 𝑀t 𝑡𝑇:  1.11 
𝑀s,t(𝑡) = 𝑀s,t(0)	𝑒Ho gx 1.12 
𝑑𝑴(𝑡)𝑑𝑡 = 𝛾(𝑴 𝑡 ×𝑩 𝑡 ) − 𝑀s(𝑡)𝑇: 𝒙 −𝑀t(𝑡)𝑇: 𝒚 −𝑀q(𝑡)𝑇9 𝒛 1.13 
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human lung where many air-tissue boundaries are present. This reduces the T2 to T2*, 
described by (Chavhan et al., 2009): 
Where ∆𝐵= is the change in magnetic field experienced by the nuclei from the original 𝐵=. 
1.2.4 Free induction decay 
As previously discussed, a single RF pulse at the Larmor frequency of the subject nuclei that 
produced a 𝐵9 field perpendicular to 𝐵= will produce a magnetisation whose subsequent 
decay can be measured (Hahn, 1953). This is a free induction decay (FID), and is illustrated 
in Figure 1-4.  
The envelope of the FID measures the rate of T2* relaxation as the total signal in the sample 
decays over time, regardless of its spatial location in the magnetic field.  
1𝑇:∗ = 1𝑇: + 1𝑇:z 1.14 
𝑇:z = 	 1∆𝐵= ∙ 𝛾 1.15 
Figure 1-4: Free induction decay after a RF pulse. The envelope of the FID 
(marked in blue) describes the T2* signal decay of the subject nuclei. 
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S(t)
B1
 13 
1.2.5 NMR to MRI: image formation in k-space 
Moving from a 1-dimensional signal peak observed in a simple FID to a spatially localised 
image is achieved by recording the signal amplitude, the phase and the frequency of the spins, 
and their variation as magnetic field gradients are applied across the sample. This information 
is mapped as complex values in the spatial-frequency domain, known as k-space, with each 
dimension (kx, ky, kz) being defined by the frequency encoding gradient, phase encoding 
gradient, or slice selection gradient. It is converted into the Cartesian (x, y, z) image by 
Fourier transformation. K-space maps the spatial frequency distribution of each 2D image 
slice. Multiple k-spaces form a 3D image, with the low frequencies (at the centre of k-space) 
representing the coarse signal to noise distribution of the image, and the high frequencies 
representing the fine detail and resolution (Lai and Lauterbur, 1981; Hinshaw and H, 1983; 
Brown et al., 2014). The principles of this technique, which allows signal localisation using 
phase, frequency, and slice encoding gradients is discussed below.  
Frequency encoding 
There are three sets of gradient coils in the MR system: Gx, Gy, and Gz. These serve to 
linearly alter the 𝐵= field strength along their respective dimentions. Within a 2D slice, 
altering the 𝐵= field in the nominal x-direction by several mT	mH9 around the magnet 
isocentre will change the Larmor frequency of the spins precession dependent on where along 
this dimension the nucleus is in. This is described by Equation 1.16, which is simply modified 
from Equation 1.6. 
Presence of this gradient during signal acquisition causes precession at a range of frequencies 
dependent upon the sample position in the gradient (Bernstein et al., 2004). A dephasing 
gradient is applied immediately before to counteract any spin dephasing it causes, a Fourier 
transform presents a plot of signal amplitude against position. This gradient allows the signal 
to be localised to single column within a slice. 
Phase encoding 
The phase encoding gradient is applied perpendicularly to the frequency encoding gradient in 
order to change the phase of spins within a column. When the gradient is switched off, the 
spins return to precessing at the same speed, but remain phase shifted from each other. This 
𝜔s = 𝛾(𝐵= + 𝑥 ∙ 𝐺s) 1.16 
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can be measured by the net signal seen as the magnitude of the phase shift caused by this 
gradient is determined by position along the gradient. By arraying many phase shift values, 
the difference in signal produced from each phase encoding step is used to accurately define 
which voxel in a column the signal originated from (Felmlee et al., 1989).  
Slice selection 
The method of slice selection is dependent upon the imaging protocol used. For 3D 
acquisitions, phase encoding is applied in two orthogonal directions, allowing spatial 
encoding in the third direction. In a 2D acquisition, slice selection works analogously to the 
frequency encoding gradient, by simply applying the gradient along the z-direction during the 
RF pulse. The RF pulse therefore excites a single slab of the sample. In this case, the 
thickness of the slab is dependent on the transmit bandwidth of the RF pulse used, and the 
applied gradient strength: 
1.2.6 The spoiled gradient echo pulse sequence 
The process of filling k-space varies upon the pulse sequence used, as it is variations in the 
way in which phase and frequency encoding gradients are activated that defines the filling 
order. A widely used imaging technique is the spoiled gradient echo (SPGR) pulse sequence. 
The SPGR sequence samples k-space linearly, the most common sampling form. A schematic 
of the 3D SPGR sequence is shown in Figure 1-5 (Haase et al., 1986; Elster, 1993).  
A spatially non-selective RF pulse is applied, producing a defined flip angle (typically 
between 0o - 90o). The phase encoding gradients are then applied immediately after the pulse. 
Simultaneously, a dephasing frequency encoding gradient equal to half the length of the 
sampling period is applied. This has the effect of causing the spins to be in phase at the centre 
of the acquisition period. The direction of the frequency encoding gradient is then switched, 
and an echo is produced as it rephrases the previously dephased spins. It is during this period 
that the signal is sampled, with the spatial resolution determined by the number of points 
collected and the amplitude of the frequency encoding gradient. Gradient spoiling may then 
be applied at the end of the sequence to dephase any magnetisation before the next repetition. 
A more effective form of spoiling which is more commonly used however is RF spoiling, 
where the phase of each successive RF excitation pulse is incremented by a specific angle 
slab	width = 	2𝜋		𝐵𝑊𝛾𝐺q  1.17 
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such that coherence of transverse magnetisation is destroyed. 
Also shown in Figure 1-5 are the echo time (TE, the time between the centre point of the RF 
pulse to the centre of the data acquisition) and the repetition time (TR, defined as the time of a 
single repetition, measured from the centre of the first RF pulse, to the centre of the next).  
Figure 1-5 represents a single phase encode step, and the sequence fills k-space linearly, 
filling one line per excitation. Therefore, to produce a two-dimensional N × N matrix, N 
phase encoding steps,	𝑁N, are required, each with a different phase encoding gradient, and this 
will have to be repeated for the number of slices, 𝑁,	and the number of signal 
averages,	𝑁𝑆𝐴, required. The time for a 3D gradient echo scan,	𝑡IHe, is therefore defined 
by (Bernstein et al., 2004): 
 
TR 
Phase encode 
(slice defining) 
Phase encode 
Frequency encode 
𝜃 
T2* 
TE 
Spoiling 
Sampling period 
Figure 1-5: A 3D spoiled gradient echo pulse sequence. The slice selection, phase 
encoding, and frequency encoding gradients are used to encode spatial information into 
the MR signal. The echo time (TE) is labelled. This figure depicts a single repetition time 
(TR), and the process must be repeated for multiple phase encode steps and signal 
averages. 
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1.2.7 RF pulse shapes 
A wide variety of RF pulse shapes are used to aid spatial localisation, as well as excitation. 
The choice of the pulse shape depends on the aims of the acquisition. Two common pulse 
shapes used in this work, the sinc pulse and the rectangular pulse, are discussed below (Dale 
et al., 2015; Brown, 2016). 
The sinc pulse 
The sinc pulse, defined as sin(𝑥) 𝑥 , and depicted in Figure 1-6a, is a widely used RF pulse 
shape due to it allowing accurate slice selective excitation for 2D acquisitions. This is due to 
its Fourier transform (the shape of the sample excited) having a sharp rectangular profile. The 
profile of a Fourier transform is representative of the frequency profile that is excited, thus, if 
the slice-selection gradient makes a slice a specific range of frequencies, a sinc RF pulse can 
be applied to excite that very same range of frequencies. 
Practically, a perfect rectangular profile is unachievable, due to the sinc function (which 
would have infinite duration) having to be heavily truncated to the first few pairs of lobes. 
This has a detrimental effect on the slice profile, as depicted in Figure 1-6b. The slice profile 
is often improved by Gaussian modulation of the sinc pulse envelope, giving greater 
weighting to the central lobes.  
𝑡IHe = 	𝑇𝑅 ∙ 𝑁N ∙ 𝑁𝑆𝐴 ∙ 𝑁 1.18 
Spatial domain, x (seconds) Frequency domain, x-1 (Hz)
a. 
b. 
Figure 1-6: a.  A	sinc	pulse,	and	its	corresponding	sharp	slice	profile.	Ringing	is	present	due	to	it	not	being	an	infinite	example.	b. A heavily truncated sinc pulse, and its 
corresponding imperfect slice profile with notable ringing. 
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A heavily truncated sinc pulse still suffers from being a relatively long duration to achieve a 
specified B1 pulse, necessitating a long TE.  
The rectangular pulse 
The rectangular RF pulse is known as a hard pulse, as its shape is not variant with time. It 
requires a much shorter time to impart the same flip angle, thus a broad bandwidth to excite 
spins with a wider range of frequencies than a sinc pulse as its Fourier transform is a sinc 
curve. This non-selective excitation therefore does not offer the ability to excite a sharp slice 
profile like the sinc pulse, but it is well suited for 3D imaging, where whole-volume 
excitation is acceptable and phase encoding is used to encode spatial information in two 
dimensions. The flip angle produced with a hard pulse is the simplest form of Equation 1.7: 𝜃 = 𝛾𝐵9𝑡, where t is the pulse length. 
1.2.8 Producing a radio frequency pulse: basic RF coil theory 
Radio frequency coils are named due to them resonating in the RF electromagnetic frequency 
range, typically tens to hundreds of MHz at 3.0 T. They serve two purposes; the first is to flip 
the net magnetisation by generating an oscillating magnetic field (B1) at the Larmor frequency 
of the target nuclei, the second is to receive the signal subsequently emitted as the nuclei 
decay to the lower energy alignment with the B0 field. This ‘transmit’ and ‘receive’ 
functionality can be carried out by individual coils, named respectively, or a single coil, 
referred to as a T/R coil. Coils can take a variety of geometries, with their design suited to 
imaging different anatomical geometries, but they can be broadly broken down into either 
surface coils, or volume coils. 
The surface coil is the simplest type of RF coil, made up of single or multiple loops in an LC 
circuit (Figure 1-7a). The coil wire can be considered an electrical inductor with inductance, 
L. With this fixed, the coil can be tuned to produce a B1 field that resonates at the Larmor 
frequency of the target nuclei, 𝜔, by varying the capacitance, C, following the equation: 
Surface coils are widely used in MRI as their design produces high SNR and enhanced 
sensitivity in superficial imaging regions proximal to the coils surface. However, the 
sensitivity of the surface coil falls off rapidly with distance (Hayes and Axel, 1985). The B1 
field it transmits (Figure 1-7b), and therefore also the flip angle, decreases with distance from 
𝜔 = 1𝐿𝐶 1.19 
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the coil (Hernández‐Flores et al., 2002).  
Volume coils offer the ability to image a large field of view with a more homogeneous B1 
than surface coils, making them distinctly more suitable for imaging a large volume such as 
the human lung. The birdcage coil is a commonly used volume coil design in MRI, fist 
designed by Hayes et al. (1985). It is often used as a T/R coil as it offers good B1 transmit 
homogeneity, and high receive uniformity. However, use as a transmit coil in conjunction 
with a surface coil offers higher receive sensitivity (Giovannetti, 2014). This work will focus 
on utilisation of birdcage coil in T/R mode. 
1.2.9 The birdcage coil 
Structure of the birdcage coil 
The birdcage coil is fabricated from a number of equally spaced conductive rungs, referred to 
as legs, connected between two conductive circular or elliptical loops, called end rings. 
Capacitors are placed at different locations on the coil to produce the desired resonant 
frequency (Hayes et al., 1985).  
A high-pass coil has the capacitors placed on the end rings, between each leg, as depicted in 
Figure 1-8a. This is in contrast to a low-pass coil, in which the capacitors are placed on each 
of the rungs, as shown in Figure 1-8b. A band-pass coil has capacitors in both locations.  
a. b. 
Figure 1-7: a. A simple LC circuit in a surface coil. b. A transverse view of a 
surface coil, with B1 field lines depicted. 
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In a high-pass coil, the high frequency signals will pass through the capacitors in the end 
rings, as they offer low impedance compared to the legs (inductors). Low frequency signals 
will be blocked by the capacitors that will offer high impedance, and shorted by the inductors 
(Vullo et al., 1992). The same is true for low-pass coils. A band-pass coil allows tuning to 
two nuclei at a high and low frequency respectively (Rath, 1990). Therefore, for high-field 19F 
MRI, a high-pass coil is considered optimal.  
Production of a homogeneous B1 field 
A homogeneous transverse B1 field can be produced in a cylinder whose axis is aligned with 
B0, by applying a current along the length of the cylinders surface with an amplitude that 
varies proportionally to the sine of the cylinders azimuthal angle,	𝜙. The birdcage coil 
approximates this with sinusoidally varying current amplitude in each leg. It is for this reason 
that a greater number of legs on a birdcage coil results in a more homogeneous B1 field, as 
displayed in Figure 1-9. However, this is a compromise as fabricating many legs can become 
impractical and uneconomical. 
a. b. 
Figure 1-8: a. Capacitor location on a high-
pass birdcage coil. b. Capacitor location on a 
low-pass birdcage coil.  
 
Figure 1-9: Simulated B1 field maps for a birdcage coil with 4, 8, and 16 legs respectively. 
These were simulated by applying the Biot-Savart law to each leg, then summing the B-
field values experienced at each point in the image. 
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The equivalent circuit of a small section of an N-rung birdcage coil is shown in Figure 1-10. 
The total phase shift around the cylinder must be an integer multiple (𝑀) of 360o to produce a 
resonant standing wave in the circuit. The phase shift of the current for the nth rung of a coil 
with N rungs must therefore satisfy the equation 𝜙 = 𝑀 360° 𝑁 𝑛. M can take N/2 values, 
each representing distinct resonant modes. The M = 1 resonant frequency is known as the 
dominant mode. It is this mode that must be tuned to the resonant frequency of the nucleus in 
question, as the other modes produce inhomogeneous B1 fields from larger phase rotation 
increments around the coil. For this reason they are unsuitable for traditional MR-studies 
(Hayes et al., 1985). 
The coil can be tuned to the required resonant frequency by adjusting the capacitance of the 
circuit. Theoretical models have been published to predict the capacitance required (Chin et 
al., 2002; Boissoles and Caloz, 2006; Gurler and Ider, 2012). However, due to the extent of 
the RF interactions, combined with an imperfect coil structure, these predictions provide only 
a starting point, and iterative adjustments are required. Further to this, the B1 field is sensitive 
to the coils external environment; RF coupling resulting from the birdcage coil interacting 
with structures in scanner when placed in the scanner bore causes a reduction in the achieved 
B1 amplitude. Loading the coil lowers the B1 homogeneity due to standing wave and 
attenuation effects. For these reasons, birdcage coils are sometimes also fitted with variable 
capacitors, allowing fine-tuning when loaded. 
 
 
Figure 1-10: A small segment of the circuit in a N-rung 
birdcage coil. 
Lleg 1 Lleg 1 Lleg 2
Lend ring 1 Lend ring 2
Lend ring 2Lend ring 1
Cend ring 1
Cend ring 1
Cend ring 2
Cend ring 2
I1 I2 g N 
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Linear and quadrature mode 
The birdcage coil can be driven in either linear or quadrature mode. In linear mode, the coil is 
excited from one port and produces a linearly polarised field of the form: 
In quadrature mode, it is driven from two orthogonal ports with a 90o phase shift, producing a 
circularly polarised field of the form: 
It is possible to compare the transmit power efficiency of the linear and quadrature coils, as 
power is proportional to the square of the B1 field created. As a linearly polarised field can be 
described as the sum two opposing circularly polarised fields,	𝑩𝟏,𝐥𝐢𝐧𝐞𝐚𝐫 = 𝑩𝟏¢+𝑩𝟏H, such that: 
Squaring this results in: 
Where 𝑃 is power, measured in Watts. 𝑃¤¥¦§¨¦©¥¨ª is proportional the square of Equation 1.21. 
By inspection, it is therefore clear that: 
Hence by using a circularly polarised field, the transmit capabilities of the coil are twice as 
efficient at tipping the nuclei, with half as much power required to produce the same B1 field. 
This can be visualised by noting that a circularly polarised field never has zero magnitude, 
and is therefore always imparting B1 on the nuclei. This is in contrast with a linearly polarised 
B1 field, which oscillates in magnitude. 
Additionally, as the signal produced is complexly summed from the two separate receive 
𝑩𝟏 = 𝐵9 cos𝜙 𝒙 1.20 
𝑩𝟏 = 𝐵9 cos𝜙 𝒙 + sin𝜙 𝒚  1.21 
𝑩𝟏,𝐥𝐢𝐧𝐞𝐚𝐫 = 𝐵92 (cos𝜙𝒙 + sin𝜙 𝒚) + 𝐵92 (cos𝜙𝒙 − sin𝜙 𝒚) 1.22 
𝑃¬­®ª¦¨ ∝ 2× 𝐵92 (cos𝜙𝒙 ± sin𝜙 𝒚) : 1.23 
𝑃¤¥¦§¨¦©¥¨ª = 2	×	𝑃¬­®ª¦¨ 1.24 
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channels, the correlated signal detected is doubled, whereas the noise detected, due to them 
being uncorrelated, increases by only a factor of 2. Therefore, for a quadrature design, along 
with a 50% reduction in power requirements, there is also a 2 improvement in SNR (Chen et 
al., 1983; Redpath, 1998).  
Tuning and impedance matching 
At the interface between the coil and the coaxial cable from the RF amplifier, a tune and 
match circuit is used to allow crucial capacitate adjustments to maximise coil performance. 
An example simple tune and match circuit diagram is shown in Figure 1-11.  
All coils behave as variations of LC circuits, where Equation 1.19 describes a simple case of 
how the resonant frequency of the oscillating field can be change by varying L or C. As 
inductance is determined by the geometry of the coil, tuning is most easily accomplished by 
varying the capacitors on the end rings using feedback from a network analyser, until 
resonance at the Larmor frequency is achieved. 
Once this has been determined, the variable matching capacitor is adjusted to match the 50	Ω 
impedance of the RF amplifier to that of the coil in order to minimise power loss and achieve 
maximum signal (Hoult and Richards, 1976; Maclaughlin, 1989).  
The coil construction theory covered in this section in addition to the pulse sequence design 
theory discussed earlier, is applied to the technical development conducted in the following 
chapters. 
  
Figure 1-11: An example tune and match circuit. The 
tuning capacitor is joined in parallel to the coil circuit, 
and the matching capacitors are connected in series. 
Ctune
Cmatch
Cmatch
To coilTo T/R switch
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1.3 Modalities for the assessment of pulmonary ventilation 
Pulmonary function tests including spirometry, plethysmography, multiple breath nitrogen 
wash-out and helium dilution are regularly used to assess the pulmonary function of patients 
with obstructive lung disease. However, they only provide a global measurement of function 
in diseases that are well known to be spatially heterogeneous (Nakawah et al., 2013). To 
address this, a number of imaging modalities have been utilised for pulmonary ventilation 
assessment. These include single-photon emission computed tomography (SPECT), positron 
emission tomography (PET), x-ray computed tomography (CT), and magnetic resonance 
imaging (MRI). The remainder of this section comprises a brief overview of each of these 
imaging modalities with a review of pertinent publications. MR imaging techniques are then 
discussed in further detail with an emphasis on imaging inhaled perfluorinated gases.  
1.3.1 Pulmonary ventilation imaging techniques utilising ionising radiation 
Radioactive tracer gases have been utilised for the assessment of regional ventilation for 
several decades. Early xenon-133 (133Xe) scintigraphy, using six scintillation cameras fixed 
vertically to the torso, was able to detect the gravity dependent ventilation distribution 
between the apex, middle and base of each lung (Ball et al., 1962). However, this relatively 
primitive study offered minimal spatial localisation of the detected gamma radiation, with an 
inability to distinguish ventilation differences within horizontal planes. SPECT extended this 
planar scintigraphic technique into a modality that is capable of producing a three-
dimensional image of radioactivity distribution by iterative reconstruction or filtered back 
projection techniques. Ventilation SPECT commonly utilises a technetium-99m (99mTc) 
labeled aerosol or 133Xe as tracers (Petersson et al., 2007; Roach et al., 2013). Both static 
ventilation distribution and dynamic wash-out images can be acquired (Suga, 2002; Yokoe et 
al., 2006). Studies have shown SPECT to be able to detect a difference in signal distribution 
between healthy volunteers and emphysematous patients at varying disease severity (Nagao et 
al., 2000; Xu et al., 2001; Yokoe et al., 2006). SPECT is a readily available technique, which 
uses relatively inexpensive tracers, making it an easily accessible lung imaging option. Its 
primary limitation is the low resolution; pulmonary imaging SPECT can produce a spatial 
resolution of typically 10 mm – 20 mm, coarser than comparable imaging methods. A 
secondary limitation is that exposure to typically 2 – 3 mSv of ionising radiation is required 
(Petersson et al., 2007). It is half the dose of a typical comparable CT scan, however this 
factor still dissuades repeated use of this technique in cases calling for longitudinal disease 
monitoring. 
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Positron emission tomography utilises decaying radionuclides as the tracer source, typically 
nitrogen-13 (13N2), fluorine-18 (18F) or neon-19 (19Ne) for ventilation imaging (Rhodes and 
Hughes, 1995; de Prost et al., 2015; Chen et al., 2017). The positrons emitted in the decay 
annihilate with an electron, producing two gamma rays travelling in opposite directions. The 
paths between each of the detected gamma-ray pairs are reconstructed, and the information 
used to form an image. Ventilation has been assessed by quantification of wash-in and wash-
out rates of the radioactive tracer gas (Senda et al., 1986; Venegas et al., 2013). PET is a 
more expensive option than SPECT, but better diagnostic accuracy can be achieved with the 
higher (typically 5 mm) resolution (Conway, 2012). 
CT is considered the gold standard for chest imaging in current clinical practice, primarily 
thanks to its ability to achieve high spatial resolution, typically less than 0.5 mm (Kakinuma 
et al., 2015). The technique utilises an x-ray generator and detector mounted on a rotating 
gantry. The x-ray attenuation from multiple angles around the patient is collected to produce a 
3D map of tissue density. This has been used to detect both airway narrowing (Kirby et al., 
2016), and alveolar enlargement (emphysema) (Lynch et al., 2015). CT can measure the 
regional distribution of ventilation with the use of a radiopaque xenon gas contrast agent. The 
signal output is directly proportional to the concentration of the xenon gas (Murphy et al., 
1989), which therefore provides a direct measure of ventilation homogeneity. Dual-energy CT 
utilises two x-ray sources, and allows dynamic ventilation imaging as well as simultaneous 
anatomical and ventilation acquisitions (Chae et al., 2008). It has been shown to be reliable at 
quantifying COPD (Park et al., 2010; Bodduluri et al., 2017). As CT is a technique that relies 
on ionising radiation, the associated carcinogenic risk of particular concern in the case of 
longitudinal pulmonary disease monitoring and paediatric imaging.  
1.3.2 1H MRI of pulmonary ventilation 
Conventional MRI exploits the high gyromagnetic ratio of hydrogen-1 (1H) nuclei to produce 
a signal that can be imaged. The primary problem with successful pulmonary MRI is the lack 
of 1H nuclei available in the lungs to produce satisfactory images. The proton density of the 
parenchyma is one fifth of that of most body tissues (Theilmann et al., 2009), resulting in 
reduced signal. Furthermore, the air-tissue boundaries produces a 9 ppm magnetic 
susceptibility gradient between the two media (Wild, 2009). This produces magnetic field 
inhomogeneities at these interfaces, resulting in the nuclei losing phase coherence at a much 
faster rate; the transverse relaxation time of the lung parenchyma is greatly reduced from T2	≈	100 ms for water in body tissues to about T2*	≈	1 ms for water in the lungs at full inspiration 
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(Hatabu et al., 1999a; Hatabu et al., 1999b). Respiratory gating or breath-hold duration scans 
are also typically required, reducing the capacity for signal averaging. Due to these 
challenging MR properties, MRI of pulmonary ventilation benefits from a departure from 
standard MR techniques. 
Ultra-short echo time (UTE) imaging is adept at imaging short-T2* tissues, such as the lung 
parenchyma, by use of non-linear sampling of k-space to permit use of short (typically <1 ms) 
echo times (Tyler et al., 2007). As this MR technique does not image the airspace it is 
therefore only capable of identifying biomarkers of ventilation defects through indirect 
methods such as measuring lung tissue density (Lederlin and Cremillieux, 2014; Sheikh et al., 
2017) or parenchymal T2* measurements (Ohno et al., 2011). 
The measurement of ventilation requires the ability to distinguish between freshly inspired 
gas and the pre-existing gas in the lungs, allowing wash-in rates to be mapped. This necessity 
has encouraged the use of contrast enhancement for ventilation imaging. Oxygen-enhanced 
pulmonary MRI uses 100% O2 as the contrast agent. It exploits the paramagnetic effects of 
dissolved molecular oxygen along with the large surface area of the lung tissue to map a 
change in signal from the parenchyma (Chen et al., 1998; Mai et al., 2002; Zhang et al., 
2015). A decrease in the longitudinal relaxation time (T1) of the tissues by 7% – 14% has 
been reported (Webb, 1988; Loffler et al., 2000; Jakob et al., 2001; Nakagawa et al., 2001; 
Mai et al., 2002). 
Ventilation and perfusion rate along with molecular oxygen diffusion speed all contribute to 
the change in oxygen levels, and consequently the change in T1, therefore this lung imaging 
technique can only give combined information about lung function. Despite being an indirect 
measure of pulmonary ventilation, and challenging to quantitate reproducibly (Triphan et al., 
2017), oxygen enhanced MRI has been shown to be significantly more precise at classifying 
the clinical stage of COPD than quantitative CT (Ohno et al., 2008). 
1.3.3 Hyperpolarised noble gas MRI of pulmonary ventilation 
Inhalable hyperpolarised (HP) noble gases, namely helium-3 (3He) and xenon-129 (129Xe) 
have been the subjects of a large body of research over the last two decades which has 
demonstrated their utility for lung ventilation imaging using hyperpolarised imaging agents. 
Their MR properties are summarised in Table 1.2. 
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3He is a stable isotope of helium with a high gyromagnetic ratio making it very sensitive to 
MRI. It is also inert and non-toxic. However, the 3He isotope has a negligible natural 
abundance, so is most commonly sourced from tritium decay of nuclear warheads. This finite 
supply makes it particularly uneconomical (Walkup and Woods, 2014). 
129Xe benefits from being more readily available, with an adequately high natural abundance 
to not require the enriched isotope (Lilburn et al., 2013). However, its gyromagnetic ratio is 
one third of that of 3He, consequently comparable polarisation would result in poorer image 
quality than 3He. Unlike 3He, 129Xe is soluble in tissue, thus can readily diffuse into the blood 
stream once inhaled and has anaesthetic properties at alveolar concentrations above 70%, and 
is therefore regulated as such (Goto et al., 2000). 
3He and 129Xe have low spin density in the gaseous phase and long longitudinal relaxation 
times (T1), which limits signal averaging. They are therefore unsuitable for MRI without the 
use of a mechanism to modify the Boltzmann thermal polarisation. Hyperpolarisation results 
in an increase in polarisation of nuclei by a factor of up to 100,000 times beyond thermal 
equilibrium to produce a polarisation of up to 50% (Mugler and Altes, 2013). Once the gas 
has been hyperpolarised, it has a T1 of several days if stored under controlled conditions; it 
must not be exposed to magnetic field gradients, radio frequency irradiation or come into 
contact with paramagnetic gases such as oxygen. Molecular oxygen can reduce the T1 of HP 
3He and 129Xe to 10 – 20 s (Albert et al., 1994); this enforces a limit on the scan length, as T1 
relaxation accelerates the moment it is inhaled and mixed with oxygen. 
3He had been the prime focus of HP gas lung imaging studies due to 129Xe historically being 
challenging to polarise above ~25% (Albert et al., 1994). Technological advances mean this 
is no longer a limitation (Hersman et al., 2008), and recent studies have shown that 129Xe can 
be more sensitive to visualising ventilation defects than 3He, and more accurate at diffusion 
weighted imaging (Kirby et al., 2013; Kołodziej et al., 2017). This could be due to 129Xe 
Isotope Spin, I Gyromagnetic ratio, 𝜸 (MHz/T) Natural abundance Cost per litre 
3He 
12 32.4 0.0001% >US$600a 
129Xe 
12 11.8 26% Enriched: US$100 Natural: US$10 
 
Table 1.2: MR properties of hyperpolarised 3He and 129Xe. a. (Kramer, 2011), all 
other values from Mugler et al., (2013). 
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being a much larger, higher density and slower-diffusing gas, with higher resistance in narrow 
obstructed airways. 
Ventilation is most commonly imaged by spin density weighted imaging sequences, in which 
the signal achieved is proportional to the volume of gas in each voxel. Spin density imaging 
of hyperpolarised gas was first demonstrated with 129Xe MR images of mouse lungs by Albert 
et al. (1994). It has since been researched extensively in humans by exploiting the 
characteristic inhomogeneous distribution of air that these diseases cause to visualise a range 
of obstructive pulmonary diseases including asthma (Lange et al., 2009; Hahn et al., 2016; 
Ebner et al., 2017), COPD (Woodhouse et al., 2009; Hamedani et al., 2016; Kirby et al., 
2017), and emphysema (Sun et al., 2011). In all cases, spin density weighted imaging exploits 
the characteristic inhomogeneous distribution of gas seen in these obstructive diseases, 
resulting in areas that are devoid of signal. A comparison of the effectiveness of 
hyperpolarised 3He spin density imaging to CT for detecting ventilation defects in lung 
transplant patients showed that 3He offers a significant improvement in the ability to detect 
defects (Gast et al., 2002). This is due to CT offering only lung structural information rather 
than visualisation of a gas. 
Alongside spin density imaging, HP gases can be used to indirectly measure pulmonary 
function status: free diffusion of gas occurs in the trachea, but the bronchiolar and alveolar 
walls restrict the movement of gases, reducing their diffusivity to that of the apparent 
diffusion coefficient (ADC), which is determined by compartment size. Diffusion weighted 
imaging allows the ADC to be mapped. This application has been valuable in studies of 
emphysema, as it allows the location and severity of tissue destruction to be visualised (Saam 
et al., 2000; Salerno et al., 2002; Kirby et al., 2014; Wang et al., 2014; Weatherley et al., 
2016). 
The T1 of hyperpolarised gas is inversely proportional to oxygen concentration; therefore T1-
weighted images can also produce information about pulmonary ventilation. Oxygen-sensitive 
HP 3He MRI is used to detect differences in oxygen partial pressures (pO2). In diseases where 
ventilation is reduced, alveolar partial pressure in the diseased regions will be reduced (Saam 
et al., 1995). The T1 shortening effect of molecular oxygen on hyperpolarised 3He has been 
used to calculate the in vivo pO2 distribution with 3% accuracy (Deninger et al., 1999). 
The high sensitivity of HP noble gas MRI to airway structure due to its high SNR has made it 
an attractive pulmonary ventilation imaging technique to research. However, the requirement 
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for expensive hyperpolarisation hardware, gas, and expertise has slowed its translation to 
clinical practice with the first diagnostic images only published within the past couple of 
years (Wild et al., 2015). An imaging modality that utilises thermally polarised gas could 
therefore present improved opportunities for widespread clinical use. 
1.3.4 MRI of pulmonary ventilation using perfluorinated gases 
Fluorine-19 (19F) is the only stable isotope of fluorine. Its MR properties in comparison to 1H 
are summarised in Table 1.3. 
The 19F isotope has a 100% natural abundance, and is the second most receptive nucleus for 
MRI, giving a relative sensitivity of 83% to that of 1H. With no detectable natural background 
signal in vivo, endogenous background signal is also minimised. The MR relaxation times of 
thermally polarised 19F molecules aren’t highly affected by exposure to oxygen, allowing 
more permissive breathing protocols than hyperpolarised gas MRI, such as gas wash-in 
measurements and acquisitions during steady-state breathing (Chang and Conradi, 2006). 
However, pulmonary imaging challenges arise from its low spin density and thermal 
polarisation. Careful selection of an appropriate perfluorinated molecule for MR studies is 
therefore necessary to attain adequate signal. 
Candidates that have previously been investigated for 19F-MRI of pulmonary ventilation 
include SF6 (sulfurhexafluoride), C2F6 (perfluoroethane), CF4 (tetrafluoromethane), cyclo-
C4F8 (cyclo-octafluorobutane) and C3F8 (perfluropropane). A summary of their chemical 
properties is displayed in Table 1.4 (Mohanty and Bernstein, 1970; Chang and Conradi, 2006; 
Wild, 2009).  
Cyclo-C4F8 has been shown to cause severe convulsions in rats thus is considered unsuitable 
for further in vivo use (Miller et al., 1972). However, the other gases listed are all chemically 
and physiologically inert, non-toxic, and insoluble (Mosbah et al., 2008).  
Isotope Spin, I Gyromagnetic ratio, 𝜸 (MHz/T) Relative sensitivity (%) 
1H 12 42.58 100 
19F 12 40.05 83 
Table 1.3: MR properties of 1H and 19F. The high gyromagnetic ratio 
of 19F produces good imaging sensitivity relative to that of 1H (Ruiz-
Cabello et al., 2011). 
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Molecule 
Molecular 
weight 
(g/mol) 
Chemical 
structure 
T1 in vitro 
at 1.5 T 
(ms) 
T2 in vitro 
at 1.5 T 
(ms) 
CF4 88.01 
 
1.9 ~T1a 
C2F6 138.02  
7.9 6.6 
Cyclo-C4F8 200.04 
 
47 - 
SF6 146.06 
 
1.7 ~T1a 
C3F8 188.02  
20 13.8 
The quality of the images produced is dependent upon the T1 and T2* relaxation times of the 
nuclei, as well as the spin density of chemically equivalent 19F atoms within a molecule. A 
shorter T1 permits a higher degree of signal averaging within a fixed acquisition time 
improving the SNR by the square root of the number of averages. A very short T2* however 
necessitates a short TE, resulting in a wide receiver bandwidth. A high bandwidth has a larger 
frequency range and therefore picks up a larger range of noise frequencies, reducing the SNR 
(Wild, 2009). 
CF4 and SF6 both exhibit particularly short T2 relaxation times in vivo due to their smaller 
molecular size and shorter correlation times, analogous to their short T1 (Mohanty and 
Bernstein, 1970; Wild, 2009), requiring high receiver bandwidths and fast gradient switching 
rates to image successfully. However, they both differ in utility primarily due to 19F density; 
with just four 19F nuclei per molecule CF4 is considered an unfavourable gaseous imaging 
agent for MRI. SF6 however, with a 50% higher signal density then CF4, has been widely 
researched in small and large animals and excised human lungs imaging studies (Jacob et al., 
2005; Perez-Sanchez et al., 2005; Scholz et al., 2009). It is well established as a safe gas due 
to its chemical and biological inertness and is the first fluorinated gas to be approved for 
human use in studies in a 78%/22% mixture with oxygen (Wolf et al., 2008). The study 
participants tolerated the gas mix well for the 3 – 5 breaths required for the study with no 
adverse events reported. For clinical use, it is preferable that the inhaled gas can be imaged 
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Table 1.4: A summary of the chemical and MR properties of perfluorinated 
gasses used in previous lung MR studies. a: Exact T2 values aren’t described 
in the literature but are described as approximately equal toT1. No value for 
cyclo-C4F8 T2 could be found in the literature. 
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within a single breath hold, noting that a patient with lung disease may be less able to hold 
their breath than a healthy individual. Previous work on SF6 (Schreiber et al., 2001) has 
shown that 3D images with adequate signal to noise ratios were obtained with a 49 second 
temporal resolution. Any considerable improvement on this acquisition time whilst 
maintaining image quality necessitates using a more suitable fluorine gas with a longer T2*. 
This obstacle to further development is reflected in the observation that SF6 hasn’t been 
utilised in any human studies in this field since 2008. 
The MR relaxation times of C2F6 are longer than those of SF6, which would make it a 
potentially suitable candidate for MR applications. It has been used as the imaging agent in a 
number of in vivo mouse and excised human lung studies of both spin density and diffusion 
weighted imaging (Jacob et al., 2005; Wolf et al., 2006; Carrero-Gonzalez et al., 2013). 
However, it has no precedent for use as an inhalable imaging agent in human subjects; 
seeking regulatory approvals and verifying safety would therefore be a primary concern 
before beginning human in vivo investigations that utilise this gas.  
Recent publications have focussed on utilising C3F8 as an inhalable agent for pulmonary 
imaging in human subjects (Couch et al., 2013; Halaweish et al., 2013; Halaweish and 
Charles, 2014). C3F8 is composed of 19F groups in two distinct chemical environments, -CF3 
and -CF2, whose resonant frequencies are separated by 48 ppm. Therefore, maximal MR 
signal is detected from the -CF3 group, providing a relatively high spin density of six 19F 
nuclei per molecule. C3F8 mixed with 21% O2 has been measured to have an in vivo T1 of 
12.4 ms at 3.0 T (Couch et al., 2013) and a T2* of 2.2 ms (Couch et al., 2013) in the human 
lung. Its comparably long relaxation times make it more suitable than SF6 and CF4 for lung 
imaging, and it has a precedent for safe inhalation in human subjects. C3F8 is therefore 
considered the most suitable MR-sensitive inhalable imaging agent for this study, and will be 
used throughout the subsequent chapters.  
As with hyperpolarised noble gas imaging, perfluorocarbons have an ADC dependent on 
alveolar size. Diffusion weighted images could therefore approximate the severity of 
ventilation defects such as emphysema. Diffusion weighted 19F MRI has been demonstrated 
(Perez-Sanchez et al., 2005; Ruiz-Cabello et al., 2005). In anatomically healthy excised 
human lungs, the ADC of perfluorocarbon gases is approximately 50% of the free diffusivity 
D0. In comparison, emphysematous lung models have produced a perfluorocarbon diffusivity 
approximately 90% of D0 (Jacob et al., 2005). Diffusion weighted imaging has been carried 
out in vivo using C2F6 gas to compare ADC measurements in a preclinical model of 
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emphysematous and healthy rat lungs (Carrero-Gonzalez et al., 2013), with the former 
resulting in an increased ADC, in agreement with diagnostic theory. 
Literature investigating 19F-MRI of pulmonary ventilation is limited. The majority of 
publications reporting application of perfluorinated gas MRI of pulmonary imaging focus on 
spin density imaging, which will be the primary focus of this thesis. Early papers have 
concentrated on acquiring spin density images, typically with a 3D gradient echo acquisition 
sequence, in rodents (Kuethe et al., 1998; Kuethe et al., 2002), pigs (Schreiber et al., 2000; 
Wolf et al., 2006), and excised human lungs (Jacob et al., 2005) with the latter achieving an 
SNR of 9:1 in 13 s using 5.5 × 5.5 × 32 mm3 voxels. These studies validated the efficacy of 
the imaging technique to provide information about the distribution of gas in the lung. 
Mapping fractional ventilation over wash-in and wash-out breathing cycles provides a tool 
with clinical utility that hyperpolarised gas MRI has a limited capacity to measure due to the 
loss of longitudinal polarisation within tens of seconds. Application of spin density weighted 
19F-MRI of inhaled perfluorinated gases to mapping wash-in and wash-out kinetics has been 
reported in a small number of studies. Its feasibility was first tested in mechanically ventilated 
porcine lungs (Schreiber et al., 2001), recording fractional ventilation during deep and 
shallow breathing protocols; 2 and 5 inspirations respectively were required for near complete 
wash-in. Since, 19F wash-out rate has been reported in rat lungs (Ouriadov et al., 2015) and 
mouse models of obstructive lung disease (Couch et al., 2016), where a slower wash-out rate 
was observed in mice with inflamed lung tissue than in comparable healthy controls.  
Spin density imaging is the only MR technique imaging inhaled perfluoropropane that has 
been studied in human subjects. The first demonstration of which used an 3D SPGR 
acquisition taken during a 15 s breath hold after inhalation of perfluoropropane in a 79%/21% 
mixture with oxygen (PFP/O2) achieving acceptable image quality with an SNR of 15:1 in a 
single healthy volunteer (Soher et al., 2010). Halaweish et al. (2013) built on this preliminary 
result to image 11 healthy volunteers and 17 subjects who had been diagnosed with 
obstructive lung disease following a similar acquisition protocol. The images produced had 
SNRs that ranged between 5 and 30 using 6.25 × 6.25 × 15 mm3 voxel sizes, and depicted 
defects typical of each of the lung diseases. The extent of ventilation defects visible 19F-MRI 
images of COPD patients was seen to qualitatively increase with previously diagnosed disease 
severity. In parallel to this, Couch et al. (2013) achieved a SNR of 18 ± 6 in healthy 
volunteers, again applying a similar acquisition protocol. In all cases acquisition times of ~15 
s were used. Application to the measurement of wash-out rates in humans has been carried out 
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under tidal breathing conditions (Charles et al., 2014). Assessment of 35 subjects recorded 
greatly reduced wash-out rates in COPD patients and smokers in comparison to non-smokers. 
These studies have demonstrated the feasibility of MR imaging of pulmonary ventilation in 
human subjects using inhaled PFP/O2.  
Although there has been no literature to-date, further development of ventilation imaging in 
vivo is likely to utilise the MR effect of the physiological environment on the gas; the 
transverse relaxation times of perfluorinated gases are known to be reduced when confined to 
small pores (Lizak et al., 1991), as is found in the lung. Therefore, the signal from T2* maps 
of an inhaled perfluorinated gas is expected to vary across regions of the lung, and with lung 
pathology. 
Unlike other pulmonary ventilation imaging techniques, the use of ionising radiation is 
negated with MRI, making it favourable particularly for repeat acquisitions for long-term 
patient monitoring. 19F MRI is demonstrably more economical than hyperpolarised noble gas 
imaging due to reduced hyperpolarisation equipment and expertise requirements, and the MR 
relaxation times are minimally affected by the presence of oxygen, unlike HP noble gases, 
permitting longer imaging studies. There have only been a handful of published human 19F 
pulmonary ventilation studies, but they have shown promising results with adequate SNR 
values being achieved, providing a solid foundation for further development of the technique. 
The larger body of in vitro studies and in vivo animal research has demonstrated the potential 
for several future avenues of development and application. 
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1.4 Outline of chapters 
The body of work described in this thesis has aimed to develop methods for quantitative 
measurement of pulmonary function using inhaled perfluoropropane as an MR sensitive 
imaging agent. It has achieved this through both optimisation of pre-existing methods in 
human subjects, as wells as the development of novel techniques which have built a 
foundation for future methodologies. This work is outlined below. 
Chapter 2 describes a preliminary 19F-MRI study imaging inhaled perfluoropropane in twelve 
healthy volunteers. This was conducted to verify the efficacy of the technique and to identify 
key limitations which were addressed in subsequent chapters. Perfluoropropane wash-in and 
wash-out rates with a deep-breathing protocol were also assessed. 
In Chapter 3 a quadrature birdcage coil was designed and constructed for use with 19F-MR 
development work in phantoms. A larger commercial quadrature transmit/receive birdcage 
coil was then assessed for suitability for imaging inhaled perfluoropropane, and compared 
with three alternative RF coils by assessment of signal homogeneity within their sensitive 
volumes as well as their power handling efficiency. 
In Chapter 4 the 3D spoiled gradient echo pulse sequence was simulated to determine the 
dependence of 19F signal to noise ratio achievable in a fixed acquisition time on acquisition 
parameters, followed by application of a compressed sensing acceleration technique. The 
optimised sequence was validated in both phantom models and healthy volunteers. 
Chapter 5 focusses on the application of susceptibility matching of gas and aqueous 
compartments to increase the T2* of perfluoropropane. Two stable lung-representative 
phantoms that mimic the magnetic properties of alveolar tissue were developed. Gadolinium 
based contrast agents were added to the lung-representative phantoms to verify the amount of 
paramagnetic contrast agent required to achieve full susceptibility matching between the 
parenchymal representative media and the perfluoropropane gas suspension.  
Chapter 6 translated this novel technique to in vivo applications. Gadobutrol was used to 
modify the susceptibility gradient in mouse alveoli, and T2* mapping of perfluoropropane –
CF3 was performed to verify this change. Finally, healthy volunteers were imaged following 
perfluoropropane inhalation with a concurrent intravenous injection of Gadobutrol. Dynamic 
acquisition sequences were used to detect the change in T2* on the first pass through the 
pulmonary vasculature.  
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       Chapter 2:  
Healthy Volunteer Proof of Concept Study 
2.1 Overview 
Imaging inhaled perfluoropropane to assess lung function is a relatively novel but promising 
concept, with just three human studies published to-date (Couch et al., 2013; Halaweish et al., 
2013; Couch et al., 2014). In this chapter, a small-scale healthy volunteer study is conducted 
in order to test and verify the potential of this technique, and to identify possible obstacles to 
future clinical application. This work was conducted with the aim of assessing magnetic 
properties and signal behaviour of the inhaled PFP/O2 as detailed below in order to guide 
further development of this imaging technique.  
19F images are acquired during a single breath hold after inhalation of perfluoropropane. Intra-
volunteer reproducibility is assessed from these images, and the benefits and limitations of the 
RF coil utilised for the study is determined and discussed. 
Satisfactory image detail requires adequate signal. The number of wash-in breaths should be 
minimised such that when utilised on patient groups, adequate contrast between areas of 
differing ventilation is achieved. It is therefore valuable to understand the wash-in rate of 
perfluoropropane. A fast dynamic imaging acquisition is thus utilised to allow assessment of 
perfluoropropane wash-in and wash-out rates after one, two, and three deep respiratory 
cycles.  
Finally, in vivo measurements of perfluoropropane –CF3 T2* are made over the full breathing 
cycle to corroborate and expand upon values published in the literature. The implications of 
these results are discussed. 
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2.2 Methods 
2.2.1 Volunteers 
This study utilised in vivo 19F MRI of healthy volunteers. Full ethical approval was in place 
(assessed by the Newcastle and North Tyneside 1 Ethics Committee. REC reference number: 
14/NE/0135, IRAS project ID: 69343), and the volunteers gave informed consent to 
participate. A respiratory clinician and MR radiographers were present throughout all human 
perfluoropropane inhalation scans. 
Twelve healthy volunteers (six male, six female) attended two MRI sessions each between 
November 2014 and June 2015. The men had a mean age of 34 with a range of 23 – 40 years. 
The women had a mean age of 24, with a range of 21 – 31 years. All volunteers were assessed 
by a clinical fellow and were confirmed to be in good health with no history of respiratory, 
cardiac, or cerebrovascular disease. Volunteers were also required to be non-smokers with a 
smoking history of less than 10 pack-years (where 20 cigarettes a day for one year is one pack 
year), and to have ceased smoking more than two years prior to the study. A spirometric test 
was carried out on each participant to confirm normal lung function. 
2.2.2 19F MRI hardware set-up 
Perfluoropropane (C3F8, PFP) was selected as the perfluorinated imaging agent, in a 79:21 
mixture with oxygen (referred to from this point forward as PFP/O2). This was due to it 
having been used successfully in previous human inhalation studies (Couch et al., 2013; 
Halaweish et al., 2013), it being available in ‘patient consumption’ grade, and it having a 
useful T2* in vivo of 2.2 ms (Couch et al., 2013). The two CF3 groups in PFP have 
chemically equivalent environments, and constitute the majority of the fluorine signal. The 
chemical environments of the CF3 and CF2 groups are separated by 48 ppm, meaning that CF2 
resonances were not visible in acquisitions at CF3 frequencies. 
An inhalation rig was designed and built to control the supply of gas to the volunteer. A 
diagram illustrating the layout of its primary components is displayed in Figure 2-1. 
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Two Douglas bags (100 L and 25 L) were filled with 100% O2 and 79:21 PFP/O2 respectively 
from non-MR safe gas cylinders (both supplied by BOC) prior to each scan. The Douglas 
bags were hung on an MR-safe PVC-U frame. 
Smooth bore, 35 mm internal diameter (ID) low resistance tubing was used to connect the gas 
supplies to a manually controlled 3-way valve (2500 series, Hans Rudolph). 22 mm ID tubing 
was used to connect all components forward of this in order to minimise dead space. A 2-way 
non-rebreathing valve (1410 series, Hans Rudolph) and tubing allowed the exhaled gas to be 
deposited away from the magnet bore and the volunteer. An antibacterial filter was fitted to a 
disposable mouthpiece. All volunteers wore nose clips during the scans to aid adherence to 
the respiration protocol. 
A pneumotach sensor (TSD127, Biopac Systems) was used for both assessing the volunteers 
breathing rate and volume compliance, as well as providing live feedback of this information 
to the volunteer.  
Oxygen saturation and heart rate values were acquired throughout each scan using a MR-safe 
pulse oximetry sensor on the volunteer’s finger (Model 7500FO, Nonin Medical). The pulse 
Figure 2-1: Diagrammatic layout of the inhalation rig components. The pneumotachometer 
and pulse oximeter are passed through the waveguide and monitored from the control room. 
The 100% O2 supply was only made available if the subject’s oxygen saturation dropped below 
90% whilst in the scanner bore.  
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oximeter and pneumotachometer cables were passed through a waveguide in the scanners 
Faraday cage, allowing the live feedback displays to be monitored by the clinician during the 
experiment. The live pneumotachometer airflow data could optionally be viewed by the 
volunteer through projection onto a display in the scanner room and a small mirror inside the 
scanner bore. 
This study was performed on a Philips Achieva 3.0 T system in conjunction with a circular 
transmit/receive 20 cm diameter surface coil tuned to the fluorine resonant frequency, 
manufactured by PulseTeq Ltd (Model MN20A2). 
During the scan, the subject was positioned supine on top of the RF coil. The coil was 
positioned beneath the lungs as shown in Figure 2-2, with the top of the coil aligned centrally 
with the volunteer’s clavicle; this ensured repeatable positioning, whilst fully covering the 
apex of both lungs.  
2.2.3 Testing intra-volunteer reproducibility 
The feasibility of this imaging technique is dependent on an adequate image quality being 
achieved, and this image quality being reproducible. Due to the strong dependence of 19F 
SNR with distance from the coil, arising from the surface coils B1 field and receive geometry, 
inter-volunteer reproducibility of SNR was deemed an unsuitable measurement, as the 
distance between the coil and the lungs varied between individuals. Intra-volunteer 
reproducibility of SNR was therefore tested instead. 
Twelve healthy volunteers performed three deep wash-in inhalations of PFP/O2. This was 
 
Figure 2-2: Positioning of 19F surface coil 
on the volunteers back. The coil was 
positioned to cover the apex of both lungs. 
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followed by a 15 second long breath-hold during which a coronal 3D spoiled gradient echo 
(SPGR) image was acquired, using the imaging parameters described in Table 2-1.  
Due to the poor B1 homogeneity associated with the surface coil design, any requested flip 
angle would not be achievable over the entire field of view. For this study, the coil was 
calibrated to achieve an average flip angle of 50o at the centre of the field of view. This was 
achieved by performing a spectroscopic free induction decay and arraying the requested flip 
angle between 0o and 180o at 10o intervals during a breath hold of PFP/O2, then calibrating the 
power delivered to the coil to achieve peak signal at 90o.  
The 1.8 s dynamics were averaged 8 times, producing a 14.4 s long acquisition. This was 
done in order to improve the SNR by a factor of N, where N is the number of averages, 
whilst maintaining a breath hold length scan time. A default slice oversampling factor of 1.28 
was used. Both the echo time and repetition time were the minimum allowed values, and the 
flip angle was chosen to be close to the Ernst angle for the gas, in order to maximise the 
signal with averaging. Each volunteer underwent this protocol twice to allow reproducibility 
testing. 
The signal-to-noise ratio (𝜇´O/𝜎) was calculated from the 14.4 s acquisition. The 
mean signal was assessed using a 50 × 50 mm region of interest (ROI) in the upper right 
section of each volunteer’s lung. The noise measurement was taken from a 50 × 50 mm ROI 
outside the lung volume in the same image slice as the signal measurement. In each case, a 
slice proximal to the coil was chosen. The reproducibility between acquisitions from each 
volunteer was tested using a two-way fixed intra-class correlation (ICC). 
Acquisition sequence 3D SPGR 
Flip angle 50o 
TE (ms) 1.55 
TR (ms) 4.95 
Bandwidth (Hz/pixel) 500 
FOV: H-F × L-R × A-P (mm3)  400 × 400 × 160 
Voxel size (mm3) 10 × 10 × 10 
Dynamic duration (s)  1.8 
Table 2.1: The acquisition parameters for a dynamic 3D spoiled 
gradient echo sequence. The field of view was designed to be larger 
than the sensitive volume of the coil. 
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2.2.4 Assessment of gas wash-in and wash-out rate 
Understanding the wash-in rate of the PFP/O2 gas mixture in healthy volunteers is necessary 
for further development of the 19F lung imaging. The benefits are two-fold: achieving images 
with maximum SNR by imaging after an adequate number of respiration cycles, and 
eventually comparing wash-in rates to those with obstructive lung disease, as it may prove a 
useful quantitative marker for assessment of lung function severity. 3D SPGR acquisitions 
were carried out to measure signal increase over time during respiration of the PFP/O2 gas 
mixture in 12 scan sessions. The same acquisition parameters as listed in Table 2.1 were used, 
with 70 dynamics, allowing collection of images over several breathing cycles.  
The volunteers followed visual timed breathing instructions. A deep-breathing protocol was 
used that required all volunteers to inhale and exhale maximally at near vital capacity. This 
was chosen as it was deemed easy for volunteers to adhere to reproducibly, and would allow 
the volume of PFP/O2 inhaled to scale with participant lung volume. Inhalation and exhalation 
times of 4 seconds were chosen as they were long enough to ensure the volunteer had time to 
inhale and exhale fully. After each inspiration, the volunteers were required to hold their 
breath for 5 seconds in order to measure the signal intensity. This breath hold duration was 
chosen to ensure that at least two 1.8 s dynamics fell within that time period. Each volunteer 
performed three ‘inhale, breath hold, exhale’ breathing manoeuvres of the PFP/O2 gas, before 
being switched to breathing room air, and repeating the same respiration procedure three more 
times. This allowed collection of images over three wash-in and wash-out respiration cycles. 
 
Figure 2-3: Diagram of the breathing and breath hold pattern followed by each 
volunteer. Three deep inhalations of PFP/O2 are followed by three deep inhalations of 
room air. The dynamic acquisition sequence runs throughout, permitting dynamics from 
the breath holds following each inhalation to be compared. 
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Figure 2-3 displays a spirometric trace of the breathing and breath hold pattern followed over 
the acquisition.  
The SNR achieved during each breath hold was measured using signal from a 50 × 50 mm 
ROI positioned near the apex of the right lung, and noise from an equal sized ROI outside the 
lung volume. 
2.2.5 In vivo measurement of T2* 
Average in vivo T2* of the inhaled PFP -CF3 resonance was measured using a dynamic free 
induction decay (FID) sequence, summarised in Table 2-2. 
The sequence was acquired while the volunteer followed a deep breathing protocol.  This 
regime allowed average T2* values to be collected at both full inspiration and expiration. The 
protocol was repeated on four volunteers. T2* was calculated by fitting FID signal decay from 
each dynamic to an exponential decay curve for the form 𝑆 = 𝑆=𝑒Hge gx∗, taken from Equation 
1.12. Where S is the signal measured in the FID at time point TE, and 𝑆= is the signal before 
any decay, ie. at TE = 0 ms. 
  
Acquisition sequence Unlocalised FID 
Flip angle / shape 90o hard pulse 
Number of FID samples 256 
Sample frequency (Hz) 8000 
Acquisition length (ms) 42 
Number of dynamics 2500 
Table 2.2: The acquisition parameters for dynamic measurement 
of average T2* in vivo. 
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2.3 Results 
2.3.1 Testing intra-volunteer reproducibility 
3D SPGR lung images with a mean SNR of 40.3 ± 5.3 were achieved in 14.4 s acquisitions 
after three vital capacity wash-in inhalations in twelve healthy volunteers. The intra-volunteer 
reproducibility of SNR measurements was calculated to be ICC(3,1) = 0.961 with a 95% 
confidence interval of 0.863 to 0.989.  
Data from three representative volunteers of the total twelve are displayed in Figure 2-4. The 
first and second rows show a single slice from the first and second acquisition respectively. 
The third row depicts the 19F signal in a slice, threshold-masked and overlaid on a proton 
image to demonstrate anatomical positioning of the signal. 
Volunteer 1 Volunteer 2 Volunteer 3 
 
Figure 2-4: Rows one and two: Slices in the coronal plane proximal to the coil from six 19F 
3D SPGR acquisitions in three healthy volunteers. All were acquired within a 15 s breath 
hold duration after wash-in of PFP/O2. Row three: Masked 19F signal overlaid on an 
anatomical proton image. 
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Figure 2-4 illustrates the good intra-volunteer reproducibility of the technique, and the 
variable signal distribution between volunteers. The absence of signal in the base of the lungs 
represents the small sensitive volume of the surface coil. Notably, analysis only of slices 
proximal to the coil (in the same coronal plane as the subjects’ spines) was performed due to 
exponential signal decay with distance. This is illustrated in Figure 2-5a, which plots the 
average SNR loss (±SD) in the A-P direction from three measurements in a representative 
subject. Example images at three A-P distances is also shown. 
2.3.2 Assessment of gas wash-in and wash-out rate 
The resulting SNR after one, two, and three deep wash-in inhalations of PFP/O2 was 
calculated from twelve scan sessions (one per subject). An increase in mean SNR and 
decrease in its standard deviation was seen as the wash-in progressed, from SNR = 9.7 ± 2.9 
 
         
Figure 2-5: a. SNR over distance from coil surface. High SNR seen posteriorly, proximal to 
the coil surface, with exponential loss of signal over the following 10 cm. b. Image of slice at 
30 mm distance from coil surface. c. Image of slice at 50 mm. d. Image of slice at 70 mm. 
   
a. 
d. c. b. 
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after the first inhalation, to 12.8 ± 2.3 after the second inhalation, and 14.3 ± 1.9 after the final 
inspiration. The results are displayed in Figure 2-6, alongside the same results displayed as a 
percentage of their final SNR. 
 It was found that the SNR range decreases with the number of inhalations despite poor inter-
volunteer reproducibility. The average increase in SNR between inhalations one and two was 
32%. This decreased to 12% between inhalation two and three, suggesting that near maximal 
wash-in is being achieved in this region of the lung after three inhalations. Fitting the mean 
SNR values to a recovering exponential curve suggests that a maximum mean SNR is 14.7, 
which is achieved in upwards of 5 inhalations. This confirms the adequacy and efficiency of 
performing a three-inhalation wash-in after which an only slightly smaller mean SNR of 14.3 
is achieved. 
Three wash-out respiratory cycles following the above wash-in protocol reduced the mean 
SNR from 14.3 ± 1.9 to 2.5 ± 1.2. The results are summarised in Figure 2-7. Fitting to a 
decaying exponential determines that approximate complete wash-out (in this case where 
mean SNR is equal to the minimum value to 1-decimal place) occurs after five deep wash-out 
respiratory cycles.  
Figure 2-6: SNR change over three deep inhalations of PFP/O2 gas, also displayed as 
percentage change. With increased wash-in an increase is SNR and a reduction in range is 
noted. The box plots display the mean SNR (horizontal line) and interquartile range. The error 
bars denote the minimum and maximum SNR values measured. 
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2.3.3 In vivo measurement of T2* 
Figure 2-8 plots representative FIDs measured at full expiration and full inspiration. This 
shows the average signal drop-off from multiple T2* values in the lung volume. For the 
purposes of this preliminary experiment, a simple monoexponential line of best fit was 
utilised and displayed on this plot to approximate the average T2* values. This was calculated 
by direct fitting of 𝑆 = 𝑆=𝑒Hge gx∗ in Matlab (R2014a, USA) with no noise flooring constant 
due to negligible noise levels being present.  Multiple initial approximations of 𝑆= and T2* 
were used to verify the robustness of the calculated fit. 
The average T2* measured at full inspiration after three deep wash-in inhalations of PFP/O2 
was 1.7 ± 0.26 ms. At full expiration, the T2* was seen to reduce to 1.3 ± 0.3 ms. 
A key observation made was that T2* varied as a function of place in the respiratory cycle. 
The fluctuation of T2* over the respiratory cycle is shown for a representative volunteer in 
Figure 2-9. PFP/O2 inhalations occurred at zero and twelve seconds. An inhalation of room air 
occurred at 28 seconds. The horizontal sections represent periods where the volunteer held 
their breath.  
  
Figure 2-7: SNR change over three deep inhalations of room air after three wash-in inhalations 
of PFP/O2, also displayed as percentage change. The box plots display the mean SNR 
(horizontal line) and interquartile range. The error bars denote the minimum and maximum 
SNR values measured. 
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Figure 2-9: Change in PFP T2* over the respiratory cycle. The relative signal amplitude 
(upper curve) is indicative of the position in the respiratory cycle when inhaling PFP/O2. The 
T2* follows the same pattern Notably, in the final 10 s, a wash-out inspiration of room air is 
performed causing the signal amplitude to stay at the level at expiration, whereas the T2* 
increases.  
Figure 2-8: FID decay curves at full inspiration and expiration, with solid lines denoting 
monoexponential fits. The poor fit is due to the unlocalised FID signals representing poly-
exponential T2* decay averaged over all regions in the sensitive volume of the coil. 
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2.4 Discussion 
The rate of PFP wash-in over three respiration cycles resembles an approximate exponential 
curve. In this case, further inhalations would continue to increase the SNR, but by a 
considerably reduced amount that is likely to be of minimal benefit for vital capacity scans, 
which has been the primary focus of this study to date. Therefore, for future healthy volunteer 
scans, a minimum of two vital capacity inhalations is recommended, with three inhalations 
nearing maximal wash-in. This fast PFP/O2 wash-in seen consistently in healthy volunteers 
offers a clear baseline to contrast with wash-in data from patients with COPD or asthma. The 
application of this information to imaging patients with lung disease will require a 
compromise between achieving an adequate SNR to produce clear images with good coverage 
in healthy areas of the lungs, and aiming to avoid wash-in to areas with airway obstruction, to 
allow clinically useful contrast in the image. The extent of PFP wash-in and gas diffusion this 
requires may vary between subjects, and cannot be decided without completing similar 
measurements on relevant patient groups. 
To date insufficient wash-in data has been collected in our tidal breathing studies to draw any 
conclusions on wash-in rate. It is known that vital capacity breathing produces different lung 
expansion homogeneity than the more natural tidal breathing, but it is apparent that tidal 
breathing wash-in is particularly uneconomical and impractical as volunteer compliance and 
repeatability of respiration volumes is considerably harder to regulate, and a larger number of 
inhalations would be required to achieve satisfactory wash-in. For this reason, only deep 
inhalation protocols will be used in this work. 
Also of note is that a previous study has measured an in vivo T2* of PFP –CF3 in the lungs of 
2.2 ms (Couch et al., 2013), however preliminary unlocalised measurements in this work 
found that the value typically decreased to 1.3 ms upon exhalation, reaching values near 2 ms 
after deep inhalation. This change in T2* is postulated to be explained by the varying 
magnetic susceptibility gradients in the alveoli between inhalation and exhalation. The exact 
physiological cause of this is unknown, but could be the increased parenchymal surface area 
to alveolar volume ratio, or the increased ratio of parenchyma to gas seen at exhalation. These 
potential determinants of T2* in the human lung will be investigated in later chapters. This 
fluctuation in T2* may be more extreme in patients with alveolar damage. If this occured, 
acquiring maps of PFP T2* in vivo could offer a useful measure of emphysematous areas of 
the lung. This would require a fast imaging protocol due to the high SNR required to calculate 
an accurate T2* map with adequate resolution within a breath hold. Optimisation of the 
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current imaging sequence is therefore necessary to achieve this, and is the focus of Chapter 4. 
The very restricted sensitive volume of the surface coil compared to lung volume, both in the 
anterior to posterior direction as well as head to foot, compromised signal homogeneity in 
return for good SNR proximal to the coil. It would be expected that the necessary move to a 
coil with improved signal homogeneity and a larger sensitive volume would be at the cost of a 
lower SNR to that achieved in this study, the extent of which is investigated in the following 
chapter. In this case, the use of an optimised imaging sequence to maximise SNR for a 
volume coil will again be valuable. 
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2.5 Conclusions 
This preliminary work has verified the utility of MRI as a pulmonary ventilation imaging 
technique at 3.0 T. Images with a SNR of 40 have been produced within a 15 s scan time at 
1.0 cm3 resolution. 
The work has laid a solid foundation for future 19F MRI studies, and identified several areas 
for improvement. These consist of: identification of a more suitable RF coil that provides full 
lung coverage, optimisation of the imaging protocol to maximise the SNR achieved in a 
breath-hold length scan time (with the understanding that using a different coil type will likely 
reduce the SNR), and development of new measures with which to assess lung function by 
further investigating the observed changes in T2* with alveolar volume. These subjects are 
investigated in the following three chapters. 
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       Chapter 3: 
19F Coil Construction and Assessment of Four 19F Coil Designs for 
Suitability for Pulmonary Imaging 
3.1 Overview 
The ideal RF coil design is highly dependent upon its application, as discussed in Section 
1.2.8. Lung imaging necessitates use of a coil that offers a large homogeneous field of view in 
order to cover the entire thoracic cavity, whilst maintaining good power efficiency in order to 
maximise SNR and temporal resolution and comply with SAR constraints. The 20 cm 
diameter surface coil utilised in the previous chapter demonstrated adequately high SNR 
proximal to the coil, but offered a very restrictive sensitive volume. It is evident from the 
resulting images (eg. Figures 2-4 and 2-5) that a more suitable coil design is required to attain 
clinically useful images of pulmonary ventilation. 
This chapter tests the hypothesis that 19F MRI of perfluoropropane using a larger RF coil 
design produces images of satisfactory quality despite reduced power efficiency. To 
investigate this, a 40 cm long quadrature birdcage torso coil was designed and constructed. 
This allowed verification of the coil performance and method development work to be carried 
out before purchase of a commercial coil with similar geometry. Initial tuning was performed 
on the lab bench, before undergoing validation checks and assessment of the coils 
performance in a Philips Achieva 3.0 T system. This aimed to test the practicalities of using a 
coil geometry that provides a more suitable FOV but lower power efficiency.  
The utility of four 19F RF coils built to differing geometric specifications was then evaluated 
and compared with the aim of defining the most suitable of the four coil designs for this 
application. The coils were: a 20 cm diameter surface coil (PulseTeq, used in the previous 
chapter), a 50 cm long linear birdcage torso coil (Rapid Biomedical – installed at the Royal 
Children’s Hospital, Melbourne), a 50 cm long quadrature birdcage torso coil (Rapid 
Biomedical), and the 40 cm long in-house built quadrature birdcage torso coil. In each case, 
the achievable SNR, power efficiency, and image homogeneity were assessed. 
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3.2 Methods 
3.2.1 Birdcage coil construction 
A 16-rung birdcage coil was designed to be elliptical, fitting body morphology, with a height 
and width of 400 mm × 500 mm respectively. The coil was constructed on a shell fabricated 
out of 6 mm thick acrylic sheets, laser cut to shape using a template produced in CAD 
software (Inventor Professional 2015). Sixteen 400 mm long rungs were cut from 8 mm 
diameter hollow copper pipe. End rings were then constructed from single sided FR-4 copper-
clad printed circuit board (PCB), sliced into thirty-two 16 mm wide strips using an industrial 
metal guillotine. The ends of each strip were cut to a taper, leaving thirty-two 3 mm spaces 
for capacitors to form two elliptical end rings (Figure 3-1). The copper legs were affixed 
between the two end rings by soldering strips of copper braid into the ends of the copper 
pipes, and onto the PCB strips through 8 mm diameter holes drilled centrally in each of the 
strips. The assembled coil structure is displayed in Figure 3-1.  
Ceramic chip capacitors (Temex Ceramics, Fr.) were soldered between end ring PCB 
sections. Capacitance values were chosen using Birdcage Builder software developed by Penn 
State Hershey College of Medicine (Chin et al., 2002). This software calculates the 
approximate capacitance distribution required around a birdcage coil of given dimensions. 
Figures 3-2a and 3-2b depict the input and output values of the software respectively. 
 
Figure 3-1: Structure of the completed coil 
frame. The coil is 400 mm long, and designed 
to be elliptical to maximise its sensitive 
volume. The 16 capacitor points are labelled. 
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The estimated capacitance required at each point to tune the coil to the resonant frequency of 
19F (120.24 MHz) was 14.95 pF. The calculated value was used as a starting point for tuning. 
The coil was tuned whilst driven in linear mode from the fourth capacitor junction clockwise 
from the top of the coil (at the right of the image displayed in Figure 3-1). Iterative 
adjustments of capacitance values at each point on the birdcage coil made until the resonant 
peak was tuned to 120.24 MHz using a network analyser.  
The effective shielding produced around the birdcage coil when placed in the scanner bore 
resulted in a different tuning to that achieved on the lab bench. To overcome this, the scanner 
bore was simulated in the lab using an aluminium-lined cylinder of equal dimensions to the 
bore. A resonance at 120.24 MHz in the scanner bore and simulator was found to be 
equivalent to 109 MHz when measured on the lab bench. A capacitance of 16.8 pF at each 
capacitor point achieved resonant tuning. The tuned resonant peak is displayed in Figure 3-3. 
a. b. 
Figure 3-2: a. The dimensions and required resonant frequency of the birdcage coil specified 
in the Birdcage Builder interface. b. The fixed capacitance distribution output from the 
Birdcage Builder interface. 
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The coil was constructed to be connected to the scanner via a set of variable capacitors, 
arranged as shown in Figure 3-4, to allow coil fine-tuning to 19F resonant frequency, and 
matching to 50 Ω.  
After validation of acceptable tuning of the coil in linear mode, the coil was then modified to 
be driven in quadrature. This required driving the coil from two points that produce an 
equivalent resonant peak on the network analyser. These should appear at any two points that 
are 90o apart. However, our test measurements showed that this did not hold true in practice 
due to the elliptical shape of the coil. The resonant frequency at each of the 16 potential input 
points was measured by interchanging the capacitor at each point for the cable/tune/match 
circuit. The values achieved are depicted in Figure 3-5. Using these values, the two driving 
ports chosen were points 7 and 11 (labelled in Figure 3-1), which both recorded peaks of 
109.0 MHz on the lab bench.  
Figure 3-4: The tune and match circuit. The tuning 
capacitor is joined in parallel to the birdcage coil circuit, 
and the matching capacitors are connected in series. 
Figure 3-3: Spectra showing all eight resonant peaks. The 
target resonant peak (red arrow) is tuned to 109 MHz on the 
lab bench. This resonance shifted to 120.24 MHz when the 
coil was placed in the scanner bore or bore simulator.  
 53 
 
3.2.2 Assessment of RF coil power performance 
The four coils assessed in the following subchapters are displayed in Figure 3-6.	 
The quadrature in-house birdcage coil was calibrated to produce an 180o flip when 180o was 
requested on the scanner interface using a phantom composed of a 2 L bottle filled with 79% 
C3F8 and 21% O2 (PFP/O2), positioned centrally in the coil. Once calibrated, the power 
handling performance under larger loading volumes could be tested. A pulse-acquire 
sequence was used with requested flip angles arrayed from 10o to 300o in 10o increments. The 
Figure 3-5: For successful quadrature use, the 
coil must be driven by two points with 90o 
separation that have approximately equal 
resonant frequencies. It was decided that points 7 
and 11 most closely match these requirements. 
Location 
number 
Resonant frequency 
on bench (MHz) 
1 109.0 
2 109.0 
3 110.4 
4 110.5 
5 113.0 
6 109.7 
7 109.0 
8 108.0 
9 108.0 
10 109.0 
11 109.0 
12 109.5 
13 110.0 
14 110.5 
15 109.3 
16 109.0 
Table 3.1: The resonant frequency achieved 
on the lab bench when driven via each of the 
16 port locations. Here, 109 MHz equates to 
achieving the 19F resonant frequency (120.24 
MHz) in the magnet bore. 
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Figure 3-6: The four transmit-receive coils assessed. a. 20 cm diameter surface coil (PulseTeq 
Ltd.). b. 50 cm long linear birdcage coil in situ at the Royal Children’s Hospital, Melbourne 
(Rapid Biomedical). c. 40 cm long birdcage coil (constructed in-house). d. 50 cm long 
quadrature birdcage coil (Rapid Biomedical). 
a. c. d. b. 
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flip angle analysis was carried out with the coil loaded with 4 L, 8 L, and 18 L volumes of 
loading solution (Rapid Biomedical standard phantom solution containing 5.0 g NaCl and 3.8 
g NiSO4∙6H2O in 1.0 L distilled water), in order to quantify the effect of loading on the flip 
angle produced. The above protocol was repeated on the commercially built quadrature 
birdcage coil in order to compare power performance. From these power measurements, the 
loading factor, defined as the factor the requested flip angle had to be changed by to achieve 
the desired flip angle, for each volume of loading was determined. 
The achievable B1 amplitude is proportional to the square of the peak power. Coil 
performance can therefore be quantified and compared by calculating 𝐵9 𝑃, where P is the 
amount of power deposited in a coil to achieve a specified B1. This measure describes the 
power efficiency of the coil. This value was assessed for each of the four coils with no 
loading, and when heavily loaded with 18 L of loading solution. 
3.2.3 Measurement of achievable SNR in four coils 
The signal-to-noise ratio achievable with each of the coils was determined. Acquisitions were 
carried out on a 2 L PFP/O2 phantom, positioned centrally in the coil. The acquisition using 
the 50 cm linear birdcage coil was conducted on a Siemens MAGNETOM Trio 3.0 T at the 
Royal Children’s Hospital, Melbourne. All other images were acquired on a Philips Achieva 
3.0 T system at the Newcastle Magnetic Resonance Centre.  
A 3D spoiled gradient echo (SPGR) acquisition sequence was implemented on each of the 
scanner and hardware configurations, and were designed to be as similar to each other as 
practically feasible. Table 3.2 shows SPGR acquisition parameters, each imaging sequence 
was considered the best achievable for the hardware set-up with the minimum achievable TE 
and TR used in each case. The most notable difference was seen in the repetition time, which 
stemmed from differing limitations on the maximum average RF power allowed in each 
configuration. This reflects the fact that the power restrictions for the birdcage coils are 
limited by a combination of several factors, namely component heating, scanner software 
limits, SAR restrictions, and the maximum allowed power from the amplifier, whereas the 
surface coil power restrictions were much more permissive due to its more efficient power 
handling. Therefore, component heating primarily restricted surface coil RF power limits. The 
minimum achievable echo times were restricted by RF pulse duration, determined by the 
maximum permitted peak power of the pulse. Opportunity for quantitative comparison is 
therefore limited, however an insight into the general practical performance of coils in a 
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breath hold length scan time was obtained.  
3.2.4 Assessment of signal homogeneity in four coils 
Signal homogeneity was assessed in all coils using a 3D SPGR imaging sequence with 
acquisition parameters as shown in Table 3.3. The images were acquired over a minimum 
FOV of 400 mm in the head-foot (H-F) and left-right (L-R) dimensions, and a minimum of 
300 mm in the anterior-posterior (A-P) dimension. As only relative signal homogeneity was 
compared with these acquisitions, the acquisition parameters used were not required to be 
comparable. A PFP/O2 phantom that filled the full sensitive volume of each coil was used to 
detect the signal over the volume. The signal intensity was then measured along the central 
axis in each dimension. 
 40 cm 
quadrature 
birdcage coil, 
built in-house 
20 cm surface 
coil, PulseTeq 
50 cm linear 
birdcage coil, 
Rapid 
50 cm 
quadrature 
birdcage coil, 
Rapid 
Acquisition 
sequence 3D SPGR  3D SPGR 3D SPGR 3D SPGR 
Field of view (mm3)        
H-F × L-R × A-P 
(mm) 
400 × 400 × 
300 
400 × 400 × 
160 
400 × 400 × 
160 
400 × 400 × 
150 
Voxel size (mm3) 10 × 10 × 10 10 × 10 × 10 10 × 10 × 10 10 × 10 × 10 
Flip angle 50o 50o 45o 50o 
Bandwidth 
(Hz/pixel) 500  500  500  500  
Echo time (ms) 0.70 1.50 1.64 1.72 
Repetition time 
(ms) 10.0 4.1 7.5 15.1 
k-space under 
sampling pattern Half-scan Elliptical filter None Half-scan 
Number of averages × length 3 × 4.38 s = 13.4 s 7 × 2.06 s = 14.4 s 3 × 4.80 s = 14.4 s 2 × 5.80 s = 11.6 s 
Table 3.2: Acquisition parameters used to measure SNR in breath hold length scan times. 
Values were chosen to be as similar as feasible whilst selecting close to the optimal 
achievable parameter values for each hardware set-up. The number of averages was 
selected to provide an acquisition length representative of a breath hold length scan (10 - 
15 s) to compare practical performance. In all cases, the acquisitions had an elliptical k-
space filter applied. 
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 40 cm 
quadrature 
birdcage coil, 
built in-house 
20 cm surface 
coil, PulseTeq 
50 cm linear 
birdcage coil, 
Rapid 
50 cm 
quadrature 
birdcage coil, 
Rapid 
Acquisition 
sequence 3D SPGR  3D SPGR 3D SPGR 3D SPGR 
Field of view (mm3)        
H-F × L-R × A-P 
(mm) 
400 × 400 × 
300 
400 × 400 × 
300 
500 × 500 × 
320 
530 × 530 × 
400 
Voxel size (mm3) 10 × 10 × 10 10 × 10 × 10 10 × 10 × 10 10 × 10 × 10 
Flip angle 50o 50o 45o 90o 
Bandwidth 
(Hz/pixel) 500  500  500  500  
Echo time (ms) 0.70 1.50 1.56 1.68 
Repetition time 
(ms) 10.0 4.1 30.0 100.0 
Table 3.3: Acquisition parameters used to test relative signal homogeneity within the coil 
volume. 
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3.3 Results 
3.3.1 Assessment of RF coil power performance  
The flip angle analysis confirmed that an 180o flip was achieved at a requested 180o flip angle 
for the unloaded in-house built birdcage coil in the chosen configuration. The flip angle array 
spectra are shown in Figure 3-7. 
Figure 3-8 displays how the actual flip angle varied with requested flip angle when the 
loading in both the in-house and commercially built coils were increased from 0 L to 18 L of 
loading solution. 
Figure 3-8: Comparison of coil efficiency when loaded with large volumes of loading solution 
in the in-house built and commercially built quadrature birdcage coils. A data point for human 
loading in the commercially built coil is also shown. 
Human load 
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Figure 3-7: Spectra from a flip angle array of the unloaded in-house built birdcage coil. The 
peak (90o) signal is seen when a ~90o flip angle is requested. This maximal signal intensity 
shifts to the right (i.e. the achieved 90o occurs at a requested flip >90o) when the coil is loaded. 
 58 
This demonstrates that the in-house built coil’s performance is greatly affected by relatively 
small amounts of loading. In order to calibrate the coil when loaded with 18 L of solution, a 
12.6-fold increase in RF power would be needed. This is less problematic for phantom 
experiments, for which this coil was designed, where loading can be minimised. 
With human loading, the commercially built birdcage coil achieves only half the flip angle 
achieved with no loading. Also of note is the poor approximation to human loading that even 
a large volume of commercially used phantom solution provides. Higher conductivity 
phantoms (constructed from sodium chloride solutions of varying concentrations) were also 
found to be poorly representative of a human load. 
The 𝐵9 𝑃	 values for the unloaded coils and heavily loaded coils respectively are displayed 
in Table 3.4 
Comparison of the power efficiency of the surface coil and the commercially built quadrature 
birdcage coil with human loads was made. 
During the preliminary healthy volunteer study (Chapter 2), the surface coil achieved an 8 µT 
B1 when receiving a peak power of 1 kW from the scanners RF amplifier. This is in contrast 
to the birdcage coil, which achieved a maximum B1 of 4 µT when receiving a peak power of 
1.5 kW from the RF amplifier (Figure 3-8). In order to achieve an 8 µT B1 on the birdcage 
 
40 cm 
quadrature 
birdcage coil, 
built in-house 
20 cm 
surface 
coil, 
PulseTeq 
50 cm 
linear 
birdcage 
coil, Rapid 
50 cm 
quadrature 
birdcage 
coil, Rapid 𝑩𝟏 √𝑷	¹ º𝝁𝑻	𝑾H𝟏𝟐¾ 0 L loading 0.28 0.25 0.25 0.21 𝑩𝟏 √𝑷¹ 	º𝝁𝑻	𝑾H𝟏𝟐¾ 18 L loading 0.11 0.25 0.17 0.14 
Maximum achievable B1, low-
load phantom (𝝁T) 8 8 10 8 
Maximum achievable B1, 
human load (𝝁T) - 8 - 4 
Table 3.4: The power efficiency measured in four coils with zero loading and heavy loading. The 
maximum achievable B1 with low loading and human loading is also displayed. No human studies 
were carried out on the 40 cm birdcage or 50 cm linear birdcage, so respective loading data is not 
available. The difference in 𝐵9 √𝑃	¹  values in the first two rows describes the power efficiency of 
the coil under loading. This change is reflected in the achievable B1 values. 
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coil with a human load, 6 kW of power would be needed. 
Although the Philips Achieva multi-nuclear RF amplifier outputs a peak power of 4 kW, 1.5 
kW was the maximum amount of power available to this birdcage coil due to power being 
attenuated in the transmission chain elements, namely the cable, T/R switch, and the coil 
connector socket. 
3.3.2 Measurement of achievable SNR in four coils 
The SNR achieved in comparable scans using each of the four coils is listed in Table 3.5.  
Notably, the 50 cm quadrature coil offered the highest SNR of the birdcage coil designs, 
despite acquisition with the longest TE and TR, and shortest scan time. There are likely 
several contributory factors that cause this including its comparably good power handling 
efficiency with loading to the in-house built birdcage coil, and the Philips 3.0 T magnet 
operating at a slightly higher field strength in practice than the Siemens system utilised for the 
linear birdcage coil. 
3.3.3 Assessment of signal homogeneity in four coils 
The signal homogeneity (normalised to percentage of each coil’s maximum value) for the 
four coils is displayed in Figure 3-9. The three graphs depict the change in SNR in the 
anterior-posterior direction, head-foot directions, and left-right directions respectively. 
 
40 cm 
quadrature 
birdcage coil, 
built in-house 
20 cm surface 
coil, PulseTeq 
50 cm linear 
birdcage coil, 
Rapid 
50 cm 
quadrature 
birdcage coil, 
Rapid 
SNR achieved 
in breath hold 
length scan 
21.8  64.4 18.7 27.7 
SNR achieved 
in a single 
dynamic 
12.6 24.3 10.8 19.6 
Table 3.5: SNR measured in the four coil designs using similar acquisition parameters, 
all achieved in a 10-15 s acquisition time. 
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Figure 3-9: a. Signal homogeneity in the anterior-posterior direction. b. Signal homogeneity in 
the head-foot direction. c. Signal homogeneity in the left-right direction. Only limited data was 
collected for the linear birdcage coil based at the RCH. 
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In Figure 3-9a, for the surface coil, the signal measurement starts at the coil surface (where 
the signal is maximal) and extends 300 mm in the anterior direction. In Figures 3-9b and 3-9c, 
the x-axis scale marks the isocentre of the scanner bore, and the approximate centre point of 
the coil, as 0 mm. 
The signal homogeneity, here defined as percentage signal drop-off across the centre 300 mm 
region of interest (chosen to approximate the linear dimensions of the thoracic cavity) in each 
of the three dimensions is displayed in Table 3.6. The values were calculated using: 	100 −¿­®­¿¥¿	À­Á®¦¬¿¦Â­¿¥¿	À­Á®¦¬ ×100  where a high percentage represents a highly inhomogeneous signal.  
 
 
Signal inhomogeneity within 300 mm imaging 
volume (%) 
L-R A-P H-F 
Surface coil 92 98 97 
50 cm linear birdcage coil 4 8 52 
40 cm quadrature birdcage coil 67 43 43 
50 cm quadrature birdcage coil 55 25 21 
Table 3.6: Percentage signal drop-off measured along each dimension. The surface coil has 
notably poor signal homogeneity. The 50 cm quadrature birdcage coil offers the most 
homogeneous coverage along the length of the lungs. 
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3.4 Discussion 
Perfluoropropane exhibits a very short 19F -CF3 T2* in vivo (Couch et al., 2013), combined 
with a low signal density in the gaseous phase. Imaging pulmonary ventilation also requires 
acquisition of images covering the relatively large FOV of the full thoracic cavity within a 
short (ideally breath hold length) scan time. Due to these challenging imaging criteria, the 
ideal coil design for 19F imaging inhaled PFP would reflect these practical requirements, and 
exhibit a large and homogeneous sensitive volume covering the entire thoracic cavity, as well 
as efficient RF power handling required to obtain short TR and TE.  
Acquiring human in vivo data on each of the coils was not feasible, and there are other coil 
designs that were not explored, but may be well suited to this application. Insight from 
research into hyperpolarised lung imaging research groups suggests that another suitable RF 
coil option would be a flexible design that conforms to the volunteers’ torso (Rao and Wild, 
2016). This would offer improved power efficiency compared to the birdcage design, as the 
sensitive volume of the coil is always close to the torso with minimal wasted volume. This 
coil design was not investigated here, but future research may benefit from improvements it 
can offer. 
Comparing the sensitive volume of the coils investigated here, the surface coil has been 
immediately identified as unsuitable for this imaging purpose primarily due to it having a 
small sensitive volume, resulting in inadequate lung coverage. Comparison of the birdcage 
coils noted that the longer 50 cm quadrature coil geometry offered a noticeable homogeneity 
advantage over the 40 cm coil design. Where a shorter coil could be theoretically built to offer 
better power efficiency than a 50 cm coil, our data show that the homogeneity across the 
central 30 cm (approximate lung length) is likely to be diminished considerably, thus making 
it a costly trade-off. Additionally, the 40 cm coil length design would necessitate more 
restrictive positioning by removing the option of acquisitions with the volunteers arms by 
their sides for the acquisitions. 
By increasing the maximum B1 amplitude, minimum echo time can be reduced. This is 
particularly valuable in maximising PFP signal due to its short T2* in vivo. Therefore, the 
efficiency of a coil at converting peak power (limited by what the RF amplifier can produce, 
and what the electrical components of the coils can handle) into a B1 field is particularly 
pertinent for large volume coils that require considerably more power than smaller surface 
coils to produce the same B1 amplitude. The 𝐵9 𝑃	 values calculated in this chapter quantify 
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the inescapable poor relative power efficiency of the birdcage coils to the surface coil under 
heavy loading. Therefore, in order to improve image quality in a birdcage coil design, higher 
input power is required. It was seen that a significant proportion of the peak power is lost in 
the transmission chain between the multi-nuclear amplifier and the coil; implementing 
hardware that allows parts of the scanner RF chain circuitry (specifically long cables and 
lossy T/R switches) to be bypassed could reduce this attenuation. However, this would deliver 
a higher average power to the subject, requiring a longer TR to maintain SAR limits. This 
trade-off will be investigated in the following chapter. 
The 50 cm quadrature birdcage coil was chosen for use in upcoming studies. This is primarily 
due to it offering a large homogeneous B1 field. As power efficiency is low in large heavily 
loaded volume coils, and there is scarce signal in perfluoropropane in vivo, it is valuable to 
optimise the imaging protocol used in human acquisitions to ensure maximum SNR is 
achieved without exceeding SAR limitations. Development of an optimised imaging protocol 
and an assessment of the potential benefits of implementing the highest achievable scan duty 
cycle is discussed in the following chapter.  
Improved SNR could be achieved in the future by utilising this birdcage coil in conjunction 
with a receive-only array coil that will offer the enhanced receive sensitivity seen in surface 
coil designs. However, the implementation of such hardware falls outside the scope of this 
thesis. 
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3.5 Conclusions 
A quadrature birdcage torso coil was constructed to operate at 120.12 MHz at 3.0 T with 
satisfactory results in phantoms. A larger commercial birdcage coil was then ordered for 
human studies and tested. This commercial coil presented improved power efficiency with 
low load; 𝐵9 𝑃	 values measured on the in-house built coil were in the same region as those 
achieved on a commercially built birdcage coil, however upon loading with phantoms a large 
decrease in power performance was noted. Although ill-suited to human use because of this, it 
enabled 19F-MRI development work in phantoms. 
This chapter has quantified the benefits of a birdcage coil design over a surface coil for lung 
imaging and quantified the corresponding trade-offs in coil RF power requirements. SNR and 
homogeneity measurements were made in gas phantoms containing PFP/O2. The results of 
these measurements confirmed that the geometry of the 50 cm long quadrature birdcage coil 
demonstrated good suitability for lung imaging using perfluorinated imaging agents, albeit 
with the expected disadvantages regarding RF power requirements. This coil was therefore 
used for subsequent human studies. 
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       Chapter 4: 
Development of an Optimised Acquisition Sequence for Imaging 
Inhaled Perfluoropropane 
4.1 Overview 
As discussed in detail in Section 1.3, the low molarity and short 19F T2* (~2 ms) of inhaled 
PFP contribute to a scarcity of detectable MR signal. This is further compounded by the 
necessarily short acquisition time available when restricted to a single breath hold. It is 
therefore highly valuable to verify that the imaging protocol used is being applied optimally; 
this requirement was the motivation for the work presented in this chapter. Here, we aim to 
develop an acquisition protocol that produces highest achievable image quality in short scan 
times. This will be achieved by two means, as follows. 
In this chapter, the 3D spoiled gradient echo imaging sequence has been optimised for the 
scanner and hardware configuration used on-site, namely a Philips Achieva 3.0 T system, in 
conjunction with a 50 cm long 19F tuned elliptical birdcage torso coil (Rapid Biomedical). RF 
power limitations, due to SAR regulations and hardware capabilities were accounted for in the 
simulation. The imaging parameters required to attain the maximum SNR available in a 
specified scan length were determined by simulating the acquisition sequence, and verified in 
vitro. 
A scan acceleration technique, compressed sensing, was then applied to the optimised 
acquisition sequence. Three compressed sensing protocols were then tested on a PFP-filled 
resolution phantom. The resultant images were compared and analysed for loss of image 
quality to identify the limitations of the compressed sensing technique. Finally, the optimised 
and accelerated acquisition protocol was tested in vivo by imaging inhaled PFP in a healthy 
volunteer.
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4.2 Derivation of the relative SNR achieved in a 3D SPGR pulse sequence 
The 3D spoiled gradient echo acquisition sequence was modelled in Matlab to facilitate 
optimisation of the imaging sequence. This section describes the theoretical derivation 
undertaken to model the key imaging parameters for a 3D SPGR imaging sequence for 
specific coil and hardware configurations. This derivation from the Bloch equations is well 
established and further detail can be found across the literature (Bernstein et al., 2004; Atlas, 
2009). This equation was then modified to describe the effect imaging parameters have upon 
the SNR achieved when limited to a pre-defined acquisition length. 
The 3D SPGR sequence is discussed in Section 1.2.6, and the pulse sequence diagram is 
repeated here, Figure 4-1, for ease of reference.  
Figure 4-1: A 3D SPGR pulse sequence. This figure depicts a single repetition time, and the 
process must be repeated for multiple phase encode steps, and signal averages. The gradient 
spoiling results in a steady-state system, where the longitudinal magnetisation immediately 
before the pulse (labelled a) is equal to the longitudinal magnetisation after the gradient 
spoilers, c (immediately before the next pulse). 
b a 
TR 
Phase encode 
(slice encoding) 
Phase encode 
Frequency encode 
𝜃 
T2* 
TE 
Phase spoiling 
Sampling period 
c 
TE 
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4.2.1 Sequence optimisation 
The net magnetisation, 𝑀Ã,ÄªÅÆ¨ª, begins in the longitudinal dimension, z (point a in Figure 4-
1). After application of an RF pulse that imparts a flip angle, 𝜃, a proportion of that 
magnetisation is tipped into the transverse (x-y) plane, such that the amount of magnetisation 
remaining in the z-dimension, 𝑀Ã,¦Å©ª¨, (point b in Figure 4-1) is: 
In a SPGR sequence where a train of RF pulses are used, 𝑀Ã,¦Å©ª¨ undergoes T1 relaxation in 
the time between the end of one excitation pulse and the start of the next (point c in Figure 4-
1). The T1 relaxation process is described by the final term in the Bloch equation (Equation 
1.8), as follows: 
Where 𝑀= is the z-direction magnetisation at equilibrium after full relaxation, and 𝑀q 𝑡  is 
the time varying magnetisation caused by 𝑀q,OÇoÈ undergoing T1 relaxation. This has the 
solution: 
Substituting Equation 4.1 into this and rearranging yields:  
A spoiler gradient is applied to remove any transverse components of the steady state 
magnetisation. 𝑀q 𝑡 = 𝑀Ã,ÄªÅÆ¨ª represents when the system has reached a steady state. In 
this case, Equation 4.4 is modified as follows:  
This is the z-direction steady-state magnetisation produced from a recurring pulse sequence 
with a specified flip angle and TR for a nucleus with known T1.  
𝑀Ã,¦Å©ª¨ = 𝑀Ã,ÄªÅÆ¨ª	cos𝜃 4.1 
𝑑𝑀q(𝑡)𝑑𝑡 = 1𝑇9 𝑀= −𝑀q(𝑡)  4.2 
𝑀q 𝑡 = 𝑀= + 𝑀Ã,¦Å©ª¨ − 𝑀= 𝑒Hg gr 4.3 
𝑀q 𝑡 = 𝑀= 1 − 𝑒Hg/gr + 𝑀Ã,ÄªÅÆ¨ª	𝑒Hg/gr	cos𝜃 4.4 
𝑀Ã,ÄªÅÆ¨ª(1 − 𝑒Hg/gr	cos𝜃) = 𝑀=(1 − 𝑒Hg/gr)  
𝑀Ã,À©ª¦§ÉHÀ©¦©ª = 𝑀=(1 − 𝑒Hg/gr)1 − 𝑒Hg/gr	cos𝜃 4.5 
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Signal, S, which is measured in the x-y plane, and is proportional to the magnetisation in the z 
direction, decays according to T2*, labelled in Figure 4-1. This is described by the solution to 
the second Bloch equation, Equation 1.12, with the substitution: 𝑀s,t(0) = 𝑀Ã,ÄªÅÆ¨ª sin 𝜃. 
This is multiplied by the T1 decay, Equation 4.5, to yield: 
Equation 4.7 is the well-known equation for the spoiled gradient echo sequence. Where 𝑀= is 
effectively a constant of proportionality describing the initial amount of magnetisation 
produced immediately after excitation. Its value depends on properties intrinsic to the scanner 
hardware as well as the 19F spin density of the perfluorinated gas. 
This standard equation for a spoiled gradient echo sequence was then modified to represent 
signal to noise ratio achievable in a specified scan length using: 
Where S is the signal from a single acquisition step and V is the voxel volume. Nx, Ny and Nz 
are the number of frequency and phase encoding steps in each dimension, Nave is the number 
of signal averages in a defined scan time, and BW is the receiver bandwidth measured in 
Hz/pixel. As each dimension in the voxel volume is calculated from: lengths,t,q =𝐹𝑂𝑉s,t,q 𝑁s,t,q, Equation 4.8 can be rewritten as: 
The number of signal averages within a defined scan time is:  
𝑆 = 𝑀s,t 𝑡 = 𝑀q,ÄªÅÆ¨ª sin 𝜃 	𝑒Hge gx∗ = 𝑀Â,É	À©ª¦§ÉHÀ©¦©ª 4.6 
𝑆ÎÏ = 	𝑀=	 1 − 𝑒Hg/gr sin 𝜃1 − 𝑒Hg/gr 	cos 𝜃 	𝑒Hge gx∗ 4.7 
𝑆𝑁𝑅 ∝ 𝑆	𝑉 𝑁t	𝑁q	𝑁¦Ðª𝐵𝑊  4.8 
𝑆𝑁𝑅 ∝ 𝑆		𝐹𝑂𝑉s		𝐹𝑂𝑉t		𝐹𝑂𝑉q 𝑁¦Ðª𝑁s:	𝑁t	𝑁q		𝐵𝑊 4.9 
𝑁¦Ðª = scan	length𝑇𝑅		𝑁t		𝑁q	 (×	partial	k	space	factors) 4.10 
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In cases where acquisition options are used such that only a fraction of k-space is collected, 
such as an elliptical shutter, partial Fourier techniques, or compressed sensing, correction 
factors to account for the modified scan length are included here.  
In order to maximise SNR and minimise scan length, TE and TR must be set to their 
minimum achievable values, TEmin and TRmin. These are both restricted by the rise times and 
amplitudes of the scanner gradients and RF pulse length. 𝜃 denotes the flip angle achieved in 
the region of interest. 
Equation 4.7 can therefore be modified to calculate the relative SNR achieved in a 3D SPGR 
acquisition in a defined acquisition time: 
4.2.2 Defining input variables for the simulation 
The input variables in Equation 4.11 were calculated as follows. 
Firstly, the length of each of the components of the pulse sequence displayed in Figure 4-1 
were determined: The length of the encoding gradient, 𝑇ª®ÔÆ§ª, is dependent on the gradient 
strength, rise time, and BW. The spoiler gradient length, 𝑇ÀÕÆ­¬ was found to be constant in the 
Philips Achieva SPGR sequence. The excitation pulse length,	𝑇ªÂÔ­©ª, was defined as:  
The minimum achievable echo time,	𝑇𝐸min, was then calculated as follows, by inspection of 
Figure 4-1: 
 
The minimum achievable TR, without accounting for SAR restrictions, was calculated 
𝑆𝑁𝑅𝑆𝑃𝐺𝑅 ∝	𝐹𝑂𝑉𝑥		𝐹𝑂𝑉𝑦		𝐹𝑂𝑉𝑧 scan	length𝑁𝑥2	𝑁𝑦2	𝑁𝑧2		𝑇𝑅𝑚𝑖𝑛	𝐵𝑊	 
× 	 1 − 𝑒HgÙÚÛ/gr sin 𝜃1 − 𝑒HgÙÚÛ/gr 	cos 𝜃) 	𝑒HgeÙÚÛ gx∗ 
4.11 
𝑇ªÂÔ­©ª = 𝜃𝜋 180𝛾	𝐵9  4.12 
𝑇𝐸min = 𝑇excite2 + 𝑇encode + 12	𝐵𝑊 4.13 
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similarly: 
SAR restrictions increase the minimum allowed TR to bring the maximum average power 
within pre-defined limits. This is such that: 
Where C is a proportionality constant, which is coil specific and determined by the 
manufacturer. For this scanner hardware configuration C was equal to 5.3 based on SAR and 
safety information provided by the manufacturer. Therefore, in cases where the SAR 
calculated from Equation 4.15 exceeds the maximum SAR limit set, the 𝑇𝑅Ý defined above 
is expressed as: 
In our calculations of sequence SNR, TR was limited to 𝑇𝑅Ý, such that SAR falls within the 
maximum SAR level. Relative SNR was calculated at each flip and bandwidth for minimum 
TR under the condition that SAR is less than or equal to the torso limit of 10 W/kg. 
  
𝑇𝑅Ý = 𝑇ªÂÔ­©ª + 𝑇ª®ÔÆ§ª + 1𝐵𝑊 + 𝑇ÀÕÆ­¬ 4.14 
𝑆𝐴𝑅 = 𝐶	×𝐵9:	𝑇ªÂÔ­©ª𝑇𝑅Ý  4.15 
𝑇𝑅Ý = 5.3	×𝐵9:	𝑇ªÂÔ­©ª𝑆𝐴𝑅ÝOs  4.16 
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4.3 Methods 
4.3.1 Simulation and optimisation of a 3D SPGR sequence 
To establish how flip angle and receiver bandwidth impact the SNR, Equation 4.11 was 
simulated in Matlab over a range of flip angles from 1o to 180o in 1o intervals, and bandwidths 
from 1 Hz/pixel to 5000 Hz/pixel in 1 Hz/pixel intervals. Equations 4.12-4.16 were 
substituted in as appropriate. Both in vivo and in vitro acquisitions were simulated by using 
T2* = 2 ms, T1 = 12.4 ms and a B1 of 4 µT for in vivo simulation, and T2* = 9 ms, T1 = 13 ms 
and B1 = 8 µT for phantom simulation. 
In the previous chapter, it was noted that less than half of the power produced by the 
multinuclear preamplifier reached the quadrature birdcage coil due to attenuation along 
components in the transmission line and so max B1 is limited by power delivered to the coil. 
The above simulation was modified to illustrate the effect of varying B1 on the SNR achieved 
in a fixed time, using:  
Where we know a power of 1.5 kW produced an in vivo B1 = 4 µT in vivo (see Figure 3-8). 
This allowed investigation into what maximum B1 could be achieved by the RF amplifier if a 
simpler RF chain was utilised to reduce attenuation from the transmission line. RF power 
required for a desired B1 could also be calculated.  
The peak power was arrayed, and the calculated new B1 values were substituted into the 
simulation accordingly. Applying this, the effect of changing B1 on SNR achieved in a fixed 
scan time was plotted. 
4.3.2 Verification of optimised parameters in vitro 
 In vitro verification of the optimum parameters was performed on a 50 cm long quadrature 
birdcage coil (Rapid Biomedical) to test whether the simulations correctly predicted optimal 
acquisition parameters. A 2 L bottle of PFP/O2 was positioned centrally in the coil. A 3D 
SPGR sequence with parameters mimicking those in the simulation was used, whilst receiver 
bandwidth and flip angle were varied independently, as shown in Table 4.1.  
𝐵9,Þ = 𝑃Þ𝑃fÞ 𝐵9,fÞ 4.17 
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Each sequence was acquired for a total scan duration of as close to 30 s as possible by 
modifying the number of averages in the scan. SNR per unit time (𝑆𝑁𝑅I=	À) was calculated 
for each acquisition to account for these minor differences in scan duration. the SNR was 
measured from a 100 mm × 300 mm ROI from a slice central in the phantom corrected by 
Equation 4.18. 
4.3.3 Application of compressed sensing techniques to the optimised imaging sequence: 
phantom based assessment of resultant image quality 
Numerous techniques exist to accelerate acquisitions, primarily by selective filling of k-space 
spatially or temporally. Compressed sensing is such a technique which uses a pseudo-random 
spatial sampling of k-space. Although the development of such a technique is beyond the 
scope of this thesis, a compressed sensing technique developed by Dr Kieren Hollingsworth 
(Newcastle University, UK) was applied to the optimised sequence developed above. As the 
sampling pattern was developed for in vivo human ventilation images, its application to 
phantoms cannot be considered a perfect reflection of the protocols utility in vivo, but 
provides a useful approximation of the comparable performance of different sequence 
accelerations. The utility of three accelerated imaging protocols were compared to that of the 
𝑆𝑁𝑅I=	À = 𝑆𝑁𝑅 30	(s)scan	length	(s) 4.18 
 Varying receiver 
bandwidth Varying flip angle 
Acquisition sequence 3D SPGR 
Field of view (mm3)        
H-F × L-R × A-P 
(mm) 
400 × 400 × 250 
Voxel size (mm3) 10 × 10 × 10 
Flip angle 50o 10o - 180o in steps of 10o 
Bandwidth (Hz/pixel) 500, 550, 600, 650, 700, 800, 1000, 2000 500 
Echo time (ms) Minimum: 1.01 to 1.63 Minimum: 1.37 to 2.90 
Repetition time (ms) Minimum: 7.5 Minimum: 4.0 to 27.0 
Table 4.1: Parameters used to test the optimum bandwidth and flip angle. Minimum 
TE and TR were used in all acquisitions. 
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full acquisition by assessing images of a resolution phantom using each of the acquisition 
sequences. 
A resolution phantom was constructed from five cylindrical obstructions of diameters 5, 10, 
15, 22, and 40 mm, positioned vertically and evenly spaced in a 240 × 170 × 100 mm3 
container, and filled with PFP/O2, Figure 4-2. The phantom was used to test visibility of gas 
obstructions using the optimised imaging protocols under different accelerations.  
SPGR images were acquired by applying the imaging protocol specified in Table 4.2, using 
the optimal acquisition parameters found by the simulation. Three compressed sensing 
protocols, with accelerations of 1.8×, 2.4×, and 3.0× the original fully sampled sequence, 
equivalent to 10.2 s, 7.5 s, and 6.0 s long acquisitions respectively were then applied. 
A comparison of achievable image quality from the three compressed sensing regimes was 
carried out in a central slice of the 3D image. Firstly, SNR was measured from an ROI in an 
Acquisition sequence 3D SPGR 
Flip angle 50o 
TE (ms) 1.7 
TR (ms) 7.5 
Bandwidth (Hz/pixel) 500 
FOV: H-F × L-R × A-P (mm3)  400 × 320 × 250 
Voxel size (mm3) 10 × 10 × 10 
Dynamic duration (s) × number of dynamics 4.5 s × 4 
Scan durations (s) 18 
Table 4.2: Acquisition parameters for a 3D spoiled gradient echo 
sequence to assess the relative image quality in scans with compressed 
sensing applied. 
 
 
 
240 mm 
170 mm 
PFP/
Figure 4-2: Schematic of the resolution phantom with 
5 cylindrical obstructions of diameters: 5 mm, 10 mm, 
15 mm, 22 mm, and 40 mm. 
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unobstructed area of the phantom, and a noise measurement was taken from an ROI placed 
outside the phantom. SNR was the calculated using ÀßÁ®¦¬H®ÆßÀªà	(®Æ­Àª) .  
The visibility of the obstructions in the four resulting images was measured by comparing the 
signal minima within each of the obstructions with the average signal achieved in an 
unobstructed area of the image. The standard deviation of the mean signal in the unobstructed 
area was calculated and used as a threshold to reference which of the obstructions could be 
distinguished from the surrounding signal. Signal intensity profiles across the centre of the 
obstructed regions were plotted for the fully sampled acquisition, and the 3× accelerated 
acquisition in order to quantify and directly compare any change in image quality. 
4.3.4 Application of the optimised protocol to imaging healthy volunteers 
After phantom based testing of the imaging protocol, a study was conducted to check its 
efficacy in healthy volunteers. Ethical approval was in place (assessed by the Newcastle and 
North Tyneside 1 ethics committee. REC reference number: 14/NE/0135, IRAS project ID: 
69343), and the volunteer gave informed consent to participate. The volunteer had no history 
of smoking or current or historic pulmonary health diagnoses. A spirometric test was 
performed on the volunteer before participation to confirm normal lung function.  
The study was carried out on a Philips Achieva 3.0 T MRI system. A 50 cm long quadrature 
birdcage coil (Rapid Biomedical, Germany) tuned to the 19F resonant frequency at 3.0 T, 
120.15 MHz, was used.  
The breathing protocol instructed three deep respiratory cycles inhaling from a supply of a 
79:21 mixture of perfluoropropane and oxygen from a 25 L Douglas bag via a breathing rig 
(as used in Chapter 2, Figure 2-1) and a mouthpiece. This was followed by a 20-second breath 
hold period, during which the acquisition sequence detailed in Table 4.2 was performed. The 
volunteer was then switched to room air by means of a 3-way valve (Hans Rudolph Inc). 
Oxygen saturation levels were monitored throughout with a NONIN 7500FO pulse oximeter 
(NONIN Medical Inc). The above protocol was repeated on the same volunteer with 
compressed sensing applied, accelerating the acquisition time from 18 s to 6 s. 
The resultant images were analysed by calculation of ventilated volume. This was done by 
masking the signal using a threshold value that was three standard deviations from the mean 
signal measured in a central ROI in the images. The number of voxels above this threshold 
were summed. 
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4.4 Results 
4.4.1 Simulation and optimisation of a 3D SPGR sequence 
The longitudinal relaxation time of the PFP/O2 gas mixture in a 2 L bottle phantom was 
measured to be 13.0 ms at 3.0 T, with a T2* of 9.0 ms. Using these values in the simulation, 
the optimum bandwidth was found to be 120 Hz/pixel, with an optimum flip angle of 62o 
(Figure 4-3). However, scanner hardware restrictions limit the achievable bandwidth to a 
minimum of 500 Hz/pixel, for which the optimum flip angle was found to be 50o. 
The PFP/O2 gas mixture was measured to have an in vivo T2* of 2.0 ms. Previous studies 
have measured a value for T1 of 12.4 ms in vivo at 3.0 T (Couch et al., 2013). Simulations 
determined the optimum flip angle and bandwidth for the minimum allowed TR and TE for a 
fixed scan length, Figure 4-4. This predicted an optimum bandwidth of 500 Hz/pixel and a 
flip angle of 40o. However, SNR achieved drops dramatically at flip angles lower than this 
optimum value, and drops only gradually at flip angle values greater than this. Due to slight 
Figure 4-3: Relative SNR achievable (colour scale) in a fixed acquisition time over a 
range of flip angles and receiver bandwidths, using PFP T1 and T2* values measured 
in vivo. Isolines mark SAR values where 2, 4 and 10 W/kg are reached. Above these, 
TR values were increased in the simulation to limit the maximum SAR to the torso 
limit of 10 W/kg. Due to scanner hardware limitations, bandwidth values below 500 
Hz/pixel were unachievable with the current scanner set-up. 
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B1 inhomogeneities expected in the coil, as well as loading changing between volunteers, a 
slightly higher flip angle of 50o is favourable in order to mitigate the potential signal loss in 
cases of under tipping. This plot depicts the optimum achievable parameters for human 
studies and illustrates the impact of deviation from optimum SNR. 
 
Achievable B1 amplitude is limited by RF amplifier output and coil loading. It is therefore 
important to know the degree to which the scan is compromised by low B1, and gauge the 
impact of potential hardware modifications to increase it. To investigate this, the simulation 
was utilised to map how the relative SNR changes across a range of B1 values, and in turn, 
how this affects the minimum allowed TR, Figure 4-5. This was calculated for three SAR 
limits up to 10 W/kg. The maximum SNR for a fixed length acquisition time at a SAR of 10 
W/kg was found to occur at 4 𝜇T. Above this value, the longer TR required to maintain 
maximum average power limitations compromises any SNR gain from a higher peak power. 
Figure 4-4: Relative SNR achievable in a fixed acquisition time over a range of flip 
angles and bandwidths, using T1 and T2* values representative of the human lung. 
Relative SNR was calculated at each flip and bandwidth for minimum TR under the 
condition of SAR ≤ the torso limit of 10 W/kg. Isolines mark SAR values of 2, 4 and 
10 W/kg. 
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4.4.2 Verification of optimised parameters in vitro 
Figure 4-6a and 4-6b display the average SNR measured over a range of flip angles and 
bandwidths respectively. The grey line on each plot demonstrates the expected SNR as 
predicted by the simulations. Maximum SNR was seen at 500 Hz/pixel bandwidth (noting 
that values below this were unachievable with the current scanner configuration), and a flip 
angle of 40o - 50o, in agreement with the pattern predicted in the simulations. The simulation 
calculated a minimum TR of 7.5 ms and a TE of 1.7 ms for these optimum values, which was 
verified on the scanner interface, confirming the accuracy of the equations used in the 
simulations. 
Figure 4-5: Relative SNR (colour scale) achievable over a range of maximum 
B1 values for SAR = 2, 4 and 10 W/kg, with the point at which maximum SNR 
is reached (circles) for each SAR level.  
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Figure 4-6: Measured SNR over a range of a. 𝜃, and b. BW. The predicted SNR (scaled to 
the SNR amplitude with least-squares fitting) is displayed as a grey line on both plots. 
Although plot b confirms the most suitable bandwidth in the 500-2000 Hz/pixel range, the 
simulated curve describes a different gradient to the collected data points. Further collection 
of data allowing the application of error bars and definition of the curve at bandwidths 
lower than 500 Hz/pixel would be required to fully investigate this finding. 
a. 
b. 
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4.4.3 Phantom based assessment of scan resolution 
Images of the resolution phantom filled with PFP/O2 acquired at four different acquisition 
accelerations are shown in Figure 4-7. An ROI in an unobstructed area of the phantom had an 
average SNR of 25 ± 2 in the four images, demonstrating minimal change between 
acquisitions.  
It was noted that loss of image detail and blurring artefacts were visible, particularly in the 
left-right phase encoding direction (in which compressed sensing was applied), becoming 
more pronounced in faster acquisitions. The obstructions were expected to produce a signal 
drop relative to the non-obstructed areas, with the reduction dependent upon the size of the 
obstruction, as some were smaller than the 10 × 10 × 10 mm3 imaging voxel size. Blurring 
from the accelerated acquisitions caused a less prominent signal change, correlated to the 
speed of the acceleration. This is visible in Figure 4-8, where for each size obstruction the 
change in signal is typically maximal for the fully sampled data set (diamond), and minimal 
for the most accelerated acquisition (cross). 
The horizontal lines in Figure 4-8 mark the levels at which two and three standard deviations 
below the mean unobstructed signal occur, above which 95% and 99.7% of the signal values 
lie respectively. These therefore provide a threshold to which the signal achieved in the 
obstructed regions can be compared. Below these lines, the signal can be considered to be 
unlikely to be from a gas-filled region, and therefore can be identified as being a result of 
obstructions. Therefore, all obstructions apart from the 5 mm diameter cylinders could be 
identified as such, with the most accelerated acquisitions of the 10 mm diameter cylinder 
being visible to a lower certainty. As the image voxels have a 10 mm isotropic volume, this 
imaging protocol was not expected to detect the 5 mm and 10 mm circular cross-sections of 
the cylinders with clarity, but were included as a metric to test the cut-off point of 
a. d. c. b. 
Figure 4-7: Images from four acquisitions with different compressed sensing regimes 
applied. a. 18 s fully sampled image. b. 10.2 s image (1.8× acceleration). c. 7.5 s image 
(2.4× acceleration). d. 6 s image (3.0× acceleration). 
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distinguishing obstructions close in size to that of a single voxel. A 10 × 10 × 10 mm3 voxel 
size represents the volume of three to ten pulmonary acini in humans, which, from these 
results, indicates the minimum volume of reduced ventilation that would be detectable in 
patients with obstructive lung disease using this technique (Schreider and Raabe, 1981; 
Osborne et al., 1983; Haefelibleuer and Weibel, 1988). 
The reduced edge definition associated with compressed sensing, results in loss of certainty of 
obstruction sizes. An example signal intensity profile drawn through the centre of the three 
largest obstructions for the fully acquired sequence and the 3× accelerated sequence is plotted 
in Figure 4-9. In both cases, all three obstructions are identifiable, but the sharpness of the 
signal gradient is reduced in the accelerated acquisition.  
These in vitro results suggest that the three times accelerated acquisition sequence offers a 
good compromise between the improved speed and the loss of edge definition, although in 
vivo testing is necessary to verify this finding.  
 
Figure 4-8: Visibility of obstructions plotted as a percentage decrease in signal measured 
within the ROI compared to the mean signal in the unobstructed regions of the phantom. 
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4.4.4 Application of the optimised protocol to imaging healthy volunteers 
25 coronal slices through the centre of the 3D image acquired using the 18 s optimised 
acquisition protocol with no compressed sensing is shown in Figure 4-10a, with an image of 
the equivalent slice acquired using the acquisition protocol with 3× acceleration shown in 4-
10b. The fully sampled acquisition achieved an SNR of 23:1, and the compressed sensing 
protocol achieved an SNR of 28:1. 
Figure 4-9: Signal intensity plot across the (left-right) 22 mm, 40 mm, and 15 mm 
diameter obstructions. The loss of edge definition is apparent. 
b. a. 
Figure 4-10: Slices through the two acquisition protocols: a. Fully sampled data, and b. 
3×acceleration. 
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After applying a binary mask to the images using a threshold set to three standard deviations 
below the measured mean signal in the lung (Figure 4-11), the volume of the image acquired 
using the unaccelerated protocol was measured to be 5.18 L. The compressed sensing 
protocol resulted in a measured ventilated lung volume of 5.30 L. These are in broad 
agreement with the spirometric measurement of the volunteers forced vital capacity, which 
was 5.40 L. As these were acquired in different breath holds a small variation in lung volume 
is expected so cannot be considered directly comparable. However, they demonstrate that this 
preliminary testing of compressed sensing regime at 3× acceleration offers an acceptable 
image quality for quantitative image analysis of ventilated regions.  
 
Figure 4-11: Lung images with a binary mask applied for a. The fully sampled acquisition, and 
b. The 3× accelerated acquisition. The threshold for masking was fixed at three standard 
deviations below the mean signal measured in an unobstructed area of the lung. 
a. b. 
 83 
4.5 Discussion 
The predicted optimal SPGR acquisition parameter values from the simulation were found to 
agree well with measured optimal acquisition parameters for the scanner hardware and 
software configuration used, under the limits imposed by SAR and maximum RF power 
restrictions. However, it was deemed unfeasible to verify the optimum in vivo values by 
arraying the acquisition parameters in vivo in human subjects due to being restricted to 
collecting data within a breath hold length acquisition time. Application of this simulation to 
other scanner configurations, such as different manufacturers or field strengths, would be 
possible with minimal modification of the simulation, and knowledge of the scanners RF 
power performance.  
The simulation of the variation in SNR over a range of maximum B1 values demonstrated that 
the achievable SNR in the current coil and scanner combination is limited by the maximum 
allowed average power due to SAR restrictions, rather than the peak power, as elevated B1 
has only a small impact on SNR. The result of this is that utilisation of a different transmit 
coil with a more permissive SAR limit will therefore have a potentially large impact on the 
SNR achieved and permit a higher maximum B1, allowing shorted echo times to be achieved. 
For example, the body coil of the Philips Achieva 3.0 T system permits a TR of 5 ms is for a 
B1 of 4 µT and a flip angle of 50o under standard SAR restrictions. Although not directly 
comparable due to different system hardware, the acquisitions utilised by previous studies 
imaging inhaled PFP/O2 utilised some notably different parameters (Couch et al., 2013; 
Halaweish et al., 2013). In both cases, a lower bandwidth of 130-140 Hz/pixel was used. 
However, the primary limitation to these studies is likely being limited by a higher minimum 
TR of 13 ms and 20 ms respectively, necessitating a higher flip angle to approximate the 
Ernst angle. 
Compressed sensing was found to offer a high degree of acceleration (3×) of the optimised 
acquisitions, but at a cost to image detail. However, due to the current sequence providing a 
10 × 10 ×10 mm3 voxel size, image detail is already limited to these dimensions. All of the 
compressed sensing protocols tested offered acceptable visibility of 10 mm diameter 
obstructions and larger, on the scale of a single voxel, so can therefore be deemed a good 
trade-off for the acceleration they provide. The in vivo comparison of the fully sampled and 
the 3× accelerated acquisition protocols produced visually similar images in a healthy 
volunteer, with ventilated volume values within 3% using a simple thresholding technique. 
The primary limitation of the compressed sensing techniques is the associated loss of edge 
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definition (Lustig et al., 2007), which in practice may lead to over- or underestimating the 
size of obstructions. Further in vivo sequence testing is needed to quantify the extent to which 
this may be a limitation, and the compressed sensing pattern adjusted appropriately to 
maintain acceptable image quality. Ideally, the accelerated imaging protocols would be tested 
and compared in a cohort of patients with ventilation defects. 
Scan acceleration from an 18 s acquisition to a 6 s acquisition will be particularly valuable for 
future in vivo patient studies. The time saved can be used to acquire data at a finer resolution, 
or be used to collect more signal averages to improve the SNR. A further use of the faster 
imaging regime is the potential it has to allow more precise T2* mapping in vivo; a multi-echo 
sequence is inaccurate for this application as it has a relatively large minimum ΔTE, limiting 
the number of useful data points for short T2*. Therefore, a faster acquisition would permit 
several SPGR images to be acquired within a signal breath hold with a range of echo times. 
Non-Cartesian acquisition sequences such as ultra-short echo time imaging may offer further 
improvement in SNR, and has been utilised in a published study (Couch et al., 2014). 
However, these radial acquisition regimes typically display artefacts caused by gridding the 
radial data onto a linear reconstruction, which reduces edge definition. They are also less 
suitable for combining with a compressed sensing acquisition scheme, which would further 
reduce the image quality. For this reason, we focussed on the optimised 3D SPGR with 
compressed sensing for our studies. 
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4.6 Conclusions 
Simulation and practical validation of a 3D SPGR sequence found that the optimum 
acquisition parameters for 19F imaging of inhaled PFP/O2 are a flip angle of 50o and a receiver 
bandwidth of 500 Hz/pixel, with the minimum allowed TE and TR. Combined with a 3× 
acceleration from a compressed sensing acquisition scheme, a SNR of 28:1 was achieved in 
vivo in a 6 s breath hold acquisition. The compressed sensing technique provided a similar 
measure of ventilated volume to that measured by both spirometry and a fully sampled 
acquisition sequence. 
It was also found that no potential improvement in SNR in a fixed scan time can be expected 
by increasing the input power from the RF amplifier to raise B1, due to the longer TR required 
to stay within the SAR restrictions. This validated the suitability of the current RF chain 
configuration. 
This acquisition protocol will be applied to acquire data for a large-scale study imaging 
healthy volunteers and patients with COPD and asthma. 
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Chapter 5: 
The Effect of Susceptibility Gradients on the T2* of Perfluoropropane: 
Studies in Lung-representative Phantoms 
5.1  Overview 
Local magnetic field gradients arise due to differences in magnetic susceptibility between the 
diamagnetic lung parenchyma and blood vessels, and the paramagnetic inhaled PFP/O2 gas. 
This gradient markedly reduces the transverse relaxation time of the MR-sensitive nuclei 
(Wild et al., 2012); the T2* of perfluoropropane –CF3 is 9 ms in a magnetically homogeneous 
environment at 3.0 T, in contrast to 2 ms in the human lung at full inspiration, as measured in 
Chapter 2. In the same chapter, it was also observed that the T2* of inhaled PFP/O2 varies 
over the respiratory cycle of healthy volunteers. This is caused by reduced influence of 
magnetic susceptibility gradients at inhalation. However, it is not known if the predominant 
mechanism for this is the changing surface area to volume ratio of the alveoli, or the bulk 
change in gas to tissue ratio seen during inhalation, or a combination of the two. This 
relationship is potentially valuable as a dependence of T2* on tissue microstructural properties 
could provide a biomarker sensitive to lung pathology and offer a novel utility for clinical 
identification of anatomical damage, such as that seen in early emphysema.  
Expanding upon this concept suggests that altering the magnetic susceptibility of water, such 
as through intravenous administration of a paramagnetic contrast agent, could reduce the 
magnetic susceptibility gradient at the alveolar walls. This would result in the lengthening of 
the originally short in vivo T2* of the –CF3 moieties of PFP, and in turn improve 19F PFP 
signal amplitude in a SPGR acquisition, providing a potential mechanism to improve 
pulmonary ventilation mapping in a dynamic contrast-enhanced 19F-MRI acquisition. 
This chapter tests the hypothesis that perfluoropropane –CF3 T2* is representative of its 
magnetic environment, and that by altering the magnetic susceptibility gradients experienced 
by the PFP, a change in T2* occurs. The objective of the following work is therefore to 
measure the magnetic properties of PFP/O2 in a range of porous environments. This is 
achieved by the construction of two novel phantom models of PFP/O2-filled lung tissue, to 
allow assessment of the effect of changing pore size, gas to liquid ratio, and magnetic 
susceptibility gradients on the T1, T2, and T2* of PFP –CF3. 
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5.2  Theoretical overview of magnetic susceptibility in pulmonary alveoli 
Magnetic susceptibility, 𝜒, is a property intrinsic to every material, and is broadly related to 
the number of unpaired electrons within the molecule of interest (Schenck, 1996). It 
characterises the degree of magnetisation induced in a material in response to an external 
magnetic field. Variation of the magnetic susceptibility of materials within an external 
magnetic field alters the field strength, increasing it if paramagnetic (𝜒 > 0) and decreasing it 
if diamagnetic (𝜒 < 0) (Duyn, 2013). Regional differences in 𝜒 cause regions of differing 
magnetisation. This results in magnetic field gradients as the field must be continuous 
between areas of different 𝜒 These magnetic field gradients on the macroscopic scale, 
between entire organs, can produce unwanted artefacts in MR images (Lüdeke et al., 1985). 
However, on the mesoscopic scale – that including entire molecules and tissues, but smaller 
than the imaging voxel size – it is magnetic susceptibility-induced internal magnetic field 
gradients within a voxel at the gas-tissue boundaries which cause increased dephasing of 
spins, resulting in expedited decay of the transverse magnetisation (Chavhan et al., 2009). 
When the nucleus is not exposed to magnetic field gradients, the primary determinant of the 
transverse magnetisation of a nucleus is the magnetic field inhomogeneities arising from 
molecular rotation of the nucleus of interest on the microscopic scale (Sukstanskii et al., 
2014). This results in the irreversible dephasing and magnetisation loss described by the T1 of 
the nucleus, which in turn limits T2 and T2*. The T2* of the –CF3 moieties of inhaled PFP is 
therefore principally related to both its molecular motion and its proximity to the magnetic 
field gradients produced by the air-tissue boundaries, thus its value reflects the surrounding 
alveolar structure.  
The contraction of T2* in the lung caused the presence of these susceptibility gradients is 
common across pulmonary MR imaging, including proton MRI and to a lesser extent, 
hyperpolarised noble gas MRI. Utilising these imaging techniques, the T2* of the nucleus of 
interest has been demonstrated to be sensitive to structural changes in the lung, both due to 
changing alveolar size after inspiration (Theilmann et al., 2009), and alveolar enlargement in 
the emphysematous lung (Takahashi et al., 2010; Ohno et al., 2014). Chapter 2 demonstrated 
that the PFP –CF3 T2* is affected by location in the respiratory cycle. However, to-date there 
is no published literature investigating the relationship between T2* and lung physiology 
using 19F-MRI of the lungs. A large body of literature exists studying the T2* of MR-sensitive 
nuclei in non-biological porous media (Watson and Chang, 1997; Valckenborg et al., 2002; 
Veith et al., 2004; Baete et al., 2008; Smith et al., 2016). These papers demonstrate the 
predominant contributor to T2* in a magnetically inhomogeneous microporous environment 
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as being the surface area to volume ratio (S/V) of the pore, such that 9gx∗ ∝ Îå. This is in 
agreement with the T2* observations made in Chapter 2, where T2* increased with the 
average alveolar volume. 
Applying this simple relationship to pulmonary structure, published theoretical models of the 
effect of lung anatomy on the T2* of inhalable imaging agents have identified the anatomical 
variables that influence T2*. These are: the dimensions of the alveoli, the volume fraction 
occupied by lung tissue and blood vessels, and the magnetic susceptibility gradient at the gas-
tissue interface (Sukstanskii et al., 2014; Yablonskiy et al., 2015). Alveoli in the human lung 
are known to have a diameter of approximately 200 µm, and although lung size varies 
significantly with subject height, alveolar size is considered largely invariant with lung size 
(Ochs et al., 2004), and a gas volume fraction ranging between 50% and 80% at full 
expiration and inspiration respectively (Glauser and Wilson, 1977). Both PFP/O2 and room air 
(predominantly composed of 21% oxygen and 79% nitrogen) are weakly paramagnetic with 
their magnetic susceptibility being predominantly determined by the molecular oxygen 
component. At a 21% partial pressure, PFP/O2 has a volume magnetic susceptibility of 𝜒æçæ/èx = +0.37×10H^ (SI units, dimensionless, used throughout this chapter unless 
otherwise specified) (Schenck, 1996). This value is slightly reduced in alveolar gas, where 
oxygen content is typically reduced to 14%. However, this change is adequately small, and 
the magnetic susceptibility of PFP is sufficiently similar to that of oxygen compared to that of 
lung tissue, that spatially localised change in the transverse relaxation time of the gas mixture 
due to this variation in oxygen content can be considered negligible.  
Water, and hence most biological tissues including lung tissue, are diamagnetic as a result of 
their constituent H2O molecules containing no unpaired electrons. The exact magnetic 
susceptibility of pulmonary tissue is determined by the summation of lung parenchyma, the 
blood content and, to a small degree, its oxygenation. The parenchyma has a magnetic 
susceptibility very close to that of water, with 𝜒Õ¦¨ª®ÔéÉ¿¦ = −9.0×10H^ (Bergin et al., 
1991). The susceptibility of whole blood varies between 𝜒Ä¬ÆÆ§,ê^%ÆÂ = −9.1×10H^ and 𝜒Ä¬ÆÆ§,ìì%ÆÂ = −8.8×10H^, this variability is minimal in practice as the percentage of 
oxygenated blood does not typically drop this low at rest, with blood oxygen saturation 
typically ranging between 75% and 97% (Thulborn et al., 1982; Weisskoff and Kiihne, 1992; 
Albert et al., 1993; Vignaud et al., 2005).  
Therefore, at the lung gas-tissue boundaries an average magnetic susceptibility gradient of 
 89 
∆𝜒¦­¨H¬¥®Á = 9.4×10H^ is present. Magnetic susceptibility gradients can be altered by 
intravenous administration of an appropriate agent. The use of an intravascular 
superparamagnetic iron oxide contrast agent, has been used to demonstrate air-tissue 
susceptibility matching in mice by measuring the increased transverse relaxation time of 
inhaled 3He after injection (Vignaud et al., 2005). This study validated the potential of this 
technique, recording a 3-fold increase in the transverse relaxation time upon susceptibility 
matching. Due to restricted availability of clinically approved iron oxide contrast agents 
(Wang, 2011; Wang, 2015), translation of this technique to human studies would require a 
more suitable contrast agent. 
Gadolinium based contrast agents are widely used with an extensive safety record for 
intravenous injection (Fok and Smith, 2017), and are highly paramagnetic due to having 7 
unpaired electrons that remain unpaired when chelated. To date, just one publication has 
utilised these for susceptibility matching of the lung tissue to the alveolar gas (Dimitrov et al., 
2005). In this study, a change in inhaled hyperpolarised 3He signal pre- and post-
administration of 30 mM Gadodiamide was noted in porcine lungs, however no T2* mapping 
was reported.  
As hyperpolarised 3He has a large free diffusivity, D0, due to its small atomic mass and small 
diameter, its transverse relaxation time is much longer than that of PFP. Due to 3He being in 
the motional narrowing regime it is influenced by the changing magnetic field gradient in the 
lung to a much smaller degree (Branca et al., 2010). Similarly, the diffusivity of 
hyperpolarised 129Xe is much larger than that of PFP, therefore, the T2* of PFP -CF3 is shorter 
and much more sensitive to susceptibility gradients. The free diffusivity, apparent diffusion 
coefficient (ADC), and T2* in the lung of hyperpolarised 3He, 129Xe, and thermally polarised 
PFP is described in Table 5.1.  
The comparably very slow D0 of PFP results in a root mean squared free displacement in one 
direction ( 2𝐷=𝑡 ) in 2 ms of 170 µm, smaller than a typical alveolar diameter. This is in 
contrast to 3He, which would travel 600 µm, and can be considered to thoroughly explore the 
magnetic environment of the airspace. As the rapid atomic motion of 3He effectively averages 
the field distortions it experiences, the effect of a magnetic susceptibility gradient on its 
precessional frequency, and therefore T2*, is less than that experienced by PFP. Reduction of 
magnetic susceptibility differences in the lung is therefore expected to have a more apparent 
effect on the relative T2* of inhaled perfluoropropane -CF3 compared to that of 
hyperpolarised 3He and 129Xe. 
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Investigating the behaviour of T2* with changing susceptibility in the lung is challenging due 
to any acquisition being time-limited to a single breath hold and the limitation of inter-
volunteer variation in physiology and breathing compliance. Having a highly controlled in 
vitro model of the alveoli therefore presents an opportunity to investigate and explain the in 
vivo observations. The requirements for such a phantom were that its gas filled pores 
represented alveolar structure and dimensions, and that the surrounding medium had a 
magnetic susceptibility equal to that of lung parenchyma such that the model reflected the gas 
to tissue ratio and magnetic susceptibility gradients found in the lung. It was also required to 
be stable over time, allowing MR acquisitions to be made. In order to investigate the 
hypothesis, control over pore size and the ability to add gadolinium chelates to the tissue-
representative medium in order to assess the effect of the magnetic susceptibility gradient on 
T2* was also required. 
A foam phantom made from a standardised liquid and PFP/O2 allowed control of both model 
physical and magnetic properties. Foam fabrication methods described in previously 
published literature (Xu et al., 2009; Parhizkar et al., 2015) were attempted, but proved to be 
unsuitable, primarily due to their instability in the quantities required for MR measurements, 
so will not be discussed further here. Two novel foam models of lung tissue were developed 
and detailed in the following section. The first produced monodisperse (uniform bubble 
diameter) foam, which allowed investigation into the effect of pore size on T2*. The second 
model was formed from a polydisperse foam, but offered a fabrication method better suited to 
investigation into the effect of changing magnetic susceptibility gradients on T2* by addition 
of varying quantities of a gadolinium based contrast agent, allowing comprehensive testing of 
the hypotheses. 
 3He diluted with N2 129Xe diluted with N2 PFP/O2 
D0 at 300 K, 1 atm. 
(cm2/s) 0.88
a 0.14c 0.07f 
ADC in healthy 
human lung (cm2/s) 0.20
a 0.05d 0.01g 
T2* at 3.0 T in 
healthy human lungs 
at inspiration (ms) 
14.4b  24.0e 2.2h 
Table 5.1: D0, apparent diffusion coefficient and T2* in the healthy human lung. Each has 
been measured at dilutions typically used in vivo. Values taken from: a. (Conradi et al., 
2006), b. (Deppe et al., 2009), c. (Chen et al., 1999), d.(Kirby et al., 2012), e. (Xu et al., 
2012), f. (Albert and Hane, 2016), g. (Albert and Hane, 2016), h. (Couch et al., 2013). 
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5.3  Methods 
5.3.1  Construction of a lung representative phantom: monodisperse foam 
Polyethyleneglycol-40 stearate (PEG-40s, CAS number 9004-99-3, Sigma-Aldrich LLC), 
with the chemical structure CH3–(CH2)17–(C2H4O)40–OH was used as a neutral surfactant to 
facilitate the formation of foam. Agarose (melting point of 90oC and gelling temperature of 
33oC - 38oC, CAS: 9012-36-6, Sigma-Aldrich LLC), was added to aqueous solutions of PEG-
40s to improve foam stability. The same PFP/O2 gas mixture utilised in earlier chapters was 
used to form the gas phase of the foam. 
2 wt% PEG-40s was added to 1 wt% agarose in water. The concentration of PEG-40s was 
chosen such that it was in excess of its critical micelle concentration, 0.01 wt% (Parhizkar et 
al., 2015), to ensure sufficient quantities were available to avoid inhibiting the yield of 
microbubbles. This solution was transferred to a sealed syringe and heated to 95oC in a water 
bath to melt the agarose. The syringe was then repeatedly inverted for one minute to ensure 
adequate mixing to produce a clear homogeneous solution, and then maintained at 95oC until 
immediately prior to use. A magnetic susceptibility balance (MK1, Sherwood Scientific Ltd, 
UK) was used to measure the magnetic susceptibility of this solution. 
Monodisperse PFP/O2-filled foam was formed by feeding the detergent solution and gas 
mixture through a 200 µm diameter T-junction microfluidic chip (Dolomite, UK) using a 
syringe pump. The PFP/O2 was fed to the T-junction directly from a cylinder via a pressure 
regulator equipped with a pressure gauge. The T-junction was warmed to 40oC in a water bath 
to ensure the solution did not gel within the chip. The resulting monodisperse foam left the 
microfluidic chip via 1 mm internal diameter tubing which passed through an ice bath and 
into a chilled 6 ml vial. This configuration allowed the foam to set rapidly, before bubble 
coalescence, producing stable foam. Figure 5-1 presents a schematic diagram of the apparatus 
configuration. 
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Figure 5-1: a. The apparatus used to produce monodisperse PFP/O2-filled foam, using an 
aqueous detergent and agarose solution. b. The microfluidic chip used. The liquid and gas 
entered the chip via the top two tubes on the left, and the foam exited via the upper right tube. 
 
The foam bubble diameter was dependent on the relative flow rate of the detergent mixture 
and the PFP/O2 pressure. A gas pressure of 12-16 psi allowed a small variation in the foam 
gas to liquid ratio, and liquid flow rates of 25 and 45 ml/hour produced foams with two 
distinct bubble diameters. These flow rates were chosen as they most robustly produced stable 
bubble sizes with the described hardware setup. Seven 6 ml samples of each bubble size were 
made and equilibrated to room temperature for 30 minutes prior to MR acquisitions. 
Following the same procedure, a single 6 ml sample of foam was made with 30 mM 
Gadodiamide (Omniscan, GE Healthcare) added to the aqueous solution, changing the 
magnetic susceptibility gradient at the gas/water boundary at the pore surface.  
5.3.2  In vitro measurements: monodisperse foam 
Photomicrographs of foam from each vial were taken using a digital microscope (Celestron, 
LLC) immediately prior to MR acquisitions. Mean bubble diameter was measured from 100 
bubbles per sample, and intra- and inter-sample size variability was assessed. 
Four 19F-MR protocols were then performed as described below to assess the MR properties 
of the PFP utilising a small (3 cm long, 2 cm diameter) 19F-tuned coil built in-house, Figure 5-
2, interfaced to a Philips Achieva 3.0 T system.  
 
   		    
 
 
 
 
Syringe pump 
PFP/O2 cylinder 
T-junction chip Ice water bath 
200 𝜇m 
b. 
a. 
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A pulse-acquire sequence was used to determine the average T2* of each foam sample by 
fitting a decaying exponential to the amplitude of the FID. The acquisition parameters used 
are listed in Table 5.2. 
A T2* map of each sample was produced by means of an SPGR sequence with varying TE. 
Image resolution was 3 × 3 × 5 mm3. Table 5.3 shows scan acquisition parameters. 
Acquisition sequence Unlocalised pulse-acquire 
Flip angle  90o hard pulse 
Number of FID samples 256 
Sample frequency (Hz) 8000 
TR (ms) 34 
Table 5.2: The acquisition parameters for measurement of the average 
T2* in the foam phantoms. 
 
Acquisition sequence 3D SPGR 
Flip angle 90o 
TE (ms) Array: 2.0, 4.0, 6.0, 8.0, 15.0 
TR (ms) 250 
Bandwidth (Hz/pixel) 500 
FOV: H-F × L-R × A-P (mm3)  60 × 60 × 60 
Voxel size (mm3) 3 × 3 × 5 
Scan duration 55 s per TE 
Table 5.3: The acquisition parameters for an echo time array of a 3D 
spoiled gradient echo sequence, allowing mapping of T2* in the 
sample. 
 
Figure 5-2: RF coil with 6 ml vial 
of foam. 
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An inversion recovery spectroscopy sequence with a hard pulse was used to measure the T1 of 
each sample by arraying inversion time (the time between the 180o and 90o pulse) and 
measuring the 19F peak amplitude, Table 5.4. From this the longitudinal relaxation recovery 
curve could be plotted from the signal measurements, and a recovering exponential equation 
fitted to the data.  
A 1D spin echo sequence was used to measure the T2 by arraying the echo time, Table 5.5. A 
chemical shift imaging (CSI) sequence was utilised to offer spatially localised signal 
measurements at short echo times. The average T2 of the sample was then calculated by fitting 
the exponential T2 decay curve to the signal measurements from each TE. Equation 1.12 was 
fitted to the data to calculate T2. 
The ratio of gas to liquid in the foam samples was determined by measuring foam density, 
with comparison to density of PFP/O2 gas and water/agarose/surfactant solution. 
5.3.3   Construction of a lung representative phantom: polydisperse foam 
Pasteurised egg white powder (Dr Oetker Ltd., UK) was mixed in a 1:6 weight ratio with 
water to form a viscous solution capable of forming a stable foam. The magnetic 
Acquisition sequence Unlocalised inversion recovery 
Flip angle 180o – TI – 90o 
TI (ms) Array: 1.0, 2.0, 3.0, 4.0, 10.0, 15.0, 20.0, 30.0 
TR (ms) 250 
Sample frequency (Hz) 8000 
Number of samples 256 
Table 5.4: The acquisition parameters for an inversion recovery sequence with an 
inversion time array, allowing measurement of average T1 in each of the foam samples. 
 
Acquisition sequence 1D CSI spin echo 
Flip angle 90o – TE – 180o 
TE (ms) Array: 1.7, 3.0, 5.0, 10.0, 20.0 
TR (ms) 250 
Sample frequency (Hz) 8000 
Number of samples 256 
Table 5.5: The acquisition parameters for a spin echo sequence, 
allowing measurement of the average T2 in the foam samples. 
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susceptibility of this solution was then modified by addition of the paramagnetic gadolinium 
based contrast agent Gadobutrol (Gadovist, Bayer Schering Pharma, UK). 1.0 M Gadobutrol 
was added to produce concentrations of 0, 15, 30, 45, and 60 mM in 3 ml volumes of egg 
white solution. Three samples were made at each concentration of Gadobutrol. 
A further twelve samples were made following the same process using the contrast agent 
Gadodiamide (Omniscan, GE Healthcare) with concentrations ranging from 0 to 70 mM to 
verify the results using a different contrast agent. 
Each 3 ml solution was mixed with 12 ml of PFP/O2 gas by passing the mixture between two 
syringes via a 2-way valve twenty times, as depicted in Figure 5-3. This process frothed the 
mixture to produce homogenous polydisperse foam, with a gas to liquid ratio similar to the 
gas to tissue ratio found in the human lung.   
    
 
5.3.4  In vitro measurements: polydisperse foam 
Photomicrographs were taken of each egg white foam sample immediately before MR 
acquisitions. The mean bubble diameter and standard deviation of the mean was determined 
from diameter measurements of 100 bubbles in each sample image. The protocols described 
in Tables 5.2-5.5 were repeated using the same scanner hardware configurations as for the 
detergent phantoms to make T1, T2, and T2* measurements of PFP in the egg white foam. 
A magnetic susceptibility balance (MK1, Sherwood Scientific Ltd, UK) was used to measure 
the magnetic susceptibility of 1.0 M Gadobutrol.
3 ml solution 
+ 12 ml PFP/O2 
Figure 5-3: Schematic depicting the method for 
frothing the egg white based foam. A sample of the 
foam was decanted into a 6 ml vial for MR 
acquisitions.  
 96 
5.4  Results 
5.4.1  In vitro measurements: monodisperse foam 
This foam fabrication technique was found to produce monodisperse bubbles with the liquid 
having a magnetic susceptibility equivalent to that of water. Photomicrographs of the two 
distinct sizes produced are shown in Figure 5-4, along with a photomicrograph of the bubble 
sample being formed at the T-junction.  
The average diameter of 100 large bubbles from a sample was measured to be 246 ± 20 µm. 
The standard deviation of mean bubble size between three samples was found to be 13.4 µm. 
The average diameter of 100 bubbles from a sample of small bubble was 138 ± 22 µm, with a 
standard deviation of 21 µm between average diameter measured in three samples.  
Figure 5-5 shows images from an SPGR echo time array experiment for two samples: the ~140 µm bubble diameter foam and the ~250 µm diameter foam. 
Figure 5-4: Microscopy images of: a. bubbles produced using a liquid flow rate of 25 
ml/hour, and b. bubbles produced using a liquid flow rate of 45 ml/hour. The scale bar in 
both images defines a length of 250 µm. c. Microbubbles leaving the T-junction during foam 
formation, where PFP/O2 was fed from the left into the stream of liquid. 
b. a. c. 
 2 ms               4 ms               6 ms                8 ms               15 ms 
140 µm diameter 
250 µm diameter 
Figure 5-5: Relative signal amplitude over varying TE for two foam samples. 
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T2* maps for the two bubble sizes is shown in Figure 5-6. 
The relaxation properties for the two bubble sizes with the standard deviation between 
samples are shown in Table 5.6. 
 250 𝛍𝐦 diameter bubble 
foam 
140 𝛍𝐦 diameter bubble 
foam 
Surface area/volume (cm-1) 12.2 22.7 
T2* (ms) 3.3 ± 0.5 2.0 ± 0.1 
T2 (ms) 8.7 ± 1.3 10.6 ± 1.3 
T1 (ms) 12.5 ± 1.3 13.1 ± 1.5 
Table 5.6: Average (±SD) relaxation properties of the foam samples with two bubble 
diameters. 
 
A plot of foam percentage liquid content against T2* is shown in Figure 5-7. 
A physiologically representative gas:liquid ratio of 80:20 at inspiration could not be reached. 
This is due to the densest possible positioning of spheres (for example, when arranged in a 
hexagonal close packed structure, as seen in Figure 5-4) being limited filling approximately 
74% of the total volume. This density of packing is only achieved with the larger bubble 
samples. Although liquid content could be controlled to some extent, homogeneity of the 
gas:liquid ratio in a large sample could not be accurately guaranteed using this fabrication 
method, due to it requiring precise gas and liquid pressure control, and immediate 
stabilisation of the foam by adequate cooling. This fabrication method was however well 
suited to producing highly monodisperse bubble sizes in two distinct sizes on a 
physiologically representative scale. 
Figure 5-6: T2* maps of: a. ~140 µm diameter bubble 
foam and b. ~250 µm diameter bubble foam. 
140 µm diameter 250 µm diameter 
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A sample of the 250 µm diameter bubbles made with the same solution containing 30 mM 
Gadodiamide produced a PFP –CF3 T2 of 12.3 ms and T2* of 9.8 ms, a three-fold increase 
compared to the comparable foam without Gadodiamide.  
The relative signal achieved in the ~250 µm diameter bubble foam and the ~250 µm diameter 
bubble foam with 30 mM Gadodiamide is depicted in Figure 5-8.  
T2* maps of the foam samples are depicted in Figure 5-9. 
Figure 5-7: Percentage liquid measured in the surfactant and agarose phantoms plotted 
against the T2* measured from a spectroscopic FID. The markers differentiate the two 
distinct bubble sizes. 
 
 2 ms               4 ms               6 ms               8 ms               15 ms 
250 µm diameter 
250 µm diameter 
+ 30 mM 
Gadodiamide 
Figure 5-8: Relative signal amplitude over varying TE for foam samples with and without 
Gadodiamide. 
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5.4.2  In vitro measurements: polydisperse foam 
The bubble sizes produced using this technique were polydisperse; a sample was found to 
have a mean diameter of 29 ± 12 µm. A representative photomicrograph of a sample of the 
bubbles is shown in Figure 5-10 next to an image of the bulk foam.  
The average T2* (±SD), T2, and T1 relaxaion times for three samples of the polydisperse foam 
is displayed in Table 5.7.  
Figure 5-9: T2* maps of: a. ~250 µm diameter bubble foam, 
and b. ~250 µm diameter bubble foam with 30 mM 
Gadodiamide. 
250 µm diameter 250 µm diameter  + 30 mM Gadodiamide 
 a. b. 
a. b. 
Figure 5-10: a. A microscope image from a sample of PFP/O2 bubbles in an egg white 
solution. The scale bar represents a length of 250 µm. b. An image of the bulk foam. c. A 
histogram depicting the spread of bubble sizes in the polydisperse bubble sample. 
c. 
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This foam fabrication method allowed precise knowledge of the gas to liquid ratio, and a 
physiologically representative ratio was achieved in all samples. However, the bubble size 
could not be controlled, and the resultant foam produced polydisperse bubbles significantly 
smaller than the human alveolar size. There was however a macoscopically homogeneous 
dispersion of bubbles in the liquid medium. The T2* of PFP –CF3 in this foam was measured 
to be much lower than that in a magnetically homogeneous environment. Monodisperse 
bubbles were therefore not necessary to study the effect of varying the susceptibility gradient 
on T2*. 
5.4.3  Altering magnetic susceptibility of the foam liquid component 
Table 5.8 displays the magnetic susceptibility of the components of the foam. Four samples of 
Gadobutrol were measured to have an average molar magnetic susceptibility of 322 ± 14 
cm3/mol. 
Using these values, the concentration of Gadobutrol required to susceptibility match the 
solution to the PFP/O2 gas can be approximated using: 
𝐶Á¦§ = ∆𝜒Á¦ÀH©­ÀÀ¥ª 𝜒Á¦§ = 0.4 − −9 322 = 29	mM 5.1 
Foam component Magnetic susceptibility, 𝝌 
Water −9.0×10H^ 
PFP/O2 +0.37×10H^ 
Gadobutrol +322 ± 14 cm3/mol 
Table 5.8: Magnetic susceptibility of the polydisperse foam 
components. 
 Polydisperse foam 
T2* (ms) 4.0 ± 0.2 
T2 (ms) 11.6 ± 0.3 
T1 (ms) 14.3 ± 0.5 
Table 5.7: Average (±SD) relaxation properties for the 
polydisperse foam. 
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T2* maps of these five samples of polydisperse foam with varying Gadobutrol concentrations 
are depicted in Figure 5-11.  
The T2* of PFP in egg white foam samples with five different Gadobutrol concentrations 
(crosses) and eleven Gadodiamide samples (circles) are marked in Figure 5-12.  
The error bars represent the standard deviation from measurements made in three samples at 
each concentration. Repeated measurements using Gadodiamide in 5 mM concentration 
intervals showed the same pattern (circles in Figure 5-12), both reaching a maximum T2* 
 
Figure 5-12: The effect of gadolinium based contrast agent concentration on the T2* of PFP 
in polydisperse foam phantoms. The crosses represent measurements from foam containing 
Gadobutrol, with the error bars displaying the standard deviation of three samples made at 
each concentration. The circle data points display results from varying the concentration of 
Gadodiamide in smaller intervals. In this case, only one sample was made for each 
concentration. Both demonstrate good agreement with Equation 5.1. 
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Figure 5-11: T2* maps of the polydisperse foam containing Gadobutrol concentrations of 0 
mM to 60 mM. 
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when a 30 mM gadolinium concentration is utilised, in agreement with the calculated value. 
Minimal change in T1 with gadolinium concentration was noted (Figure 5-13a); with an 
average value of 15.5 ms. A change in T2 was measured (Figure 5-13b). In both cases the 
error bars depict the standard deviation of measurements made in three samples at each 
concentration.  
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Figure 5-13: T1 and T2 measurements for the polydisperse foam at a range of Gadobutrol 
concentrations. The error bars represent the SD from three samples. 
a. b. 
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5.5  Discussion 
5.5.1  Assessment of the efficacy of the lung representative phantoms 
An ideal lung-representative phantom for this research would have monodisperse bubbles that 
could be fabricated to have known varying diameters around 200 µm and an 80% gas content 
to represent the gas to tissue ratio conditions seen at maximal inspiration. The material used to 
represent the lung should have a magnetic susceptibility similar to that of lung parenchymal 
tissue, with ease of addition of paramagnetic contrast agents to allow susceptibility-matching 
studies. Neither of the foam fabrication methods met the criteria in full, but both achieved 
different aspects. The polydisperse foam phantom had a much smaller average bubble size 
than the alveoli of the human lung. However, the fabrication process allowed accurate control 
over the achieved gas to liquid ratio and capacity to efficiently alter the magnetic 
susceptibility of the liquid component. The agarose and PEG-40s phantom allowed 
production of highly monodisperse bubbles that more closely resembled alveolar size; the size 
of these monodisperse bubbles could be easily varied. Although only two bubble sizes were 
fabricated and compared in this work, further variation of the relative gas and liquid 
pressures, or utilisation of a different microfluidic chip, would allow more bubble sizes to be 
investigated. However, an unavoidable change in gas to liquid ratio occurred with changing 
diameter, with the 80% gas volume being unachievable; the achievable proportional gas 
volume ranged from 30% to 75%. A further drawback is that the slow batch fabrication 
method restricted the ability to make many samples, making it an inefficient procedure to test 
susceptibility matching. 
Detailed reference to the composition of lung-representative phantoms used for MR 
investigations in the literature is scarce. Glass beads (Hopkins and Prisk, 2010), sponge 
(Minard et al., 2005; Menke et al., 2010; Molinari et al., 2014), and porous polyethylene 
(Pavlovskaya et al., 2005) have all been utilised. These designs highlight a key limitation of 
the lung models fabricated in this chapter in that it could not be translated to hyperpolarised 
gas imaging research due to the stable conditions the gas must be kept in until immediately 
before use. Sponge and glass bead phantoms are also better suited to making phantoms on a 
larger scale than those achieved in this work. However, the phantoms developed here were 
designed with the specific aim of testing the relationship between magnetic susceptibility 
gradients and T2*, something that would have been challenging to investigate using other 
media due to limitations with sourcing standardised materials, and modifying the 
susceptibility of the materials in a controlled and quantifiable means. 
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5.5.2  Determinants of PFP –CF3 T2* 
The monodisperse and polydisperse foam produced different PFP -CF3 T2* values. The T2* 
measured in the smaller (~140 𝜇m diameter, 50-70% liquid) monodisperse bubble samples 
were comparable that measured in healthy volunteers in Chapter 2 and literature values of in 
vivo measures of PFP T2* at 2.0 - 2.2 ms (Couch et al., 2013). This demonstrates the efficacy 
of this fabrication technique to produce an alveolar-representative magnetic environment for 
MR imaging, although the gas:liquid ratio unrepresentative.  
The average T2* measured in the polydisperse foam samples was around 4 ms, greater than 
that measured in healthy volunteers. The reason for this was not determined, but may be due 
to the few larger bubbles distorting the average T2* measured from the polyexponential decay 
curve, or the magnetic susceptibility of the liquid component of the foam being less 
diamagnetic than lung tissue in practice. Alternatively, as a result of motional averaging in the 
very small pores, the PFP molecules may have experienced a more homogeneous magnetic 
field than is present, resulting in the longer T2* measured. Further investigation into T2* at 
very small pore sizes in different materials will be required to confirm the cause. The 
fabrication method used to make the polydisperse foam allowed gadolinium based contrast 
agents to be easily added in varying concentrations, and clearly identified the optimal molar 
concentration of Gadobutrol to produce susceptibility matching in the phantom, 30 mM. At 
this value, the T2* of PFP -CF3 was maximised, in good agreement with theoretical 
calculations. At higher contrast agent concentrations, the magnetic susceptibility gradient 
increased due to the foam being more paramagnetic then the PFP/O2. The single measurement 
in the surfactant and agarose phantom supported these findings, with a similar T2* being 
achieved after introduction of the 30 mM Gadodiamide. Additionally, this concentration of 
gadolinium based contrast agent was utilised in a susceptibility matching study imaging 
inhaled 3He and an injected gadolinium based contrast agent reviewed at the beginning of this 
chapter (Dimitrov et al., 2005). 
Due to the larger effect of the magnetic susceptibility gradients in the lung on the T2* of PFP -
CF3 than on hyperpolarised 3He and 129Xe, techniques to alter the magnetic susceptibility 
gradient can be expected to produce a more pronounced effect on the T2* with 19F MR 
techniques than hyperpolarised gas imaging alternatives. 
The impact of temperature on the PFP –CF3 relaxation times was not investigated, so 
repetition of the study at 37oC to represent body temperature may further alter the T1 and T2* 
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of the gas. 
Despite the limitations of each fabrication technique, both produced results that demonstrate 
shortened T2* behaviour seen in the lung, and satisfactorily confirmed the potential gain in 
T2* by susceptibility matching using Gadobutrol.  
5.5.3  Translation of findings to in vivo measurements 
In Chapter 2, a relationship between position in the respiratory cycle and average T2* of 
inhaled PFP/O2 was observed in healthy volunteers. Localised measurement of T2* in the 
human lung is predominantly limited by the breath hold duration of the subject. This is 
because multiple 3D SPGR sequences must be acquired at varying TE within a single breath 
hold to allow a T2* signal decay to be plotted at each voxel. A fast and optimised acquisition 
would be required, as developed in previous chapters. Even so, the accuracy of the T2* map is 
likely to be limited due scan duration constraints strictly limiting the number of echo time 
points collected. Collection of this data at expiration, or in patients with obstructive lung 
disease would be further limited due to the reduced comfortable breath hold duration. 
The translation of the magnetic susceptibility matching findings to in vivo studies is unlikely 
to be direct as the pulmonary vasculature provides inhomogeneous coverage of the lung tissue 
making complete susceptibility matching unattainable. It is also clearly unfeasible to 
significantly change the magnetic susceptibility of the total blood volume in human subjects. 
Therefore, an adequately fast imaging technique would be required to image a bolus of 
gadolinium move through the lung vasculature immediately after injection into venous blood 
when intravascular Gadobutrol is at its highest concentration. After the first pass through the 
lungs, the dose would be sufficiently diluted by the total blood volume that there would be 
minimal effect on the magnetic susceptibility of the blood. 
5.5.4  Potential clinical applications 
These in vitro measurements detected a change in T2* associated with pore size, reflecting the 
in vivo results seen between inspiration and expiration in Chapter 2. The pathophysiology of 
emphysema, with microstructural changes in parenchymal tissue resulting in enlarged and less 
elastic alveoli present a clear clinical application of this finding. 
Reduction of the magnetic susceptibility gradient at the alveolar walls by introduction of an 
intravenous gadolinium based contrast agent would result in a longer T2* of inhaled PFP, 
permitting acquisitions with higher SNR. Application to patient cohorts would present 
 106 
another capability of this technique; as only well-perfused lung tissue would be susceptibility 
matched, a single acquisition could display pulmonary ventilation and perfusion information 
simultaneously, with signal related to both 19F spin density, and proximity of PFP molecules 
to gadolinium imbued blood. This therefore presents a potential ventilation and perfusion 
sensitive imaging modality.
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5.6  Conclusions 
This chapter has demonstrated the utility of two novel lung-representative phantoms for 
investigating the behaviour of the MR properties of inhaled PFP. The use of a microfluidic 
chip with a detergent and agarose solution and PFP/O2 gas allowed fabrication of stable 
monodisperse foam with bubbles sizes and T2* measurements representative of that seen in 
human alveoli. It was also utilised to investigate the effect of varying pore size on PFP T2*, 
with both the bubble size and the percentage gas identified as contributory factors. 
The polydisperse foam, although structurally less representative of alveolar dimensions, 
allowed susceptibility matching to be investigated and presented a two to three-fold increase 
in T2* by addition of 30 mM of Gadobutrol or Gadodiamide. This result was in good 
agreement to the preliminary measurement made in the surfactant and agarose phantom.  
This work has presented a foundation for a novel approach for visualising pulmonary 
structure using T2* mapping of inhaled perfluoropropane. Development of a T2* mapping 
protocol that can be performed ideally within a short breath hold length acquisition time 
(which patients would be capable of performing) is required, before verification of the 
technique in both healthy volunteers and patient cohorts with emphysema. It also highlights 
the potential value of introduction of an intravenously administered gadolinium based contrast 
agent to increase the T2* of inhaled PFP in the lung to achieve higher SNR images. This has 
potential to be utilised for simultaneous identification of both poorly perfused and poorly 
ventilated regions of the lung. 
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Chapter 6: 
Dynamic Contrast-enhanced 19F MRI of Inhaled Perfluoropropane in 
Rodents and Healthy Volunteers 
6.1  Overview 
Chapter 5 defined the concentrations of Gadobutrol and Gadodiamide required to 
susceptibility match a homogeneous diamagnetic aqueous solution to the paramagnetic 
PFP/O2 gas microbubbles suspended in it. When fully susceptibility-matched, a three-fold 
increase in PFP T2* was achieved in the lung-representative phantoms. This in vitro model 
demonstrated potential utility for in vivo combined ventilation and perfusion mapping. 
The motivation for this chapter was therefore the development and translation of this 
gadolinium enhanced imaging technique to 19F-MR imaging of inhaled PFP/O2 in rodents and 
healthy volunteers. We tested the hypothesis that the local magnetic susceptibility gradients at 
the alveolar walls can be reduced by intravenous injection of a paramagnetic contrast agent, 
resulting in an increased T2* of PFP -CF3. This chapter therefore aimed to achieve full 
susceptibility matching in rodent lungs by cumulative injections of a gadolinium based 
contrast agent (GBCA) and to detect a change in magnetic properties via both T2* and SNR 
measurements before and after injection of a GBCA in both rodents and healthy volunteers. 
Translation of this susceptibility-matching concept to in vivo environments is challenging due 
to the complex structure of the lung parenchyma; the macroscopically irregular distribution of 
pulmonary vasculature proximal to the alveolar walls requires the intravenously injected 
GBCA to exchange between the intravascular and extracellular regions of the parenchyma. It 
was unfeasible to produce a phantom model to accurately replicate this biological 
environment. Therefore, although the optimum concentration of Gadobutrol for susceptibility 
matching was calculated within the phantom model to be 30 mM, a higher concentration in 
the blood would be needed to account for the extravascular tissue volume. 
Initial development studies were carried out in mouse models on a preclinical MR system. 
This allowed testing of the susceptibility-matching theory and assessment of the concentration 
of Gadobutrol required for maximal elevation of PFP T2* in an in vivo environment. 
The promising preclinical results were then translated to human studies. In healthy volunteers, 
adherence to maximum dose regulations required a single bolus of Gadobutrol to be measured 
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on its first pass through the pulmonary vasculature, after which it would be diluted across the 
full blood volume to an undetectable concentration. This necessitated fast T2*-weighted 
imaging protocols to detect change in PFP -CF3 signal before, during, and after intravenous 
administration of the contrast agent. A dynamic contrast-enhanced 19F-MRI and dynamic 19F 
unlocalised spectroscopy acquisition were performed on two healthy volunteers to observe the 
impact of a bolus of intravenous GBCA on inhaled PFP –CF3 T2* during its first pass through 
the pulmonary vasculature. 
  110 
6.2  Susceptibility matching in the lung for mapping pulmonary perfusion: background 
6.2.1  Existing modalities for imaging pulmonary perfusion 
CT pulmonary angiography and ventilation/perfusion (V/Q) scintigraphy are well-established 
techniques for mapping pulmonary perfusion in current clinical practice (Stein et al., 2004; 
Freeman and Haramati, 2009). Both provide similar diagnostic capabilities (Freeman and 
Haramati, 2009) and are economical and readily available (Johns et al., 2017). However, both 
utilise ionising radiation which is associated with increased risk of cancer, particularly for 
repeated acquisitions during long-term patient monitoring. CT pulmonary angiography alone 
offers no information about ventilation, and uses an intravenous iodinated contrast agent, 
which is associated with a 3 – 15% risk of adverse reactions, dependent on iodinated contrast-
agent type (Iyer et al., 2013). 
Innovations in MRI have presented options for perfusion imaging without using ionising 
radiation. Fourier decomposition MRI has been used to simultaneously assess ventilation and 
perfusion during free-breathing, without requiring contrast agents (Bauman et al., 2013). The 
parenchymal 1H signal varies with position in respiratory cycle, and the change in blood 
velocity in the parenchymal vasculature varies throughout the cardiac cycle, with the higher 
blood velocity associated with faster dephasing of the MR signal. Fourier decomposition 
analysis of dynamic images can separate these two signal-varying effects and produce 
separate images weighted to depict ventilation or perfusion. However, as ventilation and 
perfusion are both measured by indirect means using this technique, a highly robust 
methodology for quantitative analysis is required to be clinically valuable (Johns et al., 2017). 
1H DCE-MRI has been extensively studied on clinical cohorts as a perfusion mapping method 
(Amundsen et al., 2000; Ley and Ley-Zaporozhan, 2012; Zhang et al., 2016). It utilises T1-
weighted imaging protocols to detect a transient increase in parenchymal 1H signal during 
passage of an intravenously injected GBCA bolus. This imaging technique uses a typical 
GBCA injection dose of 0.05 - 0.1 mmol/kg body weight and acquisition sequences with 0.5 - 
1 s long dynamics.  
Comparatively, the technique developed in this chapter utilises intravenously administered 
GBCA in combination with inhaled perfluoropropane. The signal intensity of the inhaled 
imaging agent provides a direct measure of ventilation, and the GBCA provides a means for 
indirect measurement of perfusion by its T2* lengthening effect on inhaled PFP proximal to 
the GBCA, as described in the previous chapter. This technique therefore avoids ionising 
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radiation and has the potential to provide simultaneous ventilation and perfusion 
measurements. 
6.2.2  Susceptibility matching in the mouse lung 
Due to the small circulating blood volume, measured to be approximately 72 ml/kg, equating 
to ~2 ml for a 30g mouse (Diehl et al., 2001), it is possible to significantly alter the magnetic 
susceptibility of the entire blood volume by intravenous injection of Gadobutrol, something 
that would be unfeasible to do in humans. A 30 mM Gadobutrol concentration can be 
achieved in a 2 ml blood volume with a 60 µL dose of 1.0 M Gadobutrol. However, 
equilibration of the Gadobutrol with organs, as well as filtration out of the vasculature by the 
kidneys, will impede susceptibility matching, therefore a larger volume of Gadobutrol was 
used in the following in vivo study. 
A further consideration in the preclinical mouse model is the small alveolar diameter, 
measured in a number of studies to range from 34 to 68 µm depending on mouse strain, lung 
region, and whether measured at inspiration or expiration (Soutiere et al., 2004; Knust et al., 
2009; Osmanagic et al., 2010; Chang et al., 2015). Following the discussion of the 
relationship between local magnetic susceptibility gradients and T2* in previous chapters, and 
the higher field strength of the 7.0 T preclinical MR system, the T2* of inhaled 
perfluoropropane would be expected to be shorter than the 2.0 ms T2* measured in humans at 
3.0 T (Couch et al., 2013).  
6.2.3  Safety review of gadolinium based contrast agents 
Intravenously administered GBCAs have been associated with nephrogenic systemic fibrosis 
(NSF) in patients with renal impairment (Agarwal et al., 2009). More recently, evidence of 
deposition of gadolinium in the brain after injection has been published, however the clinical 
and biological significance of this is currently unknown (Gulani et al., 2017). Although rare, 
GBCAs are also known to cause allergic and adverse reactions in subjects. Recent large-scale 
studies have investigated the safety of macrocyclic GBCAs. A study of 24,308 injections of 
gadoterate maglumine at 61 institutions in Germany found a 0.4% rate of adverse events, 
most rated as minor, with just one serious adverse event reported (Herborn et al., 2007). 
38,580 injections in a single institution in Seoul recorded 31 incidences of hypersensitivity. 
Four of which were described as severe meeting the criteria for anaphylaxis (Jung et al., 
2012). Intravenously administered Gadobutrol has been the subject of a recent large multi-
centre study investigating 23,708 patients in 272 institutions across four continents, which 
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demonstrated a high tolerability by subjects and a good safety record, with a 0.7% incidence 
rate of adverse reactions and 0.02% rate of serious adverse events (Prince et al., 2017). The 
risk to healthy volunteers is therefore regarded as low when used within manufacturer 
guidelines, which permit a dose up to 0.3 mmol/kg (Bayer, 2016). This is reflected in the over 
300 million doses administered since the introduction of GBCAs 30 years ago (Runge, 2015).  
Dynamic susceptibility weighted MRI (DSC-MRI) detects areas of damage to the blood-brain 
barrier by mapping locations of decreased signal intensity caused by GBCA leakage 
following bolus injection. It has been the subject of a large number of studies which typically 
utilise GBCAs in 0.5 – 1.0 mmol/ml concentrations, at a dose of 0.1 – 0.2 mmol/kg and a high 
delivery rate of 4 – 6 ml/s (Weber et al., 2005; Jarnum et al., 2010; Korfiatis and Erickson, 
2014). The dose and delivery rate of GBCAs used in the following healthy volunteer study 
were chosen in-part to not exceed these values. 
6.2.4  Susceptibility matching in healthy volunteers 
Unlike the mouse model, alteration of the magnetic susceptibility of the full circulating blood 
volume is unfeasible in human subjects. However, a bolus of Gadobutrol can be delivered to 
the pulmonary vasculature by intravenous injection into a large vein in the forearm. Upon 
entering the right atrium, it will progress through to the right ventricle and out of the 
pulmonary artery, providing a direct route to the pulmonary vasculature with minimal 
opportunity for dilution. The concentration of the bolus delivered to the pulmonary 
vasculature would therefore be dependent upon the rate of injection and the heart rate and 
stroke volume of the subject. This method requires fast measurement of the transient change 
in susceptibility as the bolus passes through the pulmonary vasculature. 
The dose of Gadobutrol required to achieve a local bolus concentration of 30 mM in the blood 
can be calculated for a known cardiac output: 
Where cardiac output is calculated from stroke volume × heart rate. Stroke volume has been 
measured to be an average of 94 ml (Maceira et al., 2006), resulting in a typical cardiac 
output of 100 to 150 ml/s for a healthy volunteer at rest. With a dose of 0.2 mmol/kg, a 30 
mM Gadobutrol concentration can therefore typically be achieved for a period of 3-5 s bolus 
injection length. 
dose	rate(mmol s) = cardiac	output ml s ×0.03 mmol ml  6.1 
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The lung is known to have a density of 0.29 g lung tissue/ml thoracic volume, with an 
approximate fractional blood volume of 0.15 ml blood/ml thoracic volume (Wollmer et al., 
1984; Brudin et al., 1987). Therefore, the gadolinium imbued blood only changes the 
magnetic susceptibility of about half the parenchymal volume, with the tissue magnetic 
susceptibility remaining unchanged. Perfect susceptibility matching is therefore unachievable 
in humans as, unlike the mouse model, the transient bolus will not equilibrate with the 
extravascular space. Furthermore, although the path to the lung from a major vein is relatively 
direct, a small amount of unavoidable dilution is expected. Anticipating this effect, a 
concentration of Gadobutrol greater than 30 mM is likely to be required for maximal 
susceptibility matching of tissue and gas components of the lung. 
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6.3  Methods 
6.3.1  Mouse study: 19F MRI preparation 
Preclinical studies were performed under a project licence granted by the Home Office in 
accordance with the Animals (Scientific Procedures) Act of 1986. The study used four 14 
week old male mice of strain C57BL/6, with an average weight of 30 ± 2 g. An anaesthetic (a 
Hypnorm/midazolam/water mixture in a 1:1:2 volume ratio, at a dose of 10 ml/kg body 
weight) was administered by intraperitoneal injection approximately 10 minutes prior to MR 
acquisitions. The dose used permitted approximately one hour of anaesthesia. A tail vein 
cannula was placed and used to inject Gadobutrol as required. 
Once anaesthetised, the mouse was placed in a 10 cm long birdcage RF coil, tuned to the 19F 
resonant frequency at 7.0 T (280 MHz). This was positioned at the isocentre of a 7.0 T Varian 
DirectDrive horizontal bore preclinical MR scanner (Varian Medical Systems, Inc. USA). A 
diagram illustrating the layout of the primary components of the hardware used is displayed in 
Figure 6-1. 
 
Figure 6-1: Schematic of the hardware configuration for imaging inhaled PFP/O2 after 
Gadobutrol injections in a 7.0 T preclinical MR system. 
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Two tubes provided a supply of oxygen (used between MR acquisitions) or 79% PFP/ 21% 
O2 (during MR acquisitions) both at a flow rate of 0.2 L/min. A third tube carried the flow of 
gas away from the scanner suite. A sealed container with a close-fitting latex neck collar was 
placed around the mouse’s head to ensure PFP was delivered to the head, minimising 
extraneous PFP/O2 gas in the imaging FOV around the animal. Microbore tubing connected to 
the cannula from a syringe pump located in the control room allowed remote injection of 
Gadobutrol. 
Respiratory bellows and a rectal thermometer were used to monitor the mouse from the 
control room. A fan and heater positioned at the end of the magnet bore were used to maintain 
mouse body temperature at 37oC.  
6.3.2  Mouse study: acquisition protocol  
Each mouse inhaled the PFP/O2 gas for a minimum of 1 minute prior to commencing the MR 
acquisitions to ensure complete equilibrated PFP wash-in over the full lung volume for the 
duration of the scan. A non-slice selective 2D spoiled gradient echo imaging sequence with 
arrayed TE was acquired, allowing calculation of PFP T2*. The principal acquisition 
parameters used are listed in Table 6.1. 
1.0 mmol/ml Gadobutrol was then injected at a rate of 600 µL/min for 20 s, resulting in an 
injection volume of 200 µL, equivalent to 0.2 mmol. A period of 40 seconds was then allowed 
to elapse to ensure equilibration of the Gadobutrol throughout the circularity system. The 
acquisition sequence described in Table 6.1 was then repeated.  This injection and imaging 
Acquisition sequence 2D SPGR 
Flip angle 90o 
TE (ms) Array: 1.0, 1.2, 1.4, 1.6, 1.8 
TR (ms) 4.0 
Bandwidth (Hz) 50000 
FOV: H-F × L-R (mm)  50 × 50 
Acquisition matrix 64 × 64 
Number of averages 200 
Scan durations (s) 256 
Table 6.1: Acquisition parameters for a 2D spoiled gradient echo sequence 
with an TE array. This acquisition protocol was repeated after intravenous 
administration of five cumulative 0.2 mmol doses of Gadobutrol. 
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protocol was repeated a further four times, resulting in a total injected volume of 1.0 ml of 
Gadobutrol. This protocol was replicated on a further three mice. All mice remained in the 
MR scanner for less than 1 hour and were euthanised by cervical dislocation whilst still 
sedated immediately after removal from the scanner. 
Mean signal achieved was calculated from a 4 × 4 pixel ROI in the centre of the left lung. 
PFP T2* was then calculated by fitting a decaying exponential to the mean signal measured 
over the TE array. 
6.3.3  Healthy volunteer study: effect of intravenous gadolinium-based contrast agent on 
PFP T2* and signal magnitude 
Translation of the technique from an animal model to a human model required a GBCA to be 
detected via its impact on PFP -CF3 T2* as the bolus passes through the pulmonary 
vasculature. 
The healthy volunteer study received ethical approval (assessed by the Newcastle and North 
Tyneside 1 Research Ethics Committee of the NHS National Research Ethics Service. 
Reference: 14/NE/0135). Two healthy volunteers were recruited and gave informed consent 
to participate. Both were non-smokers and in good health with no history of respiratory, 
cardiac, or cerebrovascular disease. A spirometric test was carried out on each participant to 
confirm normal lung function. A respiratory clinician and MR radiographers were present 
throughout the scan sessions. 
Each volunteer was cannulated in a large superficial vein in the right forearm, which was 
connected to an MR-safe power injector loaded with 1.0 mmol/ml Gadobutrol and saline 
(0.9% NaCl). Each volunteer was then positioned supine on the scanner bed with a 20 cm 
diameter 19F surface coil (PulseTeq Ltd. – as used in Chapter 2) positioned on their upper 
back, with the top of the coil aligned with the subject’s clavicle. Whilst in the magnet bore, 
volunteers breathed through an inhalation rig as depicted in Figure 2-1, allowing control over 
the supply of room air and PFP/O2 to the subject. Participant oxygen saturation and heart rate 
were continually monitored from the MR control room via a MR-compatible pulse oximeter 
sensor on their index finger (Model 7500FO, Nonin Medical). 
An unlocalised FID spectroscopy sequence was utilised to dynamically measure change in in 
vivo signal amplitude and T2* of the PFP -CF3 resonance on volunteer 1. The principal 
acquisition parameters are listed in Table 6.2. The acquisitions had a temporal resolution of 
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0.25 s. 
 Concurrent with the start of the acquisition, the volunteer was instructed to perform three 
deep respiratory cycles of PFP/O2 through the inhalation rig, ensuring wash-in of the PFP/O2, 
as deemed adequate in Chapter 3. After the third inspiration, the volunteer performed a 30 s 
breath hold. Simultaneously with the start of the breath hold, 17 ml of 1.0 mmol/ml 
Gadobutrol (0.2 mmol/kg) was injected at a rate of 4 ml/s, immediately followed by 20 ml of 
saline at the same rate. 
After a period of 5 minutes had elapsed, allowing time for complete wash-out of PFP/O2 and 
equilibration of the Gadobutrol in the body, the dynamic 19F spectroscopy acquisition 
protocol was repeated without further administration of Gadobutrol. This allowed comparison 
of relative dynamic signal and T2* patterns with and without a paramagnetic bolus. Fitting an 
exponential decay curve to the FID at each dynamic allowed calculation of the average 19F 
T2* of PFP –CF3. 
Acquisition sequence Unlocalised spectroscopy 
Flip angle 90o block pulse 
TE (ms) 0.49 
TR (ms) 250 
Bandwidth (Hz) 8000 
Number of samples per FID 256 
Number of dynamics 350 
Scan durations (s) 88 
Table 6.2: Acquisition parameters for a dynamic unlocalised FID sequence. 
The Gadobutrol bolus was injected 20 s into the acquisition. 
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The acquisition protocol applied to volunteer 2 utilised the same hardware setup in 
conjunction with a 19F 2D spoiled gradient echo sequence. The volunteer performed three 
deep respiratory cycles of PFP/O2 followed by a 30 s breath hold at maximal inspiration. 
Upon commencing the breath hold, the imaging acquisition was started and a Gadobutrol 
bolus and saline flush were delivered following the same injection protocol as for volunteer 1. 
The principal acquisition parameters are listed in Table 6.3. 
This sequence allowed spatially resolved change in signal to be mapped across the lung 
volume within the sensitive volume of the RF coil with a 0.1 s temporal resolution. After 
acquisition, averaging was applied producing images showing 4 s dynamics.
Acquisition sequence 2D SPGR 
Flip angle 50o 
TE (ms) 1.7 
TR (ms) 4.2 
Bandwidth (Hz/pixel) 500 
FOV: H-F × L-R × A-P (mm)  300 × 300 × 200 
Acquisition matrix 24 × 24 
Number of dynamics 600 
Scan durations (s) 60 
Table 6.3: Acquisition parameters for a 2D spoiled gradient echo sequence to 
dynamically detect PFP -CF3 signal. 
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6.4  Results 
6.4.1  Mouse study: effect of intravenous Gadobutrol on T2* and signal amplitude 
The T2* of the –CF3 groups of inhaled PFP/O2 was found to vary from an average of 0.75 ± 
0.11 ms without Gadobutrol to 2.6 ± 0.4 ms after injection of 400 µL of Gadobutrol, 
corresponding to a ∆R2* of -950 s-1. The relative signal detected in TE-array SPGR 
acquisitions prior to, and following Gadobutrol administration in a representative mouse is 
displayed in Figure 6-2. 
At injected Gadobutrol concentrations above 400 µL, the T2* of PFP was found to decrease, 
representing the lung parenchyma becoming more paramagnetic than the inhaled PFP/O2, 
creating an increasing magnetic susceptibility gradient between tissue and gas compartments. 
The average 19F –CF3 T2* measured in the four mice over changing Gadobutrol volumes is 
plotted in Figure 6-3. The standard deviation of T2* measured between the mice is 
represented by the error bars. 
a. 
Figure 6-2: Relative signal intensity over a range of echo times from a. inhaled PFP/O2 before 
injection of Gadobutrol, and b. inhaled PFP/O2 after injection of a total volume of 400 µL of 
Gadobutrol. 
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The associated relative signal change over the imaging protocol due to changing T2* in a 
representative mouse at a 1.0 ms TE is depicted in Figure 6-4. In the four mice, the average 
increase in signal amplitude (±SD) between 0 µL and 400 µL Gadobutrol calculated from an 
ROI in the left (brightest) lung was 198% ± 29%. The left lung is larger in the through-plane 
direction than the right lung in this non-slice selective acquisition, reulting in it being brighter.
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Figure 6-4: Average T2* (±SD) after cumulative intravenous injections of 200 µL 
volumes of 1.0 mmol/ml Gadobutrol for four mice. 
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Figure 6-3: Relative signal change over a range of injected Gadobutrol volumes in a 
representative mouse. 
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6.4.2  Healthy volunteer study: effect of intravenous gadolinium on average T2* 
The average T2* and relative signal amplitude from the unlocalised spectroscopy sequences 
acquired on volunteer 1 are displayed in Figures 6-5 and 6-6. Figure 6-5 displays the 
acquisition sequence that utilised the Gadobutrol injection during the breath hold. The results 
show a ~5 s delay after commencement of the injection at the start of the breath hold for the 
Gadobutrol to enter the pulmonary vasculature. At this point, the T2* of the PFP –CF3 
increases from an average of 1.50 ms during the breath hold prior to the effect of Gadobutrol 
to a peak of 1.67 ms, representing an increase of 11% and ∆R2* of -68 s-1. The elevation in 
T2* lasts for 10 s, demonstrating a spread from the initial 4 s bolus injection time. 
Figure 6-6 displays the dynamic spectroscopy acquisition repeated without injection of a 
bolus of Gadobutrol. Notably, a stable T2* is present throughout the breath hold. 
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Figure 6-5: Unlocalised spectroscopy data displayed as average T2*, and signal amplitude. 
The arrow denotes the time-point at which Gadobutrol was injected, coinciding with the 
commencement of a 30 s breath hold. It is seen to transiently alter the T2* of inhaled PFP 
shortly after. 
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6.4.3  Healthy volunteer study: effect of intravenous GBCA on 19F-MRI signal amplitude 
The 2D SPGR imaging sequence allowed dynamic images to be acquired with a 0.1 s 
temporal resolution. Only partial lung coverage was achieved as these were acquired due to 
the small sensitive volume of the surface coil used. 3 second averages produced by summing 
the dynamics, and scaled to depict change in signal intensity are depicted in Figure 6-7.  
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Figure 6-6: Unlocalised spectroscopy data displayed as average T2* and signal 
amplitude. This acquisition was performed without administration of intravenous 
Gadobutrol. 
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Figure 6-7: Relative signal change over the breath hold period. Peak signal is seen at 
12-15s. 
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Figure 6-8 displays the relative signal amplitude over time from each dynamic. 
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Figure 6-8: Relative signal amplitude across the 25 second breath hold. Gadobutrol is 
injected at t = 0 s. 
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6.5  Discussion 
6.5.1  Mouse study 
The 3.5 fold increase in PFP T2* achieved in the mouse models with introduction of 
intravenous Gadobutrol is analogous to the increase in PFP T2* measured in the foam models 
reported in the previous chapter, and in a publication on susceptibility matching in rodents 
measuring hyperpolarised 3He (Vignaud et al., 2005). However, the volume of Gadobutrol 
required to achieve 30 mM in the lung parenchyma was greatly increased, despite the mouse 
blood being similar in volume to the liquid component in the foam samples produced. This is 
likely to be primarily due to equilibration of the gadolinium into extravascular extracellular 
space resulting in reduced blood concentrations, with smaller contributory factors including 
filtration of the gadolinium from the mouse through the kidneys during the relatively long 
acquisitions, and a bigger range of magnetic susceptibility gradients in the lung than those 
seen in the homogeneously distributed gadolinium in the phantom models. Further 
investigation, such as taking blood samples during the study for measurement of magnetic 
susceptibility and GBCA concentration would be required to more precisely define the 
predominant contributory factors. 
The T2* of inhaled PFP in the mouse lung was found to be much lower than that measured in 
the human lung, 1.5 – 2.0 ms (our measurements and Couch et al. (2013)). This is partly due 
to the stronger magnetic field at 7.0 T causing lower T2*, but is also in part likely due to the 
alveolar diameter of the mouse being a quarter of the human alveolar diameter (Ochs et al., 
2004; Soutiere et al., 2004; Knust et al., 2009; Osmanagic et al., 2010; Chang et al., 2015). 
This results in the mouse alveoli having a larger surface area to volume ratio, consequently 
causing the inhaled PFP to be on average in closer proximity to the magnetic field gradients at 
the alveolar surface. This effect was seen in the monodisperse foam samples of differing sizes 
fabricated in Chapter 5. 
The mouse model provided an opportunity to verify the efficacy of intravenously 
administering Gadobutrol to modify the –CF3 T2* of inhaled PFP/O2 with markedly positive 
results. However, the unrepresentative alveolar diameter and the high doses of Gadobutrol 
required prevented direct translation of these results to human studies. The results however 
are invaluable at demonstrating the potential capabilities of this technique in humans with 
further development. 
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6.5.2  Healthy volunteer study 
The 10% change in both average PFP T2* and PFP signal amplitude observed in both 
volunteers after injection of Gadobutrol supported the hypothesis. Unlike in the mouse 
studies, the change was transient, requiring a fast imaging sequence and sensitive RF coil to 
be detected. Although challenging to image, the transient nature of the signal change is 
however necessary to utilise this technique for V/Q measurements. 
The mouse model has demonstrated that higher concentrations than those used in humans are 
needed to minimise the in vivo susceptibility gradient and further increase the PFP T2*. The 
difference in ∆R2* measured between the rodent and human studies suggests that a ~14-fold 
increase in Gadobutrol concentration at the parenchyma would be required for full 
susceptibility matching in humans.  
The Gadobutrol injection periods were shorter than the ~10 s long elevated T2* observed. 
This spreading of the signal peak seen reflects dilution of the Gadobutrol with blood either 
side of the bolus. A longer injection duration combined with a higher Gadobutrol 
concentration would allow greater potential for utilisation of the signal produced, but would 
necessitate a larger dose than the 0.2 mmol/kg Gadobutrol used in this study. Manufacturer 
guidelines currently allow up to 0.3 mmol/kg of Gadobutrol, which offers some flexibility in 
increasing the dose in future studies if this can be justified from an ethical standpoint. Use of 
a more paramagnetic contrast agent could potentially offer susceptibility matching with a 
smaller dose, however commercially available substitutes such as superparamagnetic iron 
oxide are not currently marketed for human use (Wang, 2011; Wang, 2015).  
Other approaches to increase the SNR would allow utilisation of a coil with a larger field of 
view, allowing images from the full lung volume to be acquired. This will be necessary for 
the technique to have clinical utility. 
6.5.3  Application to clinical practice 
Altering the magnetic susceptibility gradient present at the air-tissue boundary in the mouse 
and human alveoli resulted in a demonstrable increase in T2* of inhaled PFP. In a healthy 
lung, it is expected that this signal change would be relatively homogeneous over the full lung 
volume, assuming that the pulmonary capillaries are relatively uniformly distributed across 
the alveoli. This would allow higher SNR images of inhaled PFP/O2 to be acquired than can 
currently be achieved. In patients where the ventilation/perfusion ratio is typically spatially 
variable, such as that seen in pulmonary embolism, a T2*-weighted 19F MRI of inhaled PFP 
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with an injected Gadobutrol contrast agent would display information related to both 
ventilation and perfusion in a single acquisition. 
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6.6  Conclusions 
Mouse studies have demonstrated a 3.5-fold increase in average PFP –CF3 T2* in the alveoli 
from 0.76 to 2.61 (∆R2* = -950 s-1) with intravenous injection of 0.4 ml of 1.0 mmol/ml 
Gadobutrol, equivalent to 13.3 mmol/kg. This result was in good agreement with similar 
measurements seen in vitro in lung-representative phantoms in the previous chapter. This 
novel method for lengthening the in vivo T2* by reduction of the local magnetic field 
gradients resulted in a two-fold increase in signal intensity for acquisitions at a TE of 1 ms. 
Translation to healthy volunteer studies resulted in a transient T2* increase of 10% (∆R2* = -
68 s-1) when administering a 0.2 mmol/kg bolus of Gadobutrol at a rate of 4 ml/s. This study 
has demonstrated the first use of susceptibility matching in the human lung to enhance 19F-
MRI of inhaled PFP, allowing improved visualisation of pulmonary structure in locations 
immediately adjacent to well-perfused pulmonary parenchyma. Therefore, this technique has 
scope to be a valuable biomarker of compromised ventilation-perfusion ratio. 
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       Chapter 7: 
Conclusions and Future Work 
This thesis details 19F-MR acquisition techniques developed to image inhaled 
perfluoropropane to provide quantitative assessment of pulmonary function. The resultant 
techniques described in this work were demonstrated in healthy volunteer studies after initial 
validation in phantom and preclinical models. The outcomes of these studies demonstrate the 
utility of MRI for imaging inhaled perfluoropropane and provide a number of opportunities 
for further development of the novel imaging techniques described. 
In Chapter 2, a preliminary 19F-MRI study of inhaled PFP/O2 in healthy volunteers 
demonstrated the capabilities of the technique; 3D images with a SNR of 40:1 proximal to the 
RF coil were produced with 1.0 cm3 spatial resolution within a 15 s acquisition time. 
Assessment of PFP wash-in and wash-out rates confirmed near-complete wash-in was 
achieved after three deep inhalations of PFP/O2. This finding guided the number of 
inspirations used in healthy volunteer studies in the subsequent chapters. A change in average 
PFP -CF3 T2* with position in the respiratory cycle was also observed, with the mean T2* 
varying between 1.3 and 1.7 ms. It was postulated that this was related to alveolar size, an 
idea further researched in phantom models in a later chapter. 
The results of the study described in this chapter also identified primary areas of focus to aid 
improvement of the imaging technique, namely the requirement of an RF coil with a larger 
sensitive volume, and an acquisition sequence optimised to achieve maximal SNR in a fixed 
acquisition time. These were addressed directly in the two following chapters. 
In Chapter 3, a quadrature birdcage torso coil was constructed to operate at 120.12 MHz at 
3.0 T with satisfactory results in phantoms, however poor power performance was noted 
under heavy loading. A larger commercial quadrature transmit/receive birdcage coil was 
assessed for suitability, and compared with three alternative RF coils. This commercial coil 
presented adequate power efficiency with loading and offered the most homogeneous signal 
amplitude within its sensitive volume compared to alternative birdcage coil configurations. 
The results of these measurements confirmed good suitability of this coil for lung imaging 
using inhaled perfluoropropane. This coil was therefore used in subsequent human studies. 
In Chapter 4, the 3D SPGR sequence was simulated to define the parameter values required to 
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achieve the highest SNR in a defined acquisition period for 19F-MRI of inhaled PFP/O2. 
These were a flip angle of 50o and a receiver bandwidth of 500 Hz/pixel, with the minimum 
allowed TE and TR, where the minimum TR was SAR-limited. It was also found that no 
potential improvement in SNR in a fixed scan time can be expected by increasing the input 
power from the RF amplifier to raise the maximum B1 amplitude, due to the longer TR 
required to stay within the SAR restrictions. This validated the suitability of the current RF 
chain configuration. A compressed sensing technique was applied to allow an up to three-fold 
acceleration of the sequence. Once implemented, 3D full-lung images with a 1 cm isotropic 
resolution were acquired. A SNR of 28:1 was achieved in a 6 s breath hold acquisition 
consisting of four averages. With this technique, improvement of the spatial resolution or 
further signal averaging could be investigated whilst maintaining breath hold length 
acquisition times. The acceleration that this technique offers also presents the opportunity to 
develop dynamic ventilation imaging techniques. This could also permit imaging during 
steady-state breathing with retrospective respiratory gating to achieve static ventilation 
images removing any necessity for the subject to conform to breathing protocols. Dynamic 
MRI of inhaled perfluoropropane therefore has potential to offer additional utility to 
hyperpolarised noble gas MRI which is ill-suited to dynamic imaging due to the non-
renewable nature of its hyperpolarisation and the expense of using large gas volumes.  
This optimised ventilation imaging protocol was primarily developed for application to a 
large-scale study to test the utility of the technique in patients and healthy volunteers. This 
study will continue over the following 3 years, during which, 40 healthy volunteers, 40 
patients with asthma and 40 patients with COPD will participate to test the utility of this 
imaging technique for quantitative assessment of pulmonary ventilation defects. This will 
involve testing the reproducibility of the inhalation protocol and the optimised and accelerated 
imaging technique in healthy volunteers before they are applied to patient cohorts. The degree 
of airway disease measured will be tested against established inhaled hyperpolarised gas MRI 
methods. This study, if successful, will be a stepping stone towards the ultimate goal of 
implementation in clinical practice. 
Chapter 5 introduced susceptibility matching as a tool to offer a modality for assessment of 
pulmonary function. Two novel lung-representative phantoms were fabricated and used to 
investigate the behaviour of the MR properties of inhaled PFP with changing structural and 
magnetic environments, with both the bubble size and the percentage gas identified as 
contributory factors to the length of the PFP -CF3 T2*. Susceptibility matching the liquid 
media with the gas-phase PFP/O2 bubble suspension by addition of 30 mM Gadobutrol or 
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Gadodiamide demonstrated an up to three-fold increase in PFP -CF3 T2*. This work 
highlighted the potential value of introduction of an intravenously administered gadolinium 
based contrast agent to increase the T2* of inhaled PFP in the lung. The novel monodisperse 
microbubble phantoms developed in this chapter would benefit from further studies to 
quantitatively assess their stability over time. If determined to be highly stable, they may 
present valuable tools in microporous media research beyond the application described in this 
thesis. 
Chapter 6 described the translation of the susceptibility matching results of Chapter 5 to in 
vivo rodent and human subjects. Intravenous injection of 0.4 ml of 1.0 mmol/ml Gadobutrol 
resulted in a 3.5-fold increase in average PFP –CF3 T2* from 0.76 to 2.61 ms in four mice. 
This result was in good agreement with similar measurements seen in vitro in lung-
representative phantoms in the previous chapter. Further in vivo studies in mouse models 
would be valuable to determine the extent of susceptibility changes in the lung tissue as well 
as in the blood. This could be achieved by taking blood or tissue samples after injection of a 
GBCA and measuring their magnetic susceptibility, thus identifying the proportion of 
susceptibility matching caused by the changing circulating blood susceptibility, and the extent 
of extravascular diffusion of the GBCA. This would inform the potential extent of 
susceptibility matching we can expect to achieve in human subjects where the injected GBCA 
bolus has minimal extravascular diffusion in the lung. 
Translation to healthy volunteer studies demonstrated a transient increase in the T2* of 
inhaled PFP of 10% after intravascular injection of a 17 ml bolus of 1.0 mmol/ml Gadobutrol 
at a rate of 4 ml/s. Using this technique, susceptibility matching of the parenchyma to the 
inhaled PFP/O2 can only occur in ventilated alveoli proximal to well-perfused regions of lung 
tissue. Therefore, this technique offers the potential to concurrently acquire images reflecting 
both pulmonary ventilation and perfusion. The novel work described in this chapter is in its 
infancy, with significant potential for future development. In order to develop this further, the 
next steps would be to make the technique viable for full lung acquisitions, requiring use of a 
larger coil. In order to maintain adequate SNR and acquisition speed, the optimised imaging 
protocol combined with the compressed sensing acceleration technique developed in Chapter 
4 could be applied. Further development would necessitate investigation into the most 
suitable paramagnetic contrast agent type, volume, and injection rate to produce the most 
pronounced transient change, before reproducibility testing the protocol in healthy volunteers.  
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